
<html lang="en"     class="pb-page"  data-request-id="334c3a00-5075-4b4d-8a66-d75c34d2015a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501501a;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor" /></meta><meta name="dc.Creator" content="Oscar M.  Bautista-Aguilera" /></meta><meta name="dc.Creator" content="Abdelouahid  Samadi" /></meta><meta name="dc.Creator" content="Mourad  Chioua" /></meta><meta name="dc.Creator" content="Katarina  Nikolic" /></meta><meta name="dc.Creator" content="Slavica  Filipic" /></meta><meta name="dc.Creator" content="Danica  Agbaba" /></meta><meta name="dc.Creator" content="Elena  Soriano" /></meta><meta name="dc.Creator" content="Lucía  de Andrés" /></meta><meta name="dc.Creator" content="María Isabel  Rodríguez-Franco" /></meta><meta name="dc.Creator" content="Stefano  Alcaro" /></meta><meta name="dc.Creator" content="Rona R.  Ramsay" /></meta><meta name="dc.Creator" content="Francesco  Ortuso" /></meta><meta name="dc.Creator" content="Matilde  Yañez" /></meta><meta name="dc.Creator" content="José  Marco-Contelles" /></meta><meta name="dc.Description" content="On the basis of N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (II, ASS234) and QSAR predictions, in this work we have designed, synthesized, and..." /></meta><meta name="Description" content="On the basis of N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (II, ASS234) and QSAR predictions, in this work we have designed, synthesized, and..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 8, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501501a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501501a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501501a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501501a" /></link>
        
    
    

<title>N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501501a" /></meta><meta property="og:title" content="N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0011.jpeg" /></meta><meta property="og:description" content="On the basis of N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (II, ASS234) and QSAR predictions, in this work we have designed, synthesized, and evaluated a number of new indole derivatives from which we have identified N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine (2, MBA236) as a new cholinesterase and monoamine oxidase dual inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501501a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501501a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501501a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501501a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501501a&amp;href=/doi/10.1021/jm501501a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10455-10463</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501313x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501521d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><i>N</i>-Methyl-<i>N</i>-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1<i>H</i>-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oscar+M.++Bautista-Aguilera">Oscar M. Bautista-Aguilera</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Abdelouahid++Samadi">Abdelouahid Samadi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mourad++Chioua">Mourad Chioua</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katarina++Nikolic">Katarina Nikolic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Slavica++Filipic">Slavica Filipic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danica++Agbaba">Danica Agbaba</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Soriano">Elena Soriano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luc%C3%ADa++de+Andr%C3%A9s">Lucía de Andrés</a></span><span class="author-xref-symbol author-aff-symbol"><sup> ∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Isabel++Rodr%C3%ADguez-Franco">María Isabel Rodríguez-Franco</a></span><span class="author-xref-symbol author-aff-symbol"><sup> ∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Alcaro">Stefano Alcaro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rona+R.++Ramsay">Rona R. Ramsay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Ortuso">Francesco Ortuso</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matilde++Ya%C3%B1ez">Matilde Yañez</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9++Marco-Contelles">José Marco-Contelles</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratorio de Química Médica, (IQOG, CSIC), Juan de la Cierva 3, E-28006 Madrid, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institute of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">SEPCO, (IQOG, CSIC), Juan de la Cierva 3, 28006 Madrid, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol"> ∥</span> <span class="aff-text">Instituto de Química Médica, (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Dipartimento di Scienze della Salute, Università “Magna Græcia” di Catanzaro, Campus “S. Venuta”, Viale Europa, 88100 Catanzaro, Italy</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Biomedical Sciences Research Complex, University of St Andrews, Biomolecular Sciences Building, North Haugh, St Andrews KY16 9ST, U.K.</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">Facultad de Farmacia, Departamento de Farmacología, Universidad de Santiago de Compostela, Campus Vida, La Coruña, 15782 Santiago de Compostela, Spain</span></div><div class="corresp-info"><strong>*</strong>For J.M.-C.: phone, +34-91-5622900; fax, +34-91-5644853; E-mail, <a href="/cdn-cgi/l/email-protection#583129373b6a69183129373f763b2b313b763d2b"><span class="__cf_email__" data-cfemail="b1d8c0ded28380f1d8c0ded69fd2c2d8d29fd4c2">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For M.Y.: phone, +34-881-815529; fax, +34-881-545595; E-mail, <a href="/cdn-cgi/l/email-protection#771a16031e1b1312590e161919120d3702161a591204"><span class="__cf_email__" data-cfemail="036e62776a6f67662d7a626d6d66794376626e2d6670">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For F.O.: phone, +39-09613694197; fax, +39 0961391490; E-mail, <a href="/cdn-cgi/l/email-protection#6a05181e1f19052a1f0403091044031e"><span class="__cf_email__" data-cfemail="09667b7d7c7a66497c67606a7327607d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501501a&amp;href=/doi/10.1021%2Fjm501501a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10455–10463</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 24, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 September 2014</li><li><span class="item_label"><b>Published</b> online</span>8 December 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 December 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501501a" title="DOI URL">https://doi.org/10.1021/jm501501a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10455%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DOscar%2BM.%2BBautista-Aguilera%252C%2BAbdelouahid%2BSamadi%252C%2BMourad%2BChioua%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D24%26contentID%3Djm501501a%26title%3DN-Methyl-N-%2528%25281-methyl-5-%25283-%25281-%25282-methylbenzyl%2529piperidin-4-yl%2529propoxy%2529-1H-indol-2-yl%2529methyl%2529prop-2-yn-1-amine%252C%2Ba%2BNew%2BCholinesterase%2Band%2BMonoamine%2BOxidase%2BDual%2BInhibitor%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10463%26publicationDate%3DDecember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501501a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1854</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">47</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501501a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Oscar&quot;,&quot;last_name&quot;:&quot;M. Bautista-Aguilera&quot;},{&quot;first_name&quot;:&quot;Abdelouahid&quot;,&quot;last_name&quot;:&quot;Samadi&quot;},{&quot;first_name&quot;:&quot;Mourad&quot;,&quot;last_name&quot;:&quot;Chioua&quot;},{&quot;first_name&quot;:&quot;Katarina&quot;,&quot;last_name&quot;:&quot;Nikolic&quot;},{&quot;first_name&quot;:&quot;Slavica&quot;,&quot;last_name&quot;:&quot;Filipic&quot;},{&quot;first_name&quot;:&quot;Danica&quot;,&quot;last_name&quot;:&quot;Agbaba&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Soriano&quot;},{&quot;first_name&quot;:&quot;Lucía&quot;,&quot;last_name&quot;:&quot;de Andrés&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Isabel Rodríguez-Franco&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Alcaro&quot;},{&quot;first_name&quot;:&quot;Rona&quot;,&quot;last_name&quot;:&quot;R. Ramsay&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Ortuso&quot;},{&quot;first_name&quot;:&quot;Matilde&quot;,&quot;last_name&quot;:&quot;Yañez&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Marco-Contelles&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;10455-10463&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501501a&quot;},&quot;abstract&quot;:&quot;On the basis of N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (II, ASS234) and QSAR predictions, in this work we have designed, synthesized, and evaluated a number of new indole derivatives from which we have identified N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine (2, MBA236) as a new cholinesterase and monoamine oxidase dual inhibitor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501501a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501501a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501501a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501501a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501501a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501501a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501501a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501501a&amp;href=/doi/10.1021/jm501501a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501501a" /></input><a href="/doi/pdf/10.1021/jm501501a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (707 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501501a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501501a%26sid%3Dliteratum%253Aachs%26pmid%3D25418133%26genre%3Darticle%26aulast%3DBautista-Aguilera%26date%3D2014%26atitle%3DN-Methyl-N-%2528%25281-methyl-5-%25283-%25281-%25282-methylbenzyl%2529piperidin-4-yl%2529propoxy%2529-1H-indol-2-yl%2529methyl%2529prop-2-yn-1-amine%252C%2Ba%2BNew%2BCholinesterase%2Band%2BMonoamine%2BOxidase%2BDual%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D24%26spage%3D10455%26epage%3D10463%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jmcmar.2014.57.issue-24/20141226/jmcmar.2014.57.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">On the basis of <i>N</i>-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1<i>H</i>-indol-2-yl)methyl)-<i>N</i>-methylprop-2-yn-1-amine (<b>II</b>, ASS234) and QSAR predictions, in this work we have designed, synthesized, and evaluated a number of new indole derivatives from which we have identified <i>N</i>-methyl-<i>N</i>-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1<i>H</i>-indol-2-yl)methyl)prop-2-yn-1-amine (<b>2</b>, MBA236) as a new cholinesterase and monoamine oxidase dual inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is an age-related neurodegenerative disorder that accounts for approximatively 70% of adult dementia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Worldwide, it is estimated that 40 million people suffer from AD, and the prevalence of AD is expected to rise significantly in the next decades, as the average age of the population increases.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> AD is characterized by a progressive memory loss and a decline in language skills and other cognitive impairments.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although the etiology of AD is not completely known, common hallmarks, such as amyloid-β (Aβ)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> deposits, τ-protein aggregation,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and oxidative stress,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> are thought to play key roles in the pathophysiology of the disease.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition, the selective loss of cholinergic neurons in AD results in a deficit of acetylcholine (ACh) in specific brain regions that mediate learning and memory.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, alterations in other neurotransmitter systems, specially serotoninergic and dopaminergic, are also thought to be responsible for the behavioral disturbances observed in AD patients.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Monoamine oxidase (MAO; EC1.4.3.4), the enzyme that catalyzes the oxidative deamination of a variety of biogenic and xenobiotic amines,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> is also an important target to be considered for the treatment of specific features of AD. MAO exists as two distinct enzymatic isoforms, MAO-A and MAO-B, based on their substrate and inhibitor specificities.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> MAO-A preferentially deaminates serotonin, adrenaline, and noradrenaline and is selectively and irreversibly inhibited by clorgyline. In contrast, MAO-B preferentially deaminates β-phenylethylamine and benzylamine and is irreversibly inhibited by <span class="smallcaps smallerCapital">l</span>-deprenyl.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Selective inhibitors for MAO-A are effective antidepressants, whereas MAO-B inhibitors are useful in the treatment of Parkinson’s disease (PD)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and might also be valuable for the treatment of AD.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In fact, MAO-B inhibitors are also currently in clinical trials for the treatment of AD because an increased level of MAO-B has been detected in the plaque-associated astrocytes of brains from AD patients.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">At present, there are three FDA-approved drugs (donepezil, galantamine, and rivastigmine)<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> that improve AD symptoms by inhibiting acetylcholinesterase (AChE; EC1.1.1.7), i.e., the enzyme responsible for the hydrolysis of ACh, and thereby raising ACh content in the synapsis. Apart from the beneficial palliative properties of AChE inhibitors in AD,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> cholinergic drugs have shown little efficacy to prevent the progression of the disease. Consequently, there is no efficient therapy to cure, stop, or even slow the progression of the disease; therefore, effective therapeutics are urgently sought and needed.</div><div class="NLM_p">The failure to find such a drug or treatment is possibly due to the multifactorial nature of AD. Thus, a single drug that acts on a specific target to produce the desired clinical effects might not be suitable for the complex nature of AD. Accondingly, the multitarget-directed ligand (MTDL) approach<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> has been the subject of increasing attention by many research groups, which have developed a variety of compounds acting on very diverse targets.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23-26)</a></div><div class="NLM_p">We have previously reported <i>N</i>-((5-(benzyloxy)-1<i>H</i>-indol-2-yl)methyl)prop-2-yn-1-amine (<b>I</b>, PF9601N)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) as a potent and selective propargylamine-containing MAO-B inhibitor (MAOBI) possessing neuroprotective properties that, unlike <span class="smallcaps smallerCapital">l</span>-deprenyl does not generate amphetamines when metabolized and possesses antiapoptotic properties.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Next we used <b>I</b> as <i>hit</i> compound with therapeutic potential for the treatment of neurodegenerative diseases and started a project targeted to finding an improved <i>lead</i> compound.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic structural and functional modifications in compounds <b>I</b> and <b>II</b> leading to the new target molecules <b>1</b>–<b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a result of this effort, we found that <i>N</i>-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1<i>H</i>-indol-2-yl)methyl)-<i>N</i>-methylprop-2-yn-1-amine (<b>II</b>, ASS234, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a multipotent drug able to inhibit human AChE (hAChE) and human butyrylcholinesterase (hBuChE), showing inhibition of human MAO-A and human MAO-B (hMAO-A, hMAO-B).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The kinetic analysis demonstrated that compound <b>II</b> is not only a reversible inhibitor of both hAChE and hBuChE with micromolar affinity but a highly potent irreversible inhibitor of hMAO-A, similarly to clorgyline.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The crystal structure of human MAO-B in complex with compound <b>II</b> highlighted the covalent adduct formed with the flavin N5 atom, which, based on the spectral changes, occurs also with the MAO-A cofactor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Hybrid <b>II</b> inhibited Aβ<sub>1–42</sub> self-aggregation more efficiently than that of Aβ<sub>1–40</sub>, limiting the formation of fibrillar and oligomeric species,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and completely blocked the aggregation mediated by AChE of both Aβ<sub>1–42</sub> and Aβ<sub>1–40</sub>. Interestingly, compound <b>II</b> significantly reduced Aβ<sub>1–42</sub>-mediated toxicity in SH-SY5Y human neuroblastoma cells and showed a significant ability to capture free-radical species in vitro as well as a potent effect in preventing the Aβ<sub>1–42</sub> induced depletion of catalase and SOD-1.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Finally, compound <b>II</b> is able to cross the blood–brain barrier in vivo.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Overall, these data indicate that hybrid <b>II</b> is the desired <i>lead</i> compound in our search for neurodegenerative diseases therapy.</div><div class="NLM_p last">On the basis of these results, we started a <i>lead compound optimization program</i>, whose results are described now in this manuscript. From this study, <i>N</i>-methyl-<i>N</i>-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1<i>H</i>-indol-2-yl)methyl)prop-2-yn-1-amine (<b>2</b>, MBA236) has emerged as a permeable, potent, irreversible, and quite selective hMAO-A inhibitor (MAOAI) in the nanomolar range, showing also moderate and almost equipotent hAChE vs hBuChE inhibition power.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design</h3><div class="NLM_p">In Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, we show the modifications in compounds <b>I</b> and <b>II</b> which have resulted into the new 19 molecules that we have synthesized. Our selection was based on QSAR analysis (see below) and simple functional changes on compounds <b>II</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and <b>I</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds <b>1</b>–<b>12</b> synthesized and designed from compound <b>II</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesized compounds <b>13</b>–<b>19</b> designed from compound <b>I</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As depicted, the <i>N</i>-benzyl motif in compound <b>II</b> has been eliminated (1) or modified incorporating different substituents in the phenyl ring, such as <i>o</i>-MeC<sub>6</sub>H<sub>5</sub>CH<sub>2</sub> (2), <i>p</i>-CNC<sub>6</sub>H<sub>5</sub>CH<sub>2</sub> (3), and <i>N</i>-[(8-<i>O</i>-methyl- or 8-<i>O</i>-(<i>N</i>,<i>N</i>′-dimethylcarbamoyl)]5-methylen]quinolone (<b>4</b> and <b>5</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Taking into account the structure, inhibition power, and selectivity of compound <b>I</b> for MAO B,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> the <i>N</i>(1)Me in compound <b>II</b> has been replaced by a <i>N</i>1(H) leading to <b>6</b>; the <i>N</i>(1)Me and (indole)C(2)CH<sub>2</sub>N(<i>Me</i>)CH<sub>2</sub>C≡CH in hybrid II has been replaced by a <i>N</i>1(H) and (indole)C(2)CH<sub>2</sub>N(<i>H</i>)CH<sub>2</sub>C≡CH in <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>); compound <b>8</b> is like <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), but the acetylene has been substituted by a vinyl group. Compounds <b>9</b> and <b>10</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) are the <i>N</i>-benzyl- and <i>N</i>-phenyl-1,2,3-triazole derivatives,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> respectively, of compound <b>II</b>. Similarly, compounds <b>11</b> and <b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) result from hybrid II by eliminating the C(2)CH<sub>2</sub>N(<i>Me</i>)CH<sub>2</sub>C≡CH side chain by CH<sub>2</sub>OH, and CO<sub>2</sub>Et,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> respectively, and in both cases we have replaced the <i>N</i>(1)Me group by <i>N</i>(1)H.</div><div class="NLM_p last">Regarding compound <b>I</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> related transformations have afforded compounds <b>13</b>–<b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Compounds <b>17</b>–<b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) are ladostigil/rasagiline-like carbamates, where we wanted to explore the known ability of compounds bearing this functional motif to inhibit ChEs.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Results from recent MAO/ChE literature, such as the substitution of an acetylene by a triazole<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> or the use of a multifunctional chelator derived from 8-hydroxyquinoline,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> have been used to design molecules <b>5</b>, <b>9</b>, <b>10</b>, <b>14</b>, and <b>15</b> (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> QSAR Analysis</h3><div class="NLM_p">The 3D-QSAR study has been carried out with main aim to explain and predict the binding on the active sites of human MAO-A, MAO-B, AChE, and BuChE enzymes based on the pharmacological activities<a onclick="showRef(event, 'ref27 ref31 ref35'); return false;" href="javascript:void(0);" class="ref ref27 ref31 ref35">(27, 31, 35)</a> previously observed for the lead-improving program work with multipotent compound <b>II</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), and the results are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Experimental and QSAR-Predicted Activities of Novel MAO/ChE Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">experimental IC<sub>50</sub> (hMAO-A)<a class="ref internalNav" href="#t1fn3" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">predicted IC<sub>50</sub> (MAO-A)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>6.3 ± 0.4</b></td><td class="colsep0 rowsep0" align="center">3.9 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">10.3 ± 0.8</td><td class="colsep0 rowsep0" align="center">218.8 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">257.6 ± 11.4</td><td class="colsep0 rowsep0" align="center">306.2 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">310.6 ± 17.1</td><td class="colsep0 rowsep0" align="center">3.2 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">630.1 ± 16.1</td><td class="colsep0 rowsep0" align="center">23.7 μM</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">experimental IC<sub>50</sub> (hMAO-B)<a class="ref internalNav" href="#t1fn3" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">predicted IC<sub>50</sub> (MAO-B)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">183.6 ± 7.4</td><td class="colsep0 rowsep0" align="center">100.7 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">164.7 ± 12.1</td><td class="colsep0 rowsep0" align="center">662.2 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">196.3 ± 7.8</td><td class="colsep0 rowsep0" align="center">38.8 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">273.1 ± 8.9</td><td class="colsep0 rowsep0" align="center">58.5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 0.5</td><td class="colsep0 rowsep0" align="center">73.1 μM</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">experimental IC<sub>50</sub> (hAChE) (μM)</th><th class="colsep0 rowsep0" align="center">predicted IC<sub>50</sub> (AChE)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center"><b>2.8 ± 0.1</b></td><td class="colsep0 rowsep0" align="center">849.2 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">8.4 ± 0.9 </td><td class="colsep0 rowsep0" align="center">3.0 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">4.0 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">10.3 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">11.1 μM</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">experimental IC<sub>50</sub> (hBuChE) (μM)</th><th class="colsep0 rowsep0" align="center" char=".">predicted IC<sub>50</sub> (BuChE) (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center"><b>4.9 ± 0.2</b></td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">5.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">14.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">202.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn3"><div class="footnote" id="t1fn3"><sup>a</sup><p class="last">After 15 min preincubation, so not directly comparable with the predicted IC<sub>50</sub> values.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Inactive at 100 μM (highest concentration tested).</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">100 μM inhibits the corresponding MAO activity by approximately 40–50%. At higher concentration the compounds precipitate.</p></div></div></div><div class="NLM_p">In the data set of previously characterized indole derivatives,<a onclick="showRef(event, 'ref27 ref31 ref35'); return false;" href="javascript:void(0);" class="ref ref27 ref31 ref35">(27, 31, 35)</a> the MAO-A pIC<sub>50</sub> activity interval spanned 4 log units (3.07–9.10); for pIC<sub>50</sub> (MAO-B), it was 5.6 log units (4.00–10.60), for pIC<sub>50</sub> (AChE) 4.2 log units (4.00–8.17), and pIC<sub>50</sub> (BuChE) 3.4 log units (4.00–7.44). The relatively wide pIC<sub>50</sub> interval of the training set provide broad applicability domain for the 3D-QSAR models created. The 3D-QSAR (MAO A) model with two significant components (<i>A</i> = 2): <i>R</i><sup>2</sup>, 0.94; leave-one-out cross validation <i>Q</i><sup>2</sup>, 0.66; training set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.908; and RMSEE, 0.433), and test set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.809; and RMSEP, 0.617), was developed. The 3D-QSAR (MAO B) model with two significant components (<i>A</i> = 2): <i>R</i><sup>2</sup>, 0.97; leave-one-out cross validation <i>Q</i><sup>2</sup>, 0.85; training set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.957; and RMSEE, 0.303), and Test set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.787; and RMSEP, 0.598) was formed. Similarly, the 3D-QSAR (AChE) model with three significant components (<i>A</i> = 3): <i>R</i><sup>2</sup>, 0.87; leave-one-out cross validation <i>Q</i><sup>2</sup>, 0.61, training set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.873; and RMSEE, 0.431), and test set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.539; and RMSEP, 0.661) was developed. The 3D-QSAR (BuChE) model with two significant components (<i>A</i> = 2): <i>R</i><sup>2</sup>, 0.92; leave-one-out cross validation <i>Q</i><sup>2</sup>, 0.72; training set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.922; and RMSEE, 0.261), and test set parameters (<i>R</i><sup>2</sup><sub>Observed vs Predicted</sub>, 0.657; and RMSEP, 0.521) was created.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">The statistical parameters indicated that the 3D-QSAR (MAO-A, MAO-B, AChE, BuChE) models could be used for prediction of MAO-A, MAO-B, AChE, and BuChE inhibiting activities for novel analogues of compounds <b>I</b> and <b>II</b>. Reliability of the activities predictions is strongly related to the type and extent of structural changes of the lead compounds.</div><div class="NLM_p">3D-pharmacophores are derived from 3D maps of interaction energies between the examined molecule and four chemical probes: DRY (which represent hydrophobic interactions), O (sp<sup>2</sup> carbonyl oxygen, representing H-bond acceptor), N1 (neutral flat NH, like in amide, H-bond donor), and the TIP probe (molecular shape descriptor). The 3D pharmacophores for MAO-A and MAO-B inhibiting activities of compound <b>II</b> contain crucial favorable O-TIP/O–DRY/TIP-TIP/DRY-TIP interactions to the propargylamine moiety and to the benzyl group. Therefore, substitution of the benzyl moiety of hybrid <b>II</b> with small groups, such as an <i>o</i>-Me in <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), could enhance the MAO-A and MAO-B inhibiting activity of the examined compounds by facilitating the TIP-TIP/DRY-TIP favorable interactions. The 3D-QSAR study confirmed also previous experimental findings that the propargylamine moiety provides an essential positive influence on the MAO-A and MAO-B inhibiting activity.<a onclick="showRef(event, 'ref35 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref35 ref38 ref39">(35, 38, 39)</a></div><div class="NLM_p">The 3D-pharmacophores for BuChE inhibiting activities of <i>lead</i> compound <b>II</b> contain specific unfavorable TIP-TIP/DRY-TIP interactions between the indole and the <i>para</i> position of the benzyl moieties. Therefore, substitution with bulky substituent at <i>para</i> position of the benzyl moiety, such as a cyano group in <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), could decrease BuChE inhibiting activity of compound <b>II</b> derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The 3D-pharmacophores for AChE inhibiting activities of compound <b>II</b> contain a crucial favorable O–O interaction to the piperidine ring and to <i>ortho</i> positions of the benzyl group. Thus, a small substituent at <i>ortho</i> position of the benzyl ring, such as the methyl group in compound <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), could enhance AChE inhibiting activity of <i>lead</i> compound <b>II</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">In addition to <b>2</b>, compounds <b>4</b>, <b>3</b>, <b>13</b>, and <b>14</b> have also been investigated by QSAR analysis, and their predicted IC<sub>50</sub> values are also shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The predicted IC<sub>50</sub> values clearly suggest that (a) compound <b>II</b>-donepezil type hybrids <b>2</b>, <b>4</b>, and <b>5</b>, in this order, should be the most potent MAO-AI;, (b) the compound <b>I</b>-like derivative <b>14</b> should be a more potent inhibitor of MAO-A, AChE, and BuChE than <b>13</b>, and (c) <b>2</b> should be the most potent inhibitor against all four enzymes.</div><div class="NLM_p last">Next, the designed compound <b>II</b> analogues were synthesized and examined for MAO/ChE inhibitory activity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p last">The synthesis of the new molecules (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) has been achieved by standard or reported methods, in very efficient and short synthetic sequences, in good overall yields (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). All new molecules gave satisfactory analytical and spectroscopic data, in good agreement with their structures.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Evaluation</h3><div class="NLM_p">The biological evaluation, comprising the hMAO-A/hMAO-B and hAChE/hBuChE inhibition, has been carried out according to the protocols described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, following the usual methods.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> In <a class="ref internalNav" href="#notes-1" aria-label="Table 1S (Supporting Information)">Table 1S (Supporting Information)</a>, we have shown the IC<sub>50</sub> values for the inhibition of the MAOs and ChEs with all the 19 new compounds, using compounds <b>I</b> and <b>II</b>, reanalyzed in this work<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> as reference compounds. The established MAOI, clorgyline and <span class="smallcaps smallerCapital">l</span>-deprenyl, and the ChEI, donepezil, are also reported for comparative purposes. Note that only seven compounds, <b>2</b>, <b>5</b>–<b>8</b>, <b>11</b>, and <b>12</b>, were active simultaneously in the four enzymes (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). As shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table 1S">Supporting Information, Table 1S</a>, compound <b>6</b> is a moderate hMAO-AI and hBuChEI, in the high micromolar range, but shows very modest hMAO-B and hAChE inhibition power. <b>12</b> is almost equipotent with <b>6</b> for the hMAO-A and hAChE inhibition, but 2.6-fold more, and 4.4-fold less potent than 6, for the inhibition of hMAO-B and hBuChE, respectively. <b>7</b> is a poor hMAO-AI and hMAO-BI, but a moderate hAChEI and BuChEI, in the micromolar range. <b>8</b> is a quite poor hMAO-AI, hMAO-BI, and hBuChEI but a modest hAChEI. Furthermore, <b>5</b> and <b>11</b> were nonselective, potent hMAOI in the low micromolar range, but moderate and equipotent ChE inhibitors.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for the Inhibitory Effects of Test Compounds on the Enzymatic Activity for Human MAO or ChE Isoforms and Selectivity Ratios for MAO-B [IC<sub>50</sub> (MAO-A)]/[IC<sub>50</sub> (MAO-B)] or for AChE ([IC<sub>50</sub> (AChE)]/[IC<sub>50</sub> (BuChE)]<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0010.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hMAO-A</th><th class="colsep0 rowsep0" align="center">hMAO-B</th><th class="colsep0 rowsep0" align="center">ratio</th><th class="colsep0 rowsep0" align="center">hAChE (μM)</th><th class="colsep0 rowsep0" align="center">hBuChE (μM)</th><th class="colsep0 rowsep0" align="center" char=".">ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center"><b>6.3 ± 0.4 nM</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center"><b>183.6 ± 7.4</b> nM</td><td class="colsep0 rowsep0" align="center"><b>0.03</b></td><td class="colsep0 rowsep0" align="center"><b>2.8 ± 0.1</b></td><td class="colsep0 rowsep0" align="center"><b>4.9 ± 0.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>0.57</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5</b></td><td class="colsep0 rowsep0" align="center">257.6 ± 11.4 nM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">196.3 ± 7.8 nM</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="center">8.4 ± 0.9</td><td class="colsep0 rowsep0" align="center">5.9 ± 0.4 </td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6</b></td><td class="colsep0 rowsep0" align="center">9.1 ± 0.7 μM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">35.1 ± 2.8 μM</td><td class="colsep0 rowsep0" align="center">0.26</td><td class="colsep0 rowsep0" align="center">15.4 ± 0.9</td><td class="colsep0 rowsep0" align="center">7.1 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7</b></td><td class="colsep0 rowsep0" align="center">19.2 ± 1.3 μM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">33.6 ± 1.5 μM</td><td class="colsep0 rowsep0" align="center">0.57</td><td class="colsep0 rowsep0" align="center">4.9 ± 0.3</td><td class="colsep0 rowsep0" align="center">7.3 ± 0.8</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>8</b></td><td class="colsep0 rowsep0" align="center">45.3 ± 1.6 μM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">21.3 ± 1.9 μM</td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">4.6 ± 0.3</td><td class="colsep0 rowsep0" align="center">40.6 ± 2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>11</b></td><td class="colsep0 rowsep0" align="center">876.6 ± 25.2 nM</td><td class="colsep0 rowsep0" align="center">1.0 ± 0.02 μM</td><td class="colsep0 rowsep0" align="center">0.87</td><td class="colsep0 rowsep0" align="center">9.6 ± 0.08</td><td class="colsep0 rowsep0" align="center">9.7 ± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>12</b></td><td class="colsep0 rowsep0" align="center">9.1 ± 0.3 μM</td><td class="colsep0 rowsep0" align="center">13.5 ± 1.1 μM</td><td class="colsep0 rowsep0" align="center">0.67</td><td class="colsep0 rowsep0" align="center">13.6 ± 1.4</td><td class="colsep0 rowsep0" align="center">31.2 ± 3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>II</b></td><td class="colsep0 rowsep0" align="center">58.2 ± 1.2 nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1.2 ± 0.1 μM</td><td class="colsep0 rowsep0" align="center">0.05</td><td class="colsep0 rowsep0" align="center">3.4 ± 0.2</td><td class="colsep0 rowsep0" align="center">3.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>I</b></td><td class="colsep0 rowsep0" align="center">287.3 ± 11.2 nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">4.1 ± 0.7 nM</td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">clorgyline</td><td class="colsep0 rowsep0" align="center">4.7 ± 0.2 nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">65.8 ± 1.6 μM</td><td class="colsep0 rowsep0" align="center">0.000071</td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><span class="smallcaps smallerCapital">l</span>-deprenyl</td><td class="colsep0 rowsep0" align="center">63.6 ± 1.3 μM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">18.2 ± 0.9 nM</td><td class="colsep0 rowsep0" align="center">3494</td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">donepezil<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">0.016 ± 0.001</td><td class="colsep0 rowsep0" align="center">8.2 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> values shown in this table are the mean ± SD from five experiments. <b>hMAO</b>: IC<sub>50</sub> values were determined after 15 min preincubation of inhibitor with the enzyme. <b>hChE</b>: IC<sub>50</sub> values were determined after 10 min preincubation of inhibitor with the enzyme. Level of statistical significance:</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last"><i>P</i> < 0.01 or</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last"><i>P</i> < 0.05 versus the corresponding IC<sub>50</sub> values obtained against MAO-B, as determined by ANOVA/Dunnett’s.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Reference <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Inactive at 100 μM (highest concentration tested). nd = not determined.</p></div></div></div><div class="NLM_p">However, among all these products, as predicted by the QSAR analysis (see above), compound <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was the most potent hMAO-A, hMAO-B AChE, and BuChE multipotent inhibitor found in this work. Compound <b>2</b> is a very potent, in the nanomoloar range, and selective hMAO-AI (<i>K</i><sub>i</sub> = 7.5 ± 0.9 nM), showing a potent and slightly selective hAChE inhibition profile (<i>K</i><sub>i</sub> = 1.3 ± 0.5 μM), in the micromolar range. Compared with the reference compound <b>II</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), the new compound <b>2</b> is 9.2-fold and 6.5-fold more potent hMAO-AI and hMAO-BI, respectively, 1.2-fold more potent hAChEI, and only 1.5-fold less potent hBuChEI. Comparing with compound <b>I</b> and the standard MAOIs, for the inhibition of MAO-A, compound <b>2</b> is 45-fold more potent than compound <b>I</b>, 1.3-fold less than clorgyline, and 10095-fold more potent than <span class="smallcaps smallerCapital">l</span>-deprenyl. Conversely, for the inhibition of MAO-B, compound <b>2</b> is 45-fold less, 358-fold more, and 10-fold less potent than compound <b>I</b>, clorgyline, and <span class="smallcaps smallerCapital">l</span>-deprenyl, respectively.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of compound <b>2</b> and its IC<sub>50</sub> values for the inhibition of MAO and ChEs compared with the reference compound <b>II</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To sum up, compound <b>2</b> is a multipotent molecule of MAO and ChE, showing a very attractive pharmacological profile, as a selective and very potent MAO-AI, with high MAO-B and potent hAChE/hBuChE inhibition power. It must be also concluded that all our present and past efforts<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> to transform compound <b>I</b> into a multipotent MAO/ChE compound, by transforming the benzyl group into the ChE donepezil-like pharmacophore, have met with success but at the cost of loosing significant MAO-B inhibition capacity.</div><div class="NLM_p">Taking into account these findings, we have performed further studies on the inhibition mechanism of action of compound <b>2</b>.</div><div class="NLM_p">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> show the results of the reversibility test<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> on hMAO. Compound <b>2</b> binds as an irreversible inhibitor on both enzyme isoforms, maintaining near a 90% inhibition after the dilution of the preincubated mixture. The IC<sub>50</sub> decreased from 14.6 ± 1.2 nM in reversible conditions (no preincubation and substrate concentration 2 × <i>K</i><sub>m</sub>) to 6.3 ± 0.4 nM assayed with saturating substrate after a 15 min incubation.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Recovery of hMAO-A activity after dilution following incubation (30 min at room temperature) of the 100× enzyme concentration with 10-fold IC<sub>50</sub> concentration of compound <b>2</b> or clorgyline. The control was carried out by preincubating in the absence of inhibitor and diluting in the same way. Results are expressed as percentage of control. Represented data are mean ± SD of five independent assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Recovery of hMAO-B activity after dilution following incubation (30 min at room temperature) of the 100× enzyme concentration with 10-fold IC<sub>50</sub> concentration of compound <b>2</b> or <span class="smallcaps smallerCapital">l</span>-deprenyl. The control was carried out by preincubating in the absence of inhibitor and diluting in the same way. Results are expressed as percentage of control. Represented data are mean ± SD of five independent assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nevertheless, the recovery of ChE activity after compound <b>2</b> on ChEs was significantly greater (around 20%), allowing us to classify it as a slow inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Kinetic assays performed with this compound have shown ambiguous results, probably due to the low degree of reversibility of inhibition achieved on hAChE and hBuChE. As a result of the low reversibility, the pattern of the Lineweaver–Burk representation appears to indicate a mixed model for both enzymes (results not shown).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Recovery of hAChE (gray column) and hBuChE (black column) activity after the dilution of the incubation (30 min at room temperature) of the 100× enzyme concentration and 10-fold IC<sub>50</sub> of compound <b>2</b>. The control was carried out by preincubating in the absence of inhibitor and diluting in the same way. Results are expressed as percentage of control. Represented data are mean ± SD of five independent assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the aim of investigating compound <b>2</b> recognition with respect to either MAO-A, MAO-B, AChE, and BuChE enzymes, molecular modeling studies have been carried out. The theoretical investigation has been focused on the ligand–enzyme interaction and target structural perturbation produced by compound <b>2</b> comparing these information with respect to the same data coming from the related compound <b>II</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Only one proposed structure was found for compound <b>2</b> in hMAO-A and two for hMAO-B, with a global miminum population equal to 96.11%. Compounds <b>II</b> and <b>2</b> both adopted bent conformations in hMAO-A but were linear in hMAO–B (<a class="ref internalNav" href="#notes-1" aria-label="Figure S1, Supporting Information">Figure S1, Supporting Information</a>). Overall, the interactions between compounds <b>II</b>, <b>2</b>, and the MAOs are driven by both steric hindrance and hydrophobic contribution with an additional electrostatic term present in hMAO-A. Using the target RMSd matrix, each MD trajectory was clustered into nine groups. The visual inspection of the 10 structures for each inhibitor with each enzyme clearly indicates the conformation stabilizing effect of the <i>o</i>-methyl group in hybrid <b>2</b> (<a class="ref internalNav" href="#notes-1" aria-label="Figure S4, Supporting Information">Figure S4, Supporting Information</a>).</div><div class="NLM_p">In this work, we have designed a new and multipotent MAOI. MAOI are well-known for showing diverse therapeutic potential as the result of combining selectivity and (ir)reversible modes of binding.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> MAO-AI have been used mostly in the treatment of depression and anxiety,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and MAO-BI for the treatment of PD.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Recent studies have shown that MAO-A is involved in the regulation of serotonin for ventricular remodeling via activation of the serotonin2A receptors.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In the aged heart, the increased MAO-A concentrations results in high levels of oxygen peroxide, leading to severe cardiomyocyte damage.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> A survey of the current literature on MAOIs shows also that one of the major reasons for designing new and specific inhibitors is to function as cardioprotectants for the age-dependent increase of MAO A in the heart.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Although MAO-AIs enhance extracellular levels of dopamine produced from L-dopa, irreversible and selective MAO-AI cannot be used in the PD therapy because of cardiovascular side effects.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Another disadvantage of an irreversible MAO-AI is the hypertensive “cheese effect”<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> due to the predominance of MAO-A in the gut wall to metabolize tyramine in fermented foods such as cheese and beer. Hypertensive crises may be prevented by using reversible rather than irreversible MAO-AI or tissue-specific inhibitors such as the brain-selective ladostigil.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p">The cases of ladostigil<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and M30D<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) are of interest for this project and future possible endeavors because both are ChE, MAO-A, and MAO-B irreversible inhibitors with potential therapeutic applications as antidepressants, antiparkinson, and anti-Alzheimer drugs.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Ladostigil<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) was designed from rasagiline, a MAO-BI, bearing a propargylamine motif, responsible for the neuroprotective properties, and a carbamate group, affording ChE inhibitory activity. M30D<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) shows an inhibitory profile against ChE (hAChE IC<sub>50</sub> = 0.52 ± 0.07 μM; hBuChE IC<sub>50</sub> = 44.90 ± 6.10 μM) and against MAO (ratMAO-A, IC<sub>50</sub> = 0.0077 ± 0.0007 μM; ratMAO-B, IC<sub>50</sub> = 7.90 ± 1.34 μM) very similar to the one observed for <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), as well as other properties as potential drugs for treating AD.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of ladostigil and M30D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro Blood–Brain Barrier Permeation Assay</h3><div class="NLM_p">Finally, to evaluate the brain penetration, we used the PAMPA–BBB method described by Di,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and subsequently optimized by Rodríguez-Franco et al. for molecules with limited water-solubility.<a onclick="showRef(event, 'ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57">(55-57)</a></div><div class="NLM_p last">The in vitro permeability (<i>P</i><sub>e</sub>) value of compound <b>2</b> through a lipid extract of porcine brain was determined by using PBS:ethanol (70:30). In the same assay, 11 commercial drugs of known CNS penetration were also tested and their experimental values were compared to reported values, giving a good lineal correlation, <i>P</i><sub>e</sub> (exp) = 1.4442 <i>P</i><sub>e</sub> (bibl) + 6.5263 (<i>R</i><sup>2</sup> = 0.95). From this equation and taking account the limits established by Di for BBB permeation,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> we found that compounds with permeability values above 12.3 × 10<sup>–6</sup> cm s<sup>–1</sup> could penetrate into the CNS. Derivative <b>2</b> showed <i>P</i><sub>e</sub> = 14.4 ± 0.4 × 10<sup>–6</sup> cm s<sup>–1</sup>, and thus, it could cross BBB by passive diffusion (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this paper, we have reported the design, synthesis, and biological evaluation of 19 new donepezil–indolyl hybrids as multifunctional drugs able to bind MAO and ChE enzymes, using the MAO B inhibitor <b>I</b> hit and the multipotent <b>II</b> hybrid lead as references for lead-optimization in order to discover a new lead compound for deeper in vivo preclinical investigations targeted to neurological disorders. The QSAR-designed compound <b>II</b> analogues have been synthesized and examined for MAO/ChE inhibitory activity. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, the potent MAO/ChE inhibiting activity for the novel ligand <b>2</b> confirmed the quality of the optimized 3D-pharmacophores for use in future work to design novel donepezil–indolyl hybrids. We have found significant biological activity on the four enzymes studied in almost half of the synthesized structures. The most promising compound of the series, <b>2</b>, acted as an irreversible hMAO-AI, potent in the nanomolar range, nine times more potent than the reference compound <b>II</b>, and 29-fold more selective for hMAO-A over hMAO-B. Inhibition of the ChEs by hybrid <b>2</b> is in the micromolar range, slightly better than compound <b>II</b> for hAChEs although slightly poorer for hBuChE. Although we are confronted with unbalanced, highly preferred MAO vs ChE inhibition, the potency and desired balance between targets in MTDL-based strategies is not known.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Molecular modeling studies<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> reported similar binding modes of compounds <b>II</b> and <b>2</b> in all the evaluated biological targets. The <i>o</i>-Me group in compound <b>2</b> improves the ligand recognition, increasing the ligand–enzyme hydrophobic interaction in hBuChE and π–π stacking in hMAO-A, hMAO-B, and hAChE. Thus, it is clear that simple modification of compound <b>II</b>, such as the incorporation of an <i>o</i>-methyl instead of a hydrogen in the phenyl ring of the <i>N</i>-benzylpiperidine motif, produces significant qualitative and quantitative pharmacological changes in the inhibition of MAO and ChE enzymes. Finally, the ADMET virtual analysis<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> suggests that inhibitor <b>2</b> should present good drug-like characteristics similar to compound <b>II</b>, with a slightly better brain penetration ability, a prediction experimentally confirmed by the in vitro blood–brain barrier permeation assay.</div><div class="NLM_p last">Consequently, we have fulfilled our initial expectations, that a new, easily available, permeable multipotent MAO inhibitor has been discovered. The related pharmacological properties with ladostigil, clearly support projected in vivo studies for proof of concept targeted to probe the suitability of compounds <b>2</b> and <b>II</b> to treat neurodegeneratives disorders such AD or PD.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11"><a href="/doi/suppl/10.1021/jm501501a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">QSAR methods, ADMET analysis and descriptors, the synthesis of the target compounds, the <sup>1</sup>H and <sup>13</sup>C spectra, biological evaluation, molecular modeling, and in vitro blood–brain barrier permeation assay of compound <b>2</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501501a/suppl_file/jm501501a_si_001.pdf">jm501501a_si_001.pdf (11.37 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501501a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Ortuso</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze della Salute, Università
“Magna Græcia” di Catanzaro, Campus “S. Venuta”, Viale Europa, 88100 Catanzaro, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f7988583828498b782999e948dd99e83"><span class="__cf_email__" data-cfemail="3f504d4b4a4c507f4a51565c4511564b">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matilde Yañez</span> - <span class="hlFld-Affiliation affiliation">Facultad
de Farmacia, Departamento de Farmacología, Universidad de Santiago de Compostela, Campus Vida, La Coruña, 15782 Santiago de Compostela, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b2dfd3c6dbded6d79ccbd3dcdcd7c8f2c7d3df9cd7c1"><span class="__cf_email__" data-cfemail="dcb1bda8b5b0b8b9f2a5bdb2b2b9a69ca9bdb1f2b9af">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Marco-Contelles</span> - <span class="hlFld-Affiliation affiliation">Laboratorio
de Química Médica, (IQOG,
CSIC), Juan de la Cierva
3, E-28006 Madrid, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#791008161a4b48391008161e571a0a101a571c0a"><span class="__cf_email__" data-cfemail="127b637d712023527b637d753c71617b713c7761">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oscar M. Bautista-Aguilera</span> - <span class="hlFld-Affiliation affiliation">Laboratorio
de Química Médica, (IQOG,
CSIC), Juan de la Cierva
3, E-28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdelouahid Samadi</span> - <span class="hlFld-Affiliation affiliation">Laboratorio
de Química Médica, (IQOG,
CSIC), Juan de la Cierva
3, E-28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mourad Chioua</span> - <span class="hlFld-Affiliation affiliation">Laboratorio
de Química Médica, (IQOG,
CSIC), Juan de la Cierva
3, E-28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katarina Nikolic</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Slavica Filipic</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danica Agbaba</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Soriano</span> - <span class="hlFld-Affiliation affiliation">SEPCO, (IQOG, CSIC), Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucía de Andrés</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Isabel Rodríguez-Franco</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Alcaro</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze della Salute, Università
“Magna Græcia” di Catanzaro, Campus “S. Venuta”, Viale Europa, 88100 Catanzaro, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rona R. Ramsay</span> - <span class="hlFld-Affiliation affiliation">Biomedical
Sciences Research Complex, University of
St Andrews, Biomolecular
Sciences Building, North Haugh, St Andrews KY16 9ST, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>O.M.B.A. carried out the synthesis of the target molecules. O.M.B.A., M.C., and A.S. carried out the spectroscopic analyses. K.N., S.F., and D.A. carried out the QSAR predictions. M.Y. undertook the enzyme inhibition and mechanistic studies. E.S. did the ADMET-analysis. F.O. and S.A. carried out the computational studies. L.d.A. did the PAMPA–BBB experiment, under M.I.R.-F. supervision. R.R.R. evaluated the data and contributed to writing the manuscript. J.M.-C. conceived, designed, and supervised the project.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1582e2560-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">J.M.-C. thanks MINECO (Spain) for grant SAF2012-33304, and Universidad Camilo José Cela (Madrid, Spain) for support (MULTIMOL 2013-20). Oscar Mauricio Bautista-Aguilera thanks MINECO for a FPI fellowship. This work was supported by the COST action CM1103. D.A., K.N., and S.F. acknowledge COST action CM1207 and the project (contract no. 172033) supported by the Ministry of Education and Science of the Republic of Serbia. M.I.R.-F. acknowledges the financial support from the Spanish Ministry of Economy and Competitiveness (SAF2012-31035), CSIC (PIE-201280E074), and Fundación de Investigación Médica Mutua Madrileña Automovilística (AP103952012).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i14" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i14"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i15" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i15"> Abbreviations Used</h2><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChEI</td><td class="NLM_def"><p class="first last">acetylcholinesterase inhibitors</p></td></tr><tr><td class="NLM_term">hAChE</td><td class="NLM_def"><p class="first last">human acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, toxicity</p></td></tr><tr><td class="NLM_term">hBuChE</td><td class="NLM_def"><p class="first last">human butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human <i>ether-à-go-go</i>-related gene</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase-A/B</p></td></tr><tr><td class="NLM_term">MAOI</td><td class="NLM_def"><p class="first last">monoamine oxidase inhibitors</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multi-target-directed ligand</p></td></tr><tr><td class="NLM_term">PAMPA–BBB</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay/blood–brain barrier</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationships</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolston, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Alzheimer disease</span> <span class="citation_source-journal">Dis. Month</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.disamonth.2010.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=20831921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADC%252BC3cfhslyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=484-546&author=R.+J.+Castellaniauthor=R.+K.+Rolstonauthor=M.+A.+Smith&title=Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease</span></div><div class="casAuthors">Castellani Rudy J; Rolston Raj K; Smith Mark A</div><div class="citationInfo"><span class="NLM_cas:title">Disease-a-month : DM</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">484-546</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmW_WC2z8qAq69lAbTj9rGfW6udTcc2ebxaMfEiAOUi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfhslyhtw%253D%253D&md5=d754a0efd3421622cd05985364c70c59</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.disamonth.2010.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.disamonth.2010.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DRolston%26aufirst%3DR.%2BK.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DAlzheimer%2520disease%26jtitle%3DDis.%2520Month%26date%3D2010%26volume%3D56%26spage%3D484%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Reitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, R.</span><span> </span><span class="NLM_article-title">Epidemiology of Alzheimer disease</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fnrneurol.2011.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADC%252BC3M3kvF2jtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=137-152&author=C.+Reitzauthor=C.+Brayneauthor=R.+Mayeux&title=Epidemiology+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of Alzheimer disease</span></div><div class="casAuthors">Reitz Christiane; Brayne Carol; Mayeux Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The global prevalence of dementia is estimated to be as high as 24 million, and is predicted to double every 20 years through to 2040, leading to a costly burden of disease.  Alzheimer disease (AD) is the leading cause of dementia and is characterized by a progressive decline in cognitive function, which typically begins with deterioration in memory.  Before death, individuals with this disorder have usually become dependent on caregivers.  The neuropathological hallmarks of the AD brain are diffuse and neuritic extracellular amyloid plaques-which are frequently surrounded by dystrophic neurites-and intracellular neurofibrillary tangles.  These hallmark pathologies are often accompanied by the presence of reactive microgliosis and the loss of neurons, white matter and synapses.  The etiological mechanisms underlying the neuropathological changes in AD remain unclear, but are probably affected by both environmental and genetic factors.  Here, we provide an overview of the criteria used in the diagnosis of AD, highlighting how this disease is related to, but distinct from, normal aging.  We also summarize current information relating to AD prevalence, incidence and risk factors, and review the biomarkers that may be used for risk assessment and in diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDDnLJun7qK8yail4HZd-ifW6udTcc2ebxaMfEiAOUi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3kvF2jtQ%253D%253D&md5=10ec5b1c3f8cf52b5346896d3402fb37</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2011.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2011.2%26sid%3Dliteratum%253Aachs%26aulast%3DReitz%26aufirst%3DC.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DR.%26atitle%3DEpidemiology%2520of%2520Alzheimer%2520disease%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2011%26volume%3D7%26spage%3D137%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Terry, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonatas, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span> </span><span class="NLM_article-title">Ultrastructural studies in Alzheimer’s presenile dementia</span> <span class="citation_source-journal">Ann. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADyaF2c%252Fns12jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1964&pages=269-297&author=R.+D.+Terryauthor=N.+K.+Gonatasauthor=M.+Weiss&title=Ultrastructural+studies+in+Alzheimer%E2%80%99s+presenile+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S  PRESENILE DEMENTIA</span></div><div class="casAuthors">TERRY R D; GONATAS N K; WEISS M</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">269-97</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSclvTAJVh4qWZyxfu64m4ffW6udTcc2ebrI4dMRo97fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252Fns12jsQ%253D%253D&md5=cdcaf9fad0ceb4338cad717b01fb79f7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DR.%2BD.%26aulast%3DGonatas%26aufirst%3DN.%2BK.%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DUltrastructural%2520studies%2520in%2520Alzheimer%25E2%2580%2599s%2520presenile%2520dementia%26jtitle%3DAnn.%2520J.%2520Pathol.%26date%3D1964%26volume%3D44%26spage%3D269%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L.I.</span><span> </span><span class="NLM_article-title">Abnormal phosphorylation of the microtubule-associated protein t (tau) in Alzheimer cystoskeletal pathology</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">4913</span><span class="NLM_x">–</span> <span class="NLM_lpage">4917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1986&pages=4913-4917&author=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=Y.+C.+Tungauthor=M.+Quinlanauthor=H.+M.+Wisniewskiauthor=L.I.+Binder&title=Abnormal+phosphorylation+of+the+microtubule-associated+protein+t+%28tau%29+in+Alzheimer+cystoskeletal+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DQuinlan%26aufirst%3DM.%26aulast%3DWisniewski%26aufirst%3DH.%2BM.%26aulast%3DBinder%26aufirst%3DL.I.%26atitle%3DAbnormal%2520phosphorylation%2520of%2520the%2520microtubule-associated%2520protein%2520t%2520%2528tau%2529%2520in%2520Alzheimer%2520cystoskeletal%2520pathology%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D93%26spage%3D4913%26epage%3D4917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Oxidative stress in Alzheimer’s disease: Are we connecting the dots?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2821</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+stress+in+Alzheimer%E2%80%99s+disease%3A+Are+we+connecting+the+dots%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Are%2520we%2520connecting%2520the%2520dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2821%26epage%3D2831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perry, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesseed, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R. H.</span><span> </span><span class="NLM_article-title">Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1457</span><span class="NLM_x">–</span> <span class="NLM_lpage">1459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1136%2Fbmj.2.6150.1457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=719462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADyaE1M%252Fmtlarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1978&pages=1457-1459&author=E.+K.+Perryauthor=B.+E.+Tomlinsonauthor=G.+Blesseedauthor=K.+Bergmannauthor=P.+H.+Gibsonauthor=R.+H.+Perry&title=Correlation+of+cholinergic+abnormalities+with+senile+plaques+and+mental+test+scores+in+senile+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia</span></div><div class="casAuthors">Perry E K; Tomlinson B E; Blessed G; Bergmann K; Gibson P H; Perry R H</div><div class="citationInfo"><span class="NLM_cas:title">British medical journal</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6150</span>),
    <span class="NLM_cas:pages">1457-9</span>
        ISSN:<span class="NLM_cas:issn">0007-1447</span>.
    </div><div class="casAbstract">Necropsy brain tissue from normal (control) patients and patients with depression and dementia was examined for activities of various cholinergic components, and these related to the degree of senile plaque formation and extent of intellectual impairment.  Choline acetyltransferase and acetylcholinesterase activities decreased significantly as the mean plaque count rose, and in depressed and demented subjects the reduction in choline acetyltransferase activity correlated with the extent of intellectual impairment as measured by a memory information test; muscarinic cholinergic receptor binding activity remained unchanged with increasing senile plaque formation but butyrylcholinesterase activity increased.  The results suggest a close relation between changes in the cholinergic system and Alzheimer's dementia, but the precise role of the system in this disease remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcQ6QKOYjgVs-crCu0nI_sfW6udTcc2eaaVtadHEuKw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252Fmtlarsw%253D%253D&md5=800e19ccc531362f8ba149dfd1c8c1ef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fbmj.2.6150.1457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.2.6150.1457%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DE.%2BK.%26aulast%3DTomlinson%26aufirst%3DB.%2BE.%26aulast%3DBlesseed%26aufirst%3DG.%26aulast%3DBergmann%26aufirst%3DK.%26aulast%3DGibson%26aufirst%3DP.%2BH.%26aulast%3DPerry%26aufirst%3DR.%2BH.%26atitle%3DCorrelation%2520of%2520cholinergic%2520abnormalities%2520with%2520senile%2520plaques%2520and%2520mental%2520test%2520scores%2520in%2520senile%2520dementia%26jtitle%3DBr.%2520Med.%2520J.%26date%3D1978%26volume%3D2%26spage%3D1457%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Talesa, V. N.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase in Alzheimer’s disease</span> <span class="citation_source-journal">Mech. Ageing Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2001&pages=1961-1969&author=V.+N.+Talesa&title=Acetylcholinesterase+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalesa%26aufirst%3DV.%2BN.%26atitle%3DAcetylcholinesterase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2001%26volume%3D122%26spage%3D1961%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span> </span><span class="NLM_article-title">Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=30-38&author=A.+V.+Terryauthor=J.+J.+Buccafuscoauthor=C.+Wilson&title=Cognitive+dysfunction+in+neuropsychiatric+disorders%3A+selected+serotonin+receptor+subtypes+as+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DWilson%26aufirst%3DC.%26atitle%3DCognitive%2520dysfunction%2520in%2520neuropsychiatric%2520disorders%253A%2520selected%2520serotonin%2520receptor%2520subtypes%2520as%2520therapeutic%2520targets%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D195%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Youdim, M. B. H.; Finberg, J. P. M.; Tipton, K. F.</span><span> </span><span class="NLM_article-title">Monoamine oxidase</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Tredelenburg, U. ; Weiner, N.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">20</span>, pp  <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1007%2F978-3-642-46625-0_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=119-192&author=M.+B.+H.+Youdim&author=J.+P.+M.+Finberg&author=K.+F.+Tiptonauthor=U.+Tredelenburg&author=N.+Weiner&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-46625-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-46625-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMonoamine%2520oxidase%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DTredelenburg%26aufirst%3DU.%26pub%3DSpringer-Verlag%26date%3D1988%26volume%3D20%26spage%3D119%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Johnston, J. P.</span><span> </span><span class="NLM_article-title">Some observations upon a new inhibitor of monoamine oxidasein brain tissue</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1968&pages=1285-1297&author=J.+P.+Johnston&title=Some+observations+upon+a+new+inhibitor+of+monoamine+oxidasein+brain+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BP.%26atitle%3DSome%2520observations%2520upon%2520a%2520new%2520inhibitor%2520of%2520monoamine%2520oxidasein%2520brain%2520tissue%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1968%26volume%3D17%26spage%3D1285%26epage%3D1297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Tissue distribution of human monoamine oxidase A and B mRNA</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1111%2Fj.1471-4159.1990.tb03121.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=2398352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=1166-1169&author=J.+Grimsbyauthor=N.+C.+Lanauthor=R.+Neveauthor=K.+Chenauthor=J.+C.+Shih&title=Tissue+distribution+of+human+monoamine+oxidase+A+and+B+mRNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of human monoamine oxidase A and B mRNA</span></div><div class="casAuthors">Grimsby, Joseph; Lan, Nancy C.; Neve, Rachael; Chen, Kevin; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1166-9</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Northern anal. using 32P-labeled subfragments of human liver MAO A and B cDNA clone detected a 5- and 3-kb transcript, resp., in most human tissues examd.  However, fetal heart and thymus express minute amts. of MAO A transcript, whereas fetal brain, muscle, thymus, spleen, meninges, and placenta express minute amts. of MAO B transcript.  Small intestine and placenta express, in addn. to the MAO A 5-kb transcript, a 2-kb transcript, which may arise from an alternative polyadenylation site.  MAO A and B transcripts are expressed in similar regions of adult human being.  The highest concns. of these transcripts were located in frontal cortex and locus ceruleus.  This study demonstrates the tissue-specific distribution of the MAO genes and will provide insight into the physiol. functions of MAO A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNhXyOI-PQ87Vg90H21EOLACvtfcHk0lhalZ9d0XSJIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D&md5=e3f1af76b4168d94b13811471cf46fc5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1990.tb03121.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1990.tb03121.x%26sid%3Dliteratum%253Aachs%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DN.%2BC.%26aulast%3DNeve%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DTissue%2520distribution%2520of%2520human%2520monoamine%2520oxidase%2520A%2520and%2520B%2520mRNA%26jtitle%3DJ.%2520Neurochem.%26date%3D1990%26volume%3D55%26spage%3D1166%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Harfenist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuseur, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyner, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, H. L.</span><span> </span><span class="NLM_article-title">Selective inhibitors of monoamine oxidase. 3. Structure–activity relationship of tricyclics bearing imidazoline, oxadiazole, or tetrazole groups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1857</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950595m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1857-1863&author=H.+Harfenistauthor=D.+J.+Heuseurauthor=C.+T.+Joynerauthor=J.+F.+Batchelorauthor=H.+L.+White&title=Selective+inhibitors+of+monoamine+oxidase.+3.+Structure%E2%80%93activity+relationship+of+tricyclics+bearing+imidazoline%2C+oxadiazole%2C+or+tetrazole+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm950595m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950595m%26sid%3Dliteratum%253Aachs%26aulast%3DHarfenist%26aufirst%3DH.%26aulast%3DHeuseur%26aufirst%3DD.%2BJ.%26aulast%3DJoyner%26aufirst%3DC.%2BT.%26aulast%3DBatchelor%26aufirst%3DJ.%2BF.%26aulast%3DWhite%26aufirst%3DH.%2BL.%26atitle%3DSelective%2520inhibitors%2520of%2520monoamine%2520oxidase.%25203.%2520Structure%25E2%2580%2593activity%2520relationship%2520of%2520tricyclics%2520bearing%2520imidazoline%252C%2520oxadiazole%252C%2520or%2520tetrazole%2520groups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1857%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielczyk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünblatt, E.</span><span> </span><span class="NLM_article-title">Monoamine oxidase-B inhibition in Alzheimer’s disease</span> <span class="citation_source-journal">Neurotoxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=271-277&author=P.+Riedererauthor=W.+Danielczykauthor=E.+Gr%C3%BCnblatt&title=Monoamine+oxidase-B+inhibition+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DDanielczyk%26aufirst%3DW.%26aulast%3DGr%25C3%25BCnblatt%26aufirst%3DE.%26atitle%3DMonoamine%2520oxidase-B%2520inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotoxicology%26date%3D2004%26volume%3D25%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS neurotransmitters</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.pharmthera.2014.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=24607445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=133-152&author=J.+P.+M.+Finberg&title=Update+on+the+pharmacology+of+selective+inhibitors+of+MAO-A+and+MAO-B%3A+focus+on+modulation+of+CNS+neurotransmitters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span></div><div class="casAuthors">Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhibitors of monoamine oxidase (MAO) were initially used in medicine following the discovery of their antidepressant action.  Subsequently their ability to potentiate the effects of an indirectly-acting sympathomimetic amine such as tyramine was discovered, leading to their limitation in clin. use, except for cases of treatment-resistant depression.  More recently, the understanding that: a) potentiation of indirectly-acting sympathomimetic amines is caused by inhibitors of MAO-A but not by inhibitors of MAO-B, and b) that reversible inhibitors of MAO-A cause minimal tyramine potentiation, has led to their re-introduction to clin. use for treatment of depression (reversible MAO-A inhibitors and new dose form MAO-B inhibitor) and treatment of Parkinson's disease (MAO-B inhibitors).  The profound neuroprotective properties of propargyl-based inhibitors of MAO-B in preclin. expts. have drawn attention to the possibility of employing these drugs for their neuroprotective effect in neurodegenerative diseases, and have raised the question of the involvement of the MAO-mediated reaction as a source of reactive free radicals.  Despite the long-standing history of MAO inhibitors in medicine, the way in which they affect neuronal release of monoamine neurotransmitters is still poorly understood.  In recent years, the detailed chem. structure of MAO-B and MAO-A has become available, providing new possibilities for synthesis of mechanism-based inhibitors.  This review describes the latest advances in understanding the way in which MAO inhibitors affect the release of the monoamine neurotransmitters dopamine, noradrenaline and serotonin (5-HT) in the CNS, with an accent on the importance of these effects for the clin. actions of the drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSGMvtQ1Ca5bVg90H21EOLACvtfcHk0lhO8g-js9CMWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D&md5=0f31959bad34842d4aaaba7b8162e5b8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DUpdate%2520on%2520the%2520pharmacology%2520of%2520selective%2520inhibitors%2520of%2520MAO-A%2520and%2520MAO-B%253A%2520focus%2520on%2520modulation%2520of%2520CNS%2520neurotransmitters%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D133%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gura, T.</span><span> </span><span class="NLM_article-title">Hope in Alzheimer’s fight emerges from unexpected places</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=894&author=T.+Gura&title=Hope+in+Alzheimer%E2%80%99s+fight+emerges+from+unexpected+places"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGura%26aufirst%3DT.%26atitle%3DHope%2520in%2520Alzheimer%25E2%2580%2599s%2520fight%2520emerges%2520from%2520unexpected%2520places%26jtitle%3DNature%2520Med.%26date%3D2008%26volume%3D14%26spage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzucchelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porrello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, S.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors: novel activities of old molecules</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.phrs.2003.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=15304241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=441-451&author=M.+Racchiauthor=M.+Mazzucchelliauthor=E.+Porrelloauthor=C.+Lanniauthor=S.+Govoni&title=Acetylcholinesterase+inhibitors%3A+novel+activities+of+old+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors: novel activities of old molecules</span></div><div class="casAuthors">Racchi, Marco; Mazzucchelli, Michela; Porrello, Emanuela; Lanni, Cristina; Govoni, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The therapeutic approach for improving the cognitive function in patients with Alzheimer's disease (AD) is mainly based on the potentiation of central cholinergic activity and is achieved clin. by the use of acetylcholinesterase (AChE) inhibitors such as tacrine, donepezil, rivastigmine, galantamine and other drugs currently in clin. trials.  These are, by their pharmacol., only symptomatic drugs yet recently these mols. have shown some potential also in the modulation of amyloid precursor protein (APP) processing.  We explore in this review the exptl. evidence that suggests a role for AChEIs in APP processing and point to multiple complex mechanisms involving either a cholinergic agonist effect, coupled to multiple signal transduction pathways, or post-transcriptional effects that modulate the expression of cellular APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpOo04QwYy7Vg90H21EOLACvtfcHk0lhO8g-js9CMWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D&md5=7f81d066fa285380f75c36d18ec46313</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2003.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2003.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DMazzucchelli%26aufirst%3DM.%26aulast%3DPorrello%26aufirst%3DE.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DGovoni%26aufirst%3DS.%26atitle%3DAcetylcholinesterase%2520inhibitors%253A%2520novel%2520activities%2520of%2520old%2520molecules%26jtitle%3DPharmacol.%2520Res.%26date%3D2004%26volume%3D50%26spage%3D441%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F092986708785909067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=18855672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2433-2455&author=D.+Mu%C3%B1oz-Torrero&title=Acetylcholinesterase+inhibitors+as+disease-modifying+therapies+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease</span></div><div class="casAuthors">Munoz-Torrero, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2433-2455</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic arsenal for the treatment of Alzheimer's disease (AD) remains confined to a group of four inhibitors of AChE and one NMDA receptor antagonist, which are used to provide a relief of the very late symptoms of the dementia, i.e. the cognitive and functional decline.  In line with the growing body of evidence of the pivotal role of the β-amyloid peptide (Aβ) in the pathogenesis of AD, alternative classes of drugs targeting mainly the formation or the aggregation of Aβ are actively pursued by the pharmaceutical industry, as they could pos. modify the course of AD, stopping or slowing down disease progression.  While the first amyloid-directed disease-modifying drugs go ahead with their clin. development and could reach the market as soon as 2009, mounting preclin. and clin. evidences is pointing towards a disease-modifying role also for currently marketed anti-Alzheimer AChE inhibitors (AChEIs), particularly for donepezil.  In this review, the neuroprotective effects exhibited by currently commercialized AChEIs will be briefly discussed, together with the secondary mechanisms through which they could exert such effects.  This review will focus also on particular classes of AChEIs, namely dual binding site AChEIs, which are being purposely designed to target Aβ aggregation and / or other biol. targets that contribute to AD pathogenesis, thus constituting very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqII-Yg4R84wrVg90H21EOLACvtfcHk0ljAbg6RO4mXEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI&md5=a27eaf0ba08a4d9e5c8363f6b5621e5d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F092986708785909067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785909067%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520as%2520disease-modifying%2520therapies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2433%26epage%3D2455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span> </span><span class="NLM_article-title">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F138161206778792985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=17105433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4377-4387&author=A.+Castroauthor=A.+Mart%C3%ADnez&title=Targeting+beta-amyloid+pathogenesis+through+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4377-4387</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of the current difficulties is related to the lack of solid evidence about the ultimate factors that give rise to the pathogenesis of this disease, creating a great challenge for the definition of efficient treatments for Alzheimer's disease (AD).  Current therapeutic option for AD patients is the use of acetylcholinesterase (AChE) inhibitors, which gives only a symptomatic relief.  However, recent studies show a long-lasting effect in a certain percentage of patients.  In fact, there is accumulating evidence that an AChE has secondary non-cholinergic functions including the processing and deposition of β-amyloid (Aβ).  AChE could play a role in the Aβ metab. and during an early step in the development of the senile plaque, as revealed by the finding that AChE accelerates Aβ deposition.  Considering the non-classical AChE functions, their relationships with AD hallmarks, and the putative role of peripheral anionic site in all these functions, the dual binding site AChE inhibitors may acquire importance for AD treatment.  On the other hand, the interference of AChE inhibitors with Aβ processing is not a general rule for this class of compds. with the involvement of other features such as chem. structure and/or genetic regulation.  This review highlights the collection of several compds. with an outstanding profile against AChE-induced amyloid aggregation and potent AChE inhibitory activity, indicating the possibility of targeting Aβ through the inhibition of AChE and reveals the emergence of a new generation of AChE inhibitors aiming to be excellent candidate drugs for the future cure of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrisn7G_dIHxrVg90H21EOLACvtfcHk0ljAbg6RO4mXEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI&md5=fd41eca56c6433d9ee6a3989908ff2c5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F138161206778792985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792985%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DTargeting%2520beta-amyloid%2520pathogenesis%2520through%2520acetylcholinesterase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4377%26epage%3D4387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lhf9PB8QR5ZeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lhf9PB8QR5ZeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Anighoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7874</span><span class="NLM_x">–</span> <span class="NLM_lpage">7887</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0lgppE619lqWkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for α<sub>1</sub>-adrenoreceptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4895</span><span class="NLM_x">–</span> <span class="NLM_lpage">4903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030952q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4895-4903&author=M.+Rosiniauthor=A.+Antonelloauthor=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=G.+Marucciauthor=E.+Poggesiauthor=A.+Leonardiauthor=C.+Melchiorre&title=Prazosin-related+compounds.+Effect+of+transforming+the+piperazinylquinazoline+moiety+into+an+aminomethyltetrahydroacridine+system+on+the+affinity+for+%CE%B11-adrenoreceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm030952q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030952q%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAntonello%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DPrazosin-related%2520compounds.%2520Effect%2520of%2520transforming%2520the%2520piperazinylquinazoline%2520moiety%2520into%2520an%2520aminomethyltetrahydroacridine%2520system%2520on%2520the%2520affinity%2520for%2520%25CE%25B11-adrenoreceptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4895%26epage%3D4903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appenroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiehntopf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roegler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deufel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of NO-donor–tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701491k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=713-716&author=L.+Fangauthor=D.+Appenrothauthor=M.+Deckerauthor=M.+Kiehntopfauthor=C.+Roeglerauthor=T.+Deufelauthor=C.+Fleckauthor=S.+Pengauthor=Y.+Zhangauthor=J.+Lehmann&title=Synthesis+and+biological+evaluation+of+NO-donor%E2%80%93tacrine+hybrids+as+hepatoprotective+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm701491k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701491k%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DKiehntopf%26aufirst%3DM.%26aulast%3DRoegler%26aufirst%3DC.%26aulast%3DDeufel%26aufirst%3DT.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520NO-donor%25E2%2580%2593tacrine%2520hybrids%2520as%2520hepatoprotective%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D713%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Stosel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuppers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span> </span><span class="NLM_article-title">Dual targeting of adenosine A2A receptors and monoamine oxidase B by 4<i>H</i>-3,1-benzothiazin-4-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4580-4596&author=A.+Stoselauthor=M.+Schlenkauthor=S.+Hinzauthor=P.+Kuppersauthor=J.+Heerauthor=M.+Gutschowauthor=C.+E.+Muller&title=Dual+targeting+of+adenosine+A2A+receptors+and+monoamine+oxidase+B+by+4H-3%2C1-benzothiazin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStosel%26aufirst%3DA.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DKuppers%26aufirst%3DP.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DGutschow%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26atitle%3DDual%2520targeting%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520monoamine%2520oxidase%2520B%2520by%25204H-3%252C1-benzothiazin-4-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4580%26epage%3D4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of tacrine–ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates</span> <span class="citation_source-journal">Bioorg. Med. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2905</span><span class="NLM_x">–</span> <span class="NLM_lpage">2909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.bmcl.2008.03.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=18406135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVWjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2905-2909&author=L.+Fangauthor=B.+Krausauthor=J.+Lehmannauthor=J.+Heilmannauthor=Y.+Zhangauthor=M.+Decker&title=Design+and+synthesis+of+tacrine%E2%80%93ferulic+acid+hybrids+as+multi-potent+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates</span></div><div class="casAuthors">Fang, Lei; Kraus, Birgit; Lehmann, Jochen; Heilmann, Joerg; Zhang, Yihua; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2905-2909</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Five tacrine-ferulic acid hybrids were designed and synthesized as multi-potent anti-Alzheimer drug candidates.  All target compds. have better acetylcholinesterase inhibitory activity and comparable butyrylcholinesterase inhibitory activity in relation to tacrine.  Interestingly, I showed a reversible and non-competitive inhibitory action for acetylcholinesterase indicating interaction with the peripheral anionic site, whereas a reversible but competitive inhibitory action for butyrylcholinesterase.  The antioxidant study revealed that four target compds. have, compared to Trolox, high ability to absorb reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQXuASkdXTpbVg90H21EOLACvtfcHk0lifRZE4oK9XgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVWjsLs%253D&md5=897c1f2da05a30e87e5042ce59cb125f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.03.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.03.073%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DKraus%26aufirst%3DB.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tacrine%25E2%2580%2593ferulic%2520acid%2520hybrids%2520as%2520multi-potent%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DBioorg.%2520Med.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2905%26epage%3D2909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">V. Pérez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Álvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fsj.bjp.0702600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=10433493" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1999&pages=869-876&author=V.+V.+P%C3%A9rezauthor=J.+L.+Marcoauthor=E.+Fern%C3%A1ndez-%C3%81lvarezauthor=M.+Unzeta&title=Relevance+of+benzyloxy+group+in+2-indolyl+methylamines+in+the+selective+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702600%26sid%3Dliteratum%253Aachs%26aulast%3DV.%2BP%25C3%25A9rez%26aufirst%3DV.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DFern%25C3%25A1ndez-%25C3%2581lvarez%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DRelevance%2520of%2520benzyloxy%2520group%2520in%25202-indolyl%2520methylamines%2520in%2520the%2520selective%2520MAO-B%2520inhibition%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D127%26spage%3D869%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2013&pages=893-902&author=I.+Boleaauthor=A.+Gellaauthor=M.+Unzeta&title=Propargylamine-derived+multitarget-directed+ligands%3A+fighting+Alzheimer%E2%80%99s+disease+with+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DPropargylamine-derived%2520multitarget-directed%2520ligands%253A%2520fighting%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2013%26volume%3D120%26spage%3D893%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Ríos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouplana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling of donepezil and <i>N</i>-[(5-(benzyloxy)-1-methyl-1<i>H</i>-indol-2-yl)methyl]-<i>N</i>-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8251</span><span class="NLM_x">–</span> <span class="NLM_lpage">8270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200853t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8251-8270&author=I.+Boleaauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=C.+de+los+R%C3%ADosauthor=M.+Chiouaauthor=R.+Pouplanaauthor=F.+J.+Luqueauthor=M.+Unzetaauthor=J.+Marco-Contellesauthor=A.+Samadi&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+of+donepezil+and+N-%5B%285-%28benzyloxy%29-1-methyl-1H-indol-2-yl%29methyl%5D-N-methylprop-2-yn-1-amine+hybrids+as+new+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200853t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200853t%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DPouplana%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520of%2520donepezil%2520and%2520N-%255B%25285-%2528benzyloxy%2529-1-methyl-1H-indol-2-yl%2529methyl%255D-N-methylprop-2-yn-1-amine%2520hybrids%2520as%2520new%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8251%26epage%3D8270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span> </span><span class="NLM_article-title">Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234 a multi-target compound for designed for use in Alzheimer’s disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1844</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.bbapap.2014.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVeqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1844&publication_year=2014&pages=1104-1110&author=G.+Estebanauthor=J.+Allanauthor=A.+Samadiauthor=A.+Matteviauthor=M.+Unzetaauthor=J.+Marco-Contellesauthor=C.+Bindaauthor=R.+R.+Ramsay&title=Kinetic+and+structural+analysis+of+the+irreversible+inhibition+of+human+monoamine+oxidases+by+ASS234+a+multi-target+compound+for+designed+for+use+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease</span></div><div class="casAuthors">Esteban, Gerard; Allan, Jennifer; Samadi, Abdelouahid; Mattevi, Andrea; Unzeta, Mercedes; Marco-Contelles, Jose; Binda, Claudia; Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1844</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1104-1110</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Monoamine oxidases (MAO) and cholinesterases are validated targets in the design of drugs for the treatment of Alzheimer's disease.  The multi-target compd. N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (ASS234), bearing the MAO-inhibiting propargyl group attached to a donepezil moiety that inhibits cholinesterases, retained activity against human acetyl- and butyryl-cholinesterases.  The inhibition of MAO A and MAO B by ASS234 was characterized and compared to other known MAO inhibitors.  ASS234 was almost as effective as clorgyline (kinact/KI = 3 × 106 min- 1 M- 1) and was shown by structural studies to form the same N5 covalent adduct with the FAD cofactor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqdbntEH0c5rVg90H21EOLACvtfcHk0lifRZE4oK9XgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVeqtLg%253D&md5=6bb57337217cbf2813593c9cb36eea0f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DAllan%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DKinetic%2520and%2520structural%2520analysis%2520of%2520the%2520irreversible%2520inhibition%2520of%2520human%2520monoamine%2520oxidases%2520by%2520ASS234%2520a%2520multi-target%2520compound%2520for%2520designed%2520for%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2014%26volume%3D1844%26spage%3D1104%26epage%3D1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">The multipotent, permeable drug ASS234 inhibits Aβ aggregation, possesses antioxidant properties and protects from Aβ-induced apoptosis</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F15672050113109990151" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=797-808&author=I.+Boleaauthor=A.+Gellaauthor=L.+Monjasauthor=C.+P%C3%A9rezauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=J.+L.+Marco-Contellesauthor=A.+Samadiauthor=M.+Unzeta&title=The+multipotent%2C+permeable+drug+ASS234+inhibits+A%CE%B2+aggregation%2C+possesses+antioxidant+properties+and+protects+from+A%CE%B2-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F15672050113109990151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15672050113109990151%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%2BL.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DThe%2520multipotent%252C%2520permeable%2520drug%2520ASS234%2520inhibits%2520A%25CE%25B2%2520aggregation%252C%2520possesses%2520antioxidant%2520properties%2520and%2520protects%2520from%2520A%25CE%25B2-induced%2520apoptosis%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2013%26volume%3D9%26spage%3D797%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">del Pino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span> </span><span class="NLM_article-title">Wnt signaling pathway, a potential target for Alzheimer’s disease treatment, is activated by a novel multitarget compound ASS234</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1111%2Fcns.12269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=24712554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ygsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=568-570&author=J.+del+Pinoauthor=E.+Ramosauthor=O.+M.+Bautista+Aguileraauthor=J.+Marco-Contellesauthor=A.+Romero&title=Wnt+signaling+pathway%2C+a+potential+target+for+Alzheimer%E2%80%99s+disease+treatment%2C+is+activated+by+a+novel+multitarget+compound+ASS234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt Signaling Pathway, a Potential Target for Alzheimer's Disease Treatment, is Activated by a Novel Multitarget Compound ASS234</span></div><div class="casAuthors">del Pino, Javier; Ramos, Eva; Aguilera, Oscar M. Bautista; Marco-Contelles, Jose; Romero, Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">568-570</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This article discusses the Wnt signaling pathway, potential target for Alzheimer's disease treatment, as activated by novel multitarget compd. ASS234.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLOsI2pG90nbVg90H21EOLACvtfcHk0lge-ckH27a_nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ygsbw%253D&md5=9820f13ea52a716359b2ae215bd90e7f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fcns.12269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12269%26sid%3Dliteratum%253Aachs%26aulast%3Ddel%2BPino%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DE.%26aulast%3DBautista%2BAguilera%26aufirst%3DO.%2BM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DA.%26atitle%3DWnt%2520signaling%2520pathway%252C%2520a%2520potential%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%252C%2520is%2520activated%2520by%2520a%2520novel%2520multitarget%2520compound%2520ASS234%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2014%26volume%3D20%26spage%3D568%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Stasiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, W. A.</span><span> </span><span class="NLM_article-title">Effects of novel monoamine oxidases and cholinesterases targeting compounds on brain neurotransmitters and behavior in rat model of vascular dementia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F13816128113199990026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=23701539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=161-171&author=A.+Stasiakauthor=M.+Mussurauthor=M.+Unzetaauthor=A.+Samadiauthor=J.+L.+Marco-Contellesauthor=W.+A.+Fogel&title=Effects+of+novel+monoamine+oxidases+and+cholinesterases+targeting+compounds+on+brain+neurotransmitters+and+behavior+in+rat+model+of+vascular+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia</span></div><div class="casAuthors">Stasiak, Anna; Mussur, Miroslaw; Unzeta, Mercedes; Samadi, Abdelouahid; Marco-Contelles, Jose L.; Fogel, W. Agnieszka</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Neurodegenerative disorders are assocd. with different neurochem. and morphol. alterations in the brain leading to cognitive and behavioral impairments.  New therapeutic strategies comprise multifunctional drugs.  The aim of the presented studies is to evaluate in vivo the novel compds. - ASS188 and ASS234 - which combine the benzylpiperidine moiety of the acetylcholinesteras (AChE) inhibitor donepezil and the indolyl propargylamino moiety of the monoaminooxidase (MAO) inhibitor, N-[(5-benzyloxy-1- methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine, with respect to their influence on cerebral amine neurotransmitters systems and neuroprotective activity.  The presumed therapeutic potential of these compds. has been evaluated following their administration to rats with exptl. vascular dementia.  A rat model of the permanent bilateral occlusion of the common carotid arteries (BCCAO) and the holeboard memory test were employed for this purpose.  Wistar rats were used, either intact or 1 day after BCCAO.  ASS188 (1 mg/kg) and ASS234 (5 mg/kg) were given s.c. for 5 consecutive days.  Working and ref. memory in rats was evaluated by holeboard tests before- and 7 and 12 days after BCCAO.  The activities of MAOs, AChE and histamine N-methyltransferase (HMT), as well as cerebral amines concns. were assayed.  A significant inhibition of brain MAO A (>95%) and weaker MAO B (ca 60%) and HMT (<30%) and reduced AChE activities were recorded with a pronounced (2 - 10 fold) increase in the cerebral concns. of serotonin, dopamine, and noradrenaline and smaller rises (up to 30%) of histamine.  The BCCAO rats treated with ASS188 or ASS234 tended to perform holeboard tests better than the BCCAO untreated group, indicating a beneficial effect of the administered therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod78mIR4gCubVg90H21EOLACvtfcHk0lge-ckH27a_nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOhtr4%253D&md5=45a25792f918f9f1b481cedf84f75e50</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F13816128113199990026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128113199990026%26sid%3Dliteratum%253Aachs%26aulast%3DStasiak%26aufirst%3DA.%26aulast%3DMussur%26aufirst%3DM.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%2BL.%26aulast%3DFogel%26aufirst%3DW.%2BA.%26atitle%3DEffects%2520of%2520novel%2520monoamine%2520oxidases%2520and%2520cholinesterases%2520targeting%2520compounds%2520on%2520brain%2520neurotransmitters%2520and%2520behavior%2520in%2520rat%2520model%2520of%2520vascular%2520dementia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D161%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zhu, Z. J.</span><span> </span><span class="NLM_article-title">‘Clik’ assemby of selective inhibitors of MAO-A</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6222</span><span class="NLM_x">–</span> <span class="NLM_lpage">6225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6222-6225&author=Z.+J.+Zhu&title=%E2%80%98Clik%E2%80%99+assemby+of+selective+inhibitors+of+MAO-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%2BJ.%26atitle%3D%25E2%2580%2598Clik%25E2%2580%2599%2520assemby%2520of%2520selective%2520inhibitors%2520of%2520MAO-A%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6222%26epage%3D6225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbaba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil–indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=82-95&author=O.+M.+Bautista-Aguileraauthor=G.+Estebanauthor=I.+Boleaauthor=K.+Nikolicauthor=D.+Agbabaauthor=I.+Moraledaauthor=I.+Iriepaauthor=A.+Samadiauthor=E.+Sorianoauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Design%2C+synthesis%2C+pharmacological+evaluation%2C+QSAR+analysis%2C+molecular+modeling+and+ADMET+of+novel+donepezil%E2%80%93indolyl+hybrids+as+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+potential+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DAgbaba%26aufirst%3DD.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520pharmacological%2520evaluation%252C%2520QSAR%2520analysis%252C%2520molecular%2520modeling%2520and%2520ADMET%2520of%2520novel%2520donepezil%25E2%2580%2593indolyl%2520hybrids%2520as%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D75%26spage%3D82%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikcolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxyl aminoindan and phenethylamine as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Mikcolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=J.+Finbergauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxyl+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMikcolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxyl%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D54%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span> </span><span class="NLM_article-title">Site-activated multifunctional chelator with acetycholinesterase and neuroprotective-neurorestorative moieties for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4098</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900504c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4095-4098&author=H.+Zhengauthor=M.+B.+H.+Youdimauthor=M.+Fridkin&title=Site-activated+multifunctional+chelator+with+acetycholinesterase+and+neuroprotective-neurorestorative+moieties+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm900504c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900504c%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DFridkin%26aufirst%3DM.%26atitle%3DSite-activated%2520multifunctional%2520chelator%2520with%2520acetycholinesterase%2520and%2520neuroprotective-neurorestorative%2520moieties%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4095%26epage%3D4098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1096%2Ffj.05-4910fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=16935943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2177-2179&author=M.+Yogev-Falachauthor=O.+Bar-Amauthor=T.+Amitauthor=O.+Weinrebauthor=M.+B.+Youdim&title=A+multifunctional%2C+neuroprotective+drug%2C+ladostigil+%28TV3326%29%2C+regulates+holo-APP+translation+and+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span></div><div class="casAuthors">Yogev-Falach, Merav; Bar-Am, Orit; Amit, Tamar; Weinreb, Orly; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2177-2179</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of the bifunctional drug ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5-yl)-Et Me carbamate].  Ladostigil combines the neuroprotective effects of the antiparkinson drug rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine in a single mol., as a potential treatment for Alzheimer's disease (AD) and Lewy Body disease.  Here, we assessed the dual effects of lodostigil in terms of the mol. mechanism of neuroprotection and amyloid precursor protein (APP) regulation/processing by using an apoptotic model of neuroblastoma SK-N-SH cells.  Ladostigil dose-dependently decreased cell death via inhibition of the cleavage and prevention of caspase-3 activation (IC50=1.05 μM) through a mechanism related to regulation of the Bcl-2 family proteins, which resulted in reduced levels of Bad and Bax and induced levels of Bcl-2 gene and protein expression.  We have also followed APP regulation/processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP protein without altering APP mRNA levels, suggesting a posttranscriptional mechanism.  In addn., the drug-elevated phosphorylated protein kinase C (pPKC) levels and stimulated the release of the nonamyloidogenic ot-secretase proteolytic pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor but lacks MAO inhibitory activity, exerted neuroprotective properties and regulated APP processing, indicating that these effects are independent of MAO inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEeVwmkmV5FrVg90H21EOLACvtfcHk0liotYR8qmB-4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ&md5=98af5388c49c4d1a4cf7b56752367fc6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1096%2Ffj.05-4910fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.05-4910fje%26sid%3Dliteratum%253Aachs%26aulast%3DYogev-Falach%26aufirst%3DM.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DA%2520multifunctional%252C%2520neuroprotective%2520drug%252C%2520ladostigil%2520%2528TV3326%2529%252C%2520regulates%2520holo-APP%2520translation%2520and%2520processing%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D2177%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1023%2FA%3A1015131516649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=555-573&author=M.+B.+Youdimauthor=M.+Weinstock&title=Molecular+basis+of+neuroprotective+activities+of+rasagiline+and+the+anti-Alzheimer+drug+TV3326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]</span></div><div class="casAuthors">Youdim, Moussa B. H.; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-573</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review.  Rasagiline (N-propargyl-1-(R)-aminoindan) is a selective, irreversible monoamine oxidase B (MAO B) inhibitor which has been developed as an anti-Parkinson drug.  In controlled monotherapy and as adjunct to L-dopa it has shown anti-Parkinson activity.  In cell culture (PC-12 and neuroblastoma SH-SY5Y cells) it exhibits neuroprotective and antiapoptotic activity against several neurotoxins (SIN-1, MPTP, 6-hydroxydopamine and N-methyl-(R)-salsolinol) and ischemia.  In vivo, it reduces the sequelae of traumatic brain injury in mice and speeds their recovery.  The neuroprotective activity of rasagaline does not result from MAO B inhibition, since its S-enantiomer, TVP1022, which has 1000-fold weaker MAO inhibitory activity, exhibits similar neuroprotective properties.  Introduction of a carbamate moiety into the rasagiline mol. to confer cholinesterase inhibitory activity for the treatment of Alzheimer's disease, resulted in compds. TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Et Me Carbamate] and its S-enantiomer TV3279 [(N-Propargyl-(3S)Aminoindan-5-YL)-Et Me Carbamate], which retain the neuroprotective activities of rasagiline and TVP1.022.  They also antagonize scopolamine-induced impairments in spatial memory.  In addn., TV3326 exhibits brain-selective MAO A and B inhibitory activity after chronic administration and has antidepressant-like activity in the forced swim test.  This is assocd. with an increase in brain levels of serotonin.  The antiapoptotic activity of these propargylamine-contg. derivs. may be related to their ability to delay the opening of voltage-dependent anion channels (VDAC), which are part of the mitochondrial permeability transition pore.  The propargylarnine moiety is responsible for the increase in the mitochondrial family of Bcl-2 proteins, prevention in the fall in mitochondrial membrane potential, prevention of the activation of caspase 3, and of translocation of glycerlatdehyde-3-phosphate dehydrogenase from the cytoplasm to the nucleus.  The latter processes are closely assocd. with neurotoxin-induced apoptosis.  Rasagiline interacts with and prevents the binding of PK11195 to the pro-apoptotic peripheral benzodiazepine receptor, which together with Bcl-2, hexokinase, porin, and adenine nucleotide translocator constitutes part of the VDAC.  Furthermore, rasagiline, TV3326 and TV3279 are able to influence the processing of amyloid precursor protein by activation of alpha-secretase and increasing the release of sol. alpha APP in rat PC-12 and human neuroblastoma SH-SY5Y cells and in rat and mice cortex and hippocampus.  This process has been shown to involve the upregulation of PKC and MAP kinase.  It is quite likely that the induction of Bcl-2 and activation of PKC by rasagiline and TV3326 is closely linked to the anti-apoptotic action of these drugs and their ability to process APP by activation of alpha-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLWVipqroE7Vg90H21EOLACvtfcHk0li1-G16HP5xjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D&md5=6069320591cce7df19a0f29f91cf6911</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015131516649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015131516649%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DMolecular%2520basis%2520of%2520neuroprotective%2520activities%2520of%2520rasagiline%2520and%2520the%2520anti-Alzheimer%2520drug%2520TV3326%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2002%26volume%3D21%26spage%3D555%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=B.+J.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0li1-G16HP5xjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DB.%2BJ.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraiz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span> </span><span class="NLM_article-title">Inhibitory effects of <i>cis</i>- and <i>trans</i>-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2006&pages=688-695&author=M.+Y%C3%A1%C3%B1ezauthor=N.+Fraizauthor=E.+Canoauthor=F.+Orallo&title=Inhibitory+effects+of+cis-+and+trans-resveratrol+on+noradrenaline+and+5-hydroxytryptamine+uptake+and+on+monoamine+oxidase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DFraiz%26aufirst%3DN.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DInhibitory%2520effects%2520of%2520cis-%2520and%2520trans-resveratrol%2520on%2520noradrenaline%2520and%25205-hydroxytryptamine%2520uptake%2520and%2520on%2520monoamine%2520oxidase%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D344%26spage%3D688%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">Reevaluation of reference inhibitors has been carried out under different conditions (enzymatic source and concentrations, measurement method) than our previous study (refs <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">29</a> and <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>, cited herein) but finding similar qualitative inhibition and selectivity for all compounds tested. Because IC<sub>50</sub> values depends directly on enzyme and substrate concentrations, normal quantitative discrepancies were achieved.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26pub%3DWiley-Interscience%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Youdim, B. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The therapeutic potential of monoamine oxidase inhibitors</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fnrn1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=16552415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=295-309&author=B.+H.+M.+Youdimauthor=D.+Edmondsonauthor=K.+F.+Tipton&title=The+therapeutic+potential+of+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of monoamine oxidase inhibitors</span></div><div class="casAuthors">Youdim, Moussa B. H.; Edmondson, Dale; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such.  It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity.  However, many claims and some counter-claims have been made about the physiol. importance of these enzymes and the potential of their inhibitors.  We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3A0wRL6nnL7Vg90H21EOLACvtfcHk0li1-G16HP5xjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D&md5=b35546920d95fa031ff2f884949372a7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrn1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1883%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DB.%2BH.%2BM.%26aulast%3DEdmondson%26aufirst%3DD.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Palhagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinonen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagglund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaugesaar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki-Ikola, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palm, R.</span><span> </span><span class="NLM_article-title">Selegiline slows the progression of the symptoms of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1200-1206&author=S.+Palhagenauthor=E.+Heinonenauthor=J.+Hagglundauthor=T.+Kaugesaarauthor=O.+Maki-Ikolaauthor=R.+Palm&title=Selegiline+slows+the+progression+of+the+symptoms+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalhagen%26aufirst%3DS.%26aulast%3DHeinonen%26aufirst%3DE.%26aulast%3DHagglund%26aufirst%3DJ.%26aulast%3DKaugesaar%26aufirst%3DT.%26aulast%3DMaki-Ikola%26aufirst%3DO.%26aulast%3DPalm%26aufirst%3DR.%26atitle%3DSelegiline%2520slows%2520the%2520progression%2520of%2520the%2520symptoms%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D1200%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lairez, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calise, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordener, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreux-Varoquaux, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbeau-Frugier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escourrou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seif, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncalli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzinat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mialet-Pérez, J.</span><span> </span><span class="NLM_article-title">Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload</span> <span class="citation_source-journal">J. Mol. Cell Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.yjmcc.2008.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=19162038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVenu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2009&pages=587-95&author=O.+Lairezauthor=D.+Caliseauthor=P.+Bianchiauthor=C.+Ordenerauthor=O.+Spreux-Varoquauxauthor=C.+Guilbeau-Frugierauthor=G.+Escourrouauthor=I.+Seifauthor=J.+Roncalliauthor=N.+Pizzinatauthor=M.+Galinierauthor=A.+Pariniauthor=J.+Mialet-P%C3%A9rez&title=Genetic+deletion+of+MAO-A+promotes+serotonin-dependent+ventricular+hypertrophy+by+pressure+overload"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload</span></div><div class="casAuthors">Lairez, Olivier; Calise, Denis; Bianchi, Pascale; Ordener, Catherine; Spreux-Varoquaux, Odile; Guilbeau-Frugier, Celine; Escourrou, Ghislaine; Seif, Isabelle; Roncalli, Jerome; Pizzinat, Nathalie; Galinier, Michel; Parini, Angelo; Mialet-Perez, Jeanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">587-595</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The potential role of serotonin (5-HT) in cardiac function has generated much interest in recent years.  In particular, the need for a tight regulation of 5-HT to maintain normal cardiovascular activity has been demonstrated in different exptl. models.  However, it remains unclear how increased levels of 5-HT could contribute to the development of cardiac hypertrophy.  Availability of 5-HT depends on the mitochondrial enzyme monoamine oxidase A (MAO-A).  Therefore, we investigated the consequences of MAO-A deletion on ventricular remodeling in the model of aortic banding in mice.  At baseline, MAO-A deletion was assocd. with an increase in whole blood 5-HT (39.4 ± 1.9 μM vs. 24.0 ± 0.9 μM in KO and WT mice, resp.).  Cardiac 5-HT2A, but not 5-HT2B receptors were overexpressed in MAO-A KO mice, as demonstrated by real-time PCR and Western-blot expts.  After aortic banding, MAO-A KO mice demonstrated greater increase in heart wall thickness, heart to body wt. ratios, cardiomyocyte cross-section areas, and myocardial fibrosis compared to WT.  Exacerbation of hypertrophy in KO mice was assocd. with increased amts. of 5-HT in the heart.  In order to det. the role of 5-HT and 5-HT2A receptors in ventricular remodeling in MAO-A KO mice, we administered the 5-HT2A receptor antagonists ketanserin (1 mg/kg/day) or M100907 (0.1 mg/kg/day) during 4 wk of aortic banding.  Chronic administration of these antagonists strongly prevented exacerbation of ventricular hypertrophy in MAO-A KO mice.  These results show for the first time that regulation of peripheral 5-HT by MAO-A plays a role in ventricular remodeling via activation of 5-HT2A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ7tr-XWyH5bVg90H21EOLACvtfcHk0liWzRxY71i3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVenu70%253D&md5=73094fae33c2a704eb17c522d27d09e0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2008.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2008.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DLairez%26aufirst%3DO.%26aulast%3DCalise%26aufirst%3DD.%26aulast%3DBianchi%26aufirst%3DP.%26aulast%3DOrdener%26aufirst%3DC.%26aulast%3DSpreux-Varoquaux%26aufirst%3DO.%26aulast%3DGuilbeau-Frugier%26aufirst%3DC.%26aulast%3DEscourrou%26aufirst%3DG.%26aulast%3DSeif%26aufirst%3DI.%26aulast%3DRoncalli%26aufirst%3DJ.%26aulast%3DPizzinat%26aufirst%3DN.%26aulast%3DGalinier%26aufirst%3DM.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DMialet-P%25C3%25A9rez%26aufirst%3DJ.%26atitle%3DGenetic%2520deletion%2520of%2520MAO-A%2520promotes%2520serotonin-dependent%2520ventricular%2520hypertrophy%2520by%2520pressure%2520overload%26jtitle%3DJ.%2520Mol.%2520Cell%2520Cardiol.%26date%3D2009%26volume%3D46%26spage%3D587%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Di Lisa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaludercic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menabo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giogio, M.</span><span> </span><span class="NLM_article-title">Mitochondrial pathways for ROS formation and myocardial injury: The relevance of p66She and monoamine oxidase</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1007%2Fs00395-009-0008-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=19242637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVSis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=131-139&author=F.+Di+Lisaauthor=N.+Kaludercicauthor=A.+Carpiauthor=R.+Menaboauthor=M.+Giogio&title=Mitochondrial+pathways+for+ROS+formation+and+myocardial+injury%3A+The+relevance+of+p66She+and+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66Shc and monoamine oxidase</span></div><div class="casAuthors">Di Lisa, Fabio; Kaludercic, Nina; Carpi, Andrea; Menabo, Roberta; Giorgio, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">A review.  Although mitochondria are considered the most relevant site for the formation of reactive oxygen species (ROS) in cardiac myocytes, a major and unsolved issue is where ROS are generated in mitochondria.  Respiratory chain is generally indicated as a main site for ROS formation.  However, other mitochondrial components are likely to contribute to ROS generation.  Recent reports highlight the relevance of monoamine oxidases (MAO) and p66Shc.  The importance of these systems in the irreversibility of ischemic heart injury will be discussed along with the cardioprotective effects elicited by both MAO inhibition and p66Shc knockout.  Finally, recent evidence will be reviewed that highlight the relevance of mitochondrial ROS formation also in myocardial failure and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNAiKfgbSe9LVg90H21EOLACvtfcHk0liWzRxY71i3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVSis7k%253D&md5=4003f9329d680b8787fb383c3ed9ea0b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00395-009-0008-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-009-0008-4%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DCarpi%26aufirst%3DA.%26aulast%3DMenabo%26aufirst%3DR.%26aulast%3DGiogio%26aufirst%3DM.%26atitle%3DMitochondrial%2520pathways%2520for%2520ROS%2520formation%2520and%2520myocardial%2520injury%253A%2520The%2520relevance%2520of%2520p66She%2520and%2520monoamine%2520oxidase%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2009%26volume%3D104%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F13816128113190990406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=23701542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=155-160&author=D.+E.+Edmondson&title=Hydrogen+peroxide+produced+by+mitochondrial+monoamine+oxidase+catalysis%3A+biological+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications</span></div><div class="casAuthors">Edmondson, Dale E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The biol. roles of mitochondrial-produced reactive oxygen species continue to receive intensive investigation since one of the products (H2O2) has important cellular signaling roles as well as contributing to apoptotic responses.  In general, the source of mitochondrial reactive oxygen species is thought to be the superoxide anion produced from Complex I and Complex III components of the electron transport chain.  Superoxide anion readily dismutates to H2O2 with subsequent transformation to the hydroxyl radical by Fenton chem.  An overlooked source of H2O2 in the mitochondrion is its prodn. as a catalytic reaction product from the outer membrane enzymes: monoamine oxidases A and B.  The literature is reviewed to document identified degenerative reactions attributed to H2O2 produced by MAO A and by MAO B catalysis.  Available information on the topologies of these enzymes in the mitochondrial outer membrane is also discussed with relevance to H2O2 prodn. and involvement in cell signaling functions as well as degenerative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHat4RJctm7Vg90H21EOLACvtfcHk0lgVLZFDIWYgKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D&md5=75d670b395b063ff5c876121a7d6dd0b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F13816128113190990406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128113190990406%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DHydrogen%2520peroxide%2520produced%2520by%2520mitochondrial%2520monoamine%2520oxidase%2520catalysis%253A%2520biological%2520implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D155%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Finberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loboda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fsj.bjp.0706908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=17016505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=647-656&author=J.+P.+Finbergauthor=A.+Grossauthor=O.+Bar-Amauthor=R.+Friedmanauthor=Y.+Lobodaauthor=M.+B.+Youdim&title=Cardiovascular+responses+to+combined+treatment+with+selective+monoamine+oxidase+type+B+inhibitors+and+L-DOPA+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat</span></div><div class="casAuthors">Finberg, J. P. M.; Gross, A.; Bar-Am, O.; Friedman, R.; Loboda, Y.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Postural hypotension is a common side-effect of L-DOPA treatment of Parkinson's disease, and may be potentiated when L-DOPA is combined with selegiline, a selective inhibitor of monoamine oxidase B (MAO-B).  Rasagiline is a new, potent and selective MAO-B inhibitor, which does not possess the sympathomimetic effects of selegiline.  The authors have studied the effects of these selective MAO inhibitors, L-DOPA and dopamine on the cardiovascular system of the rat.  Blood pressure and heart rate was measured in conscious rats following acute or chronic administration of rasagiline, selegiline and L-DOPA, by comparison with the selective MAO-A inhibitor clorgyline, or the MAO-A/B inhibitor tranylcypromine.  Cardiovascular responses, catecholamine release, and modification of pressor response to dopamine were studied in pithed rats.  In conscious rats neither rasagiline nor selegiline caused significant potentiation of the effects of L-DOPA (50, 100, 150 mg/kg) on blood pressure or heart rate at doses which selectively inhibited MAO-B, but L-DOPA responses were potentiated by clorgyline and tranylcypromine.  In rats treated twice daily for 8 days with L-DOPA and carbidopa, selegiline (5 mg/kg) but not rasagiline (0.2 mg/kg) caused a significant hypotensive response to L-DOPA and carbidopa, although both drugs caused similar inhibition of MAO-A and MAO-B.  In pithed rats, selegiline but not rasagiline increased catecholamine release and heart rate, and potentiated dopamine pressor response at MAO-B selective dose.  The different responses to the two MAO-B inhibitors may be explained by the amine releasing effect of amphetamine metabolites formed from selegiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltdSrkYUF2LVg90H21EOLACvtfcHk0lgVLZFDIWYgKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbrM&md5=cb6df4252517715f16e86a6efb46ebba</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706908%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DLoboda%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DCardiovascular%2520responses%2520to%2520combined%2520treatment%2520with%2520selective%2520monoamine%2520oxidase%2520type%2520B%2520inhibitors%2520and%2520L-DOPA%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D647%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Finberg, J. P.; Gillman, P. K.</span><span> </span><span class="NLM_article-title">Selective inhibitors of monoamine oxidase Type B and the “cheese effect”</span>. In  <span class="citation_source-book">International Review of Neurobiology</span>; <span class="NLM_contrib-group">Youdim, M. B.; Riederer, P.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Burlington</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">100</span>, pp  <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2FB978-0-12-386467-3.00009-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=169-190&author=J.+P.+Finberg&author=P.+K.+Gillmanauthor=M.+B.+Youdim&author=P.+Riederer&title=International+Review+of+Neurobiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-386467-3.00009-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-386467-3.00009-1%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26atitle%3DSelective%2520inhibitors%2520of%2520monoamine%2520oxidase%2520Type%2520B%2520and%2520the%2520%25E2%2580%259Ccheese%2520effect%25E2%2580%259D%26btitle%3DInternational%2520Review%2520of%2520Neurobiology%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26pub%3DAcademic%2520Press%26date%3D2011%26volume%3D100%26spage%3D169%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorodetsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=999-1005&author=M.+Weinstockauthor=E.+Gorodetskyauthor=R.+H.+Wangauthor=A.+Grossauthor=O.+Weinrebauthor=M.+B.+Youdim&title=Limited+potentiation+of+blood+pressure+response+to+oral+tyramine+by+brain-selective+monoamine+oxidase+A-B+inhibitor%2C+TV-3326+in+conscious+rabbits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DGorodetsky%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DR.%2BH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DLimited%2520potentiation%2520of%2520blood%2520pressure%2520response%2520to%2520oral%2520tyramine%2520by%2520brain-selective%2520monoamine%2520oxidase%2520A-B%2520inhibitor%252C%2520TV-3326%2520in%2520conscious%2520rabbits%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D999%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1096%2Ffj.05-4910fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=16935943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2177-2179&author=M.+Yogev-Falachauthor=O.+Bar-Amauthor=T.+Amitauthor=O.+Weinrebauthor=M.+B.+H.+Youdim&title=A+multifunctional%2C+neuroprotective+drug%2C+ladostigil+%28TV3326%29%2C+regulates+holo-APP+translation+and+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span></div><div class="casAuthors">Yogev-Falach, Merav; Bar-Am, Orit; Amit, Tamar; Weinreb, Orly; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2177-2179</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of the bifunctional drug ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5-yl)-Et Me carbamate].  Ladostigil combines the neuroprotective effects of the antiparkinson drug rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine in a single mol., as a potential treatment for Alzheimer's disease (AD) and Lewy Body disease.  Here, we assessed the dual effects of lodostigil in terms of the mol. mechanism of neuroprotection and amyloid precursor protein (APP) regulation/processing by using an apoptotic model of neuroblastoma SK-N-SH cells.  Ladostigil dose-dependently decreased cell death via inhibition of the cleavage and prevention of caspase-3 activation (IC50=1.05 μM) through a mechanism related to regulation of the Bcl-2 family proteins, which resulted in reduced levels of Bad and Bax and induced levels of Bcl-2 gene and protein expression.  We have also followed APP regulation/processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP protein without altering APP mRNA levels, suggesting a posttranscriptional mechanism.  In addn., the drug-elevated phosphorylated protein kinase C (pPKC) levels and stimulated the release of the nonamyloidogenic ot-secretase proteolytic pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor but lacks MAO inhibitory activity, exerted neuroprotective properties and regulated APP processing, indicating that these effects are independent of MAO inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEeVwmkmV5FrVg90H21EOLACvtfcHk0lgVLZFDIWYgKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ&md5=98af5388c49c4d1a4cf7b56752367fc6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1096%2Ffj.05-4910fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.05-4910fje%26sid%3Dliteratum%253Aachs%26aulast%3DYogev-Falach%26aufirst%3DM.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DA%2520multifunctional%252C%2520neuroprotective%2520drug%252C%2520ladostigil%2520%2528TV3326%2529%252C%2520regulates%2520holo-APP%2520translation%2520and%2520processing%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D2177%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2117</span><span class="NLM_x">–</span> <span class="NLM_lpage">2123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1007%2Fs11064-010-0293-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=20981484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2117-2123&author=H.+Zhengauthor=M.+Fridkinauthor=M.+B.+H.+Youdim&title=Site-activated+chelators+derived+from+anti-Parkinson+drug+rasagiline+as+a+potential+safer+and+more+effective+approach+to+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Activated Chelators Derived from Anti-Parkinson Drug Rasagiline as a Potential Safer and More Effective Approach to the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Zheng, Hailin; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2117-2123</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Chelators can modulate β-amyloid accumulation, protect against tau hyperphosphorylation, and block metal-related oxidative stress, and thereby hold considerable promise as effective anti-AD drugs.  At present, a growing interest is focusing on increasing the efficacy and targeting of chelators through drug design.  To this end, we have developed a new class of multifunctional prochelators from three FDA- approved drugs rasagiline, rivastigmine, and donepezil or tacrine.  HLA20 A was designed by merging the important pharmacophores of rasagiline, rivastigmine, and donepezil into our newly developed multifunctional chelator HLA20.  M30D was constructed using the key pharmacophoric moieties from rasagiline, rivastigmine, and tacrine.  Expts. showed that both compds. possess potent anti-acetylcholinesterase (AChE) activity in vitro with weak inhibition of butyrylcholinesterase (BuChE), and without significant metal-binding activity.  M30D was found also to be a highly potent MAO A inhibitor with moderate inhibition of MAO B in vitro.  Both HLA20 and M30D can be activated by inhibition of AChE to release active chelators HLA20 and M30, resp.  HLA20 and M30 have been shown to be able to modulate amyloid precursor protein regulation and beta-amyloid redn., suppress oxidative stress, and passivate excess metal ions (Fe, Cu, and Zn).  Compared with the activated chelator HLA20 or M30, both HLA20A and M30D exhibited lower cytotoxicity in SH-SY5Y neuroblastoma cells, substantiating the prochelator strategy for minimizing toxicity assocd. with poor targeted chelators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRLPYQHRVwWrVg90H21EOLACvtfcHk0lhOM88TkzhSHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtrbP&md5=2198fbf602fc18106e8216e4b46c1387</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs11064-010-0293-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-010-0293-1%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DSite-activated%2520chelators%2520derived%2520from%2520anti-Parkinson%2520drug%2520rasagiline%2520as%2520a%2520potential%2520safer%2520and%2520more%2520effective%2520approach%2520to%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26spage%3D2117%26epage%3D2123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández-Ledesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, B.</span><span> </span><span class="NLM_article-title">Novel tacrine–melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=B.+Hern%C3%A1ndez-Ledesmaauthor=B.+Bartolom%C3%A9&title=Novel+tacrine%E2%80%93melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DHern%25C3%25A1ndez-Ledesma%26aufirst%3DB.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DNovel%2520tacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New tacrine-4-oxo-4<i>H</i>-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine-4-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+beta-amyloid-reducing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine-4-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520beta-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">López-Iglesias, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso-Gil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New melatonin-<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3773</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5000613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3773-3785&author=B.+L%C3%B3pez-Iglesiasauthor=C.+P%C3%A9rezauthor=J.+A.+Morales-Garc%C3%ADaauthor=S.+Alonso-Gilauthor=A.+P%C3%A9rez-Castilloauthor=A.+Romeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=S.+Condeauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+melatonin-N%2CN-dibenzyl%28N-methyl%29amine+hybrids%3A+potent+neurogenic+agents+with+antioxidant%2C+cholinergic%2C+and+neuroprotective+properties+as+innovative+drugs+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm5000613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000613%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Iglesias%26aufirst%3DB.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520melatonin-N%252CN-dibenzyl%2528N-methyl%2529amine%2520hybrids%253A%2520potent%2520neurogenic%2520agents%2520with%2520antioxidant%252C%2520cholinergic%252C%2520and%2520neuroprotective%2520properties%2520as%2520innovative%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3773%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassib, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Two diseases, one approach: multitarget drug discovery in Alzheimer’s and neglected tropical diseases</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1039%2Fc4md00069b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=853-861&author=F.+Pratiauthor=E.+Uliassibauthor=M.+L.+Bolognesi&title=Two+diseases%2C+one+approach%3A+multitarget+drug+discovery+in+Alzheimer%E2%80%99s+and+neglected+tropical+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2Fc4md00069b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4md00069b%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DUliassib%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTwo%2520diseases%252C%2520one%2520approach%253A%2520multitarget%2520drug%2520discovery%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520neglected%2520tropical%2520diseases%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D853%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="note"><p class="first last">ADMET and molecular modeling details and results have been reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':[],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 47 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Carina Lemke, Joscha Christmann, Jiafei Yin, José M. Alonso, Estefanía Serrano, Mourad Chioua, Lhassane Ismaili, María Angeles Martínez-Grau, Christopher D. Beadle, Tatiana Vetman, Florian M. Dato, Ulrike Bartz, Paul W. Elsinghorst, Markus Pietsch, Christa E. Müller, Isabel Iriepa, Timo Wille, José Marco-Contelles, <span class="NLM_string-name hlFld-ContribAuthor">Michael Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Chromenones as Multineurotargeting Inhibitors of Human Enzymes. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (26)
                                     , 22161-22168. <a href="https://doi.org/10.1021/acsomega.9b03409" title="DOI URL">https://doi.org/10.1021/acsomega.9b03409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DChromenones%252Bas%252BMultineurotargeting%252BInhibitors%252Bof%252BHuman%252BEnzymes%26aulast%3DLemke%26aufirst%3DCarina%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14102019%26date%3D21112019%26date%3D11122019%26volume%3D4%26issue%3D26%26spage%3D22161%26epage%3D22168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Irene Reyes-Resina, Abdelouahid Samadi, Gemma Navarro, Haythem A. Saadeh, Mohammad A. Khasawneh, Jordi Mestres, José Marco-Contelles, <span class="NLM_string-name hlFld-ContribAuthor">Rafael Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a Tool Compound to Study the Mechanisms of Functional Selectivity between D2 and D3 Dopamine Receptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (12)
                                     , 17368-17375. <a href="https://doi.org/10.1021/acsomega.8b02509" title="DOI URL">https://doi.org/10.1021/acsomega.8b02509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02509%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DIdentification%252Bof%252Ba%252BTool%252BCompound%252Bto%252BStudy%252Bthe%252BMechanisms%252Bof%252BFunctional%252BSelectivity%252Bbetween%252BD2%252Band%252BD3%252BDopamine%252BReceptors%26aulast%3DReyes-Resina%26aufirst%3DIrene%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25092018%26date%3D03122018%26volume%3D3%26issue%3D12%26spage%3D17368%26epage%3D17375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Óscar M. Bautista-Aguilera, Josiane Budni, Francielle Mina, Eduarda Behenck Medeiros, Winnie Deuther-Conrad, José M. Entrena, Ignacio Moraleda, Isabel Iriepa, Francisco López-Muñoz, <span class="NLM_string-name hlFld-ContribAuthor">José Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Contilisant, a Tetratarget Small Molecule for Alzheimer’s Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6937-6943. <a href="https://doi.org/10.1021/acs.jmedchem.8b00848" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00848%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DContilisant%25252C%252Ba%252BTetratarget%252BSmall%252BMolecule%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%252BCombining%252BCholinesterase%25252C%252BMonoamine%252BOxidase%252BInhibition%25252C%252Band%252BH3R%252BAntagonism%252Bwith%252BS1R%252BAgonism%252BProfile%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593scar%2BM.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29052018%26date%3D18072018%26date%3D03072018%26volume%3D61%26issue%3D15%26spage%3D6937%26epage%3D6943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Van-Hai  Hoang</span>, <span class="hlFld-ContribAuthor ">Phuong-Thao  Tran</span>, <span class="hlFld-ContribAuthor ">Minghua  Cui</span>, <span class="hlFld-ContribAuthor ">Van T. H.  Ngo</span>, <span class="hlFld-ContribAuthor ">Jihyae  Ann</span>, <span class="hlFld-ContribAuthor ">Jongmi  Park</span>, <span class="hlFld-ContribAuthor ">Jiyoun  Lee</span>, <span class="hlFld-ContribAuthor ">Kwanghyun  Choi</span>, <span class="hlFld-ContribAuthor ">Hanyang  Cho</span>, <span class="hlFld-ContribAuthor ">Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Jin  Ha</span>, <span class="hlFld-ContribAuthor ">Hyun-Seok  Hong</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>, <span class="hlFld-ContribAuthor ">Young-Ho  Kim</span>, and <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2573-2590. <a href="https://doi.org/10.1021/acs.jmedchem.7b00098" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00098%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BHuman%252BGlutaminyl%252BCyclase%252BInhibitors%252Bas%252BAnti-Alzheimer%2525E2%252580%252599s%252BAgents%252BBased%252Bon%252BRational%252BDesign%26aulast%3DHoang%26aufirst%3DVan-Hai%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19012017%26date%3D13032017%26date%3D23032017%26date%3D24022017%26volume%3D60%26issue%3D6%26spage%3D2573%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Criado</span>, <span class="hlFld-ContribAuthor ">José  Mulet</span>, <span class="hlFld-ContribAuthor ">Francisco  Sala</span>, <span class="hlFld-ContribAuthor ">Salvador  Sala</span>, <span class="hlFld-ContribAuthor ">Inés  Colmena</span>, <span class="hlFld-ContribAuthor ">Luis  Gandía</span>, <span class="hlFld-ContribAuthor ">Oscar M.  Bautista-Aguilera</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, and <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>  . </span><span class="cited-content_cbyCitation_article-title">N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (8)
                                     , 1157-1165. <a href="https://doi.org/10.1021/acschemneuro.6b00122" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00122%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DN-Benzylpiperidine%252BDerivatives%252Bas%252B%2525CE%2525B17%252BNicotinic%252BReceptor%252BAntagonists%26aulast%3DCriado%26aufirst%3DManuel%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D02062016%26date%3D10062016%26date%3D17082016%26date%3D02062016%26volume%3D7%26issue%3D8%26spage%3D1157%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangjing  Lv</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105070. <a href="https://doi.org/10.1016/j.bioorg.2021.105070" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bexploration%252Bof%252Bmultifunctional%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChangjun%26date%3D2021%26volume%3D114%26spage%3D105070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Hui  Zhong</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1016/j.apsb.2021.02.023" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DGains%252Bfrom%252Bno%252Breal%252BPAINS%25253A%252BWhere%252B%2525E2%252580%252598Fair%252BTrial%252BStrategy%2525E2%252580%252599%252Bstands%252Bin%252Bthe%252Bdevelopment%252Bof%252Bmulti-target%252Bligands%26aulast%3DSun%26aufirst%3DJianbo%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László  Petri</span>, <span class="hlFld-ContribAuthor ">Péter  Ábrányi‐Balogh</span>, <span class="hlFld-ContribAuthor ">Imre  Tímea</span>, <span class="hlFld-ContribAuthor ">Gyula  Pálfy</span>, <span class="hlFld-ContribAuthor ">András  Perczel</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Martina  Hrast</span>, <span class="hlFld-ContribAuthor ">Martina  Gobec</span>, <span class="hlFld-ContribAuthor ">Izidor  Sosič</span>, <span class="hlFld-ContribAuthor ">Kinga  Nyíri</span>, <span class="hlFld-ContribAuthor ">Beáta G.  Vértessy</span>, <span class="hlFld-ContribAuthor ">Niklas  Jänsch</span>, <span class="hlFld-ContribAuthor ">Charlotte  Desczyk</span>, <span class="hlFld-ContribAuthor ">Franz‐Josef  Meyer‐Almes</span>, <span class="hlFld-ContribAuthor ">Iza  Ogris</span>, <span class="hlFld-ContribAuthor ">Simona  Golič Grdadolnik</span>, <span class="hlFld-ContribAuthor ">Luca Giacinto  Iacovino</span>, <span class="hlFld-ContribAuthor ">Claudia  Binda</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (4)
                                     , 743-753. <a href="https://doi.org/10.1002/cbic.202000700" title="DOI URL">https://doi.org/10.1002/cbic.202000700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000700%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DAssessment%252Bof%252BTractable%252BCysteines%252Bfor%252BCovalent%252BTargeting%252Bby%252BScreening%252BCovalent%252BFragments%26aulast%3DPetri%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D4%26spage%3D743%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Scarpino</span>, <span class="hlFld-ContribAuthor ">László  Petri</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Tímea  Imre</span>, <span class="hlFld-ContribAuthor ">Péter  Ábrányi-Balogh</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2021,</strong> <em>35 </em>
                                    (2)
                                     , 223-244. <a href="https://doi.org/10.1007/s10822-020-00371-5" title="DOI URL">https://doi.org/10.1007/s10822-020-00371-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-020-00371-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-020-00371-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DWIDOCK%25253A%252Ba%252Breactive%252Bdocking%252Bprotocol%252Bfor%252Bvirtual%252Bscreening%252Bof%252Bcovalent%252Binhibitors%26aulast%3DScarpino%26aufirst%3DAndrea%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D2%26spage%3D223%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhavna  Saroha</span>, <span class="hlFld-ContribAuthor ">Gourav  Kumar</span>, <span class="hlFld-ContribAuthor ">Ekta  Lathwal</span>, <span class="hlFld-ContribAuthor ">Sanjeev  Kumar</span>, <span class="hlFld-ContribAuthor ">Meena  Kumari</span>, <span class="hlFld-ContribAuthor ">Nitika  Mor</span>, <span class="hlFld-ContribAuthor ">Neera  Raghav</span>, <span class="hlFld-ContribAuthor ">Suresh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of propynyloxy substituted some novel aurones as potent cathepsin B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2021,</strong> <em>31 </em>, 100630. <a href="https://doi.org/10.1016/j.cdc.2020.100630" title="DOI URL">https://doi.org/10.1016/j.cdc.2020.100630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2020.100630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2020.100630%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DSynthesis%252Bof%252Bpropynyloxy%252Bsubstituted%252Bsome%252Bnovel%252Baurones%252Bas%252Bpotent%252Bcathepsin%252BB%252Binhibitors%26aulast%3DSaroha%26aufirst%3DBhavna%26date%3D2021%26volume%3D31%26spage%3D100630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Guieu</span>, <span class="hlFld-ContribAuthor ">Cedric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (1)
                                     , 80. <a href="https://doi.org/10.3390/molecules26010080" title="DOI URL">https://doi.org/10.3390/molecules26010080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26010080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26010080%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFirst%252BSynthesis%252Bof%252BRacemic%252BTrans%252BPropargylamino-Donepezil%25252C%252Ba%252BPleiotrope%252BAgent%252BAble%252Bto%252BBoth%252BInhibit%252BAChE%252Band%252BMAO-B%25252C%252Bwith%252BPotential%252BInterest%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGuieu%26aufirst%3DBenjamin%26date%3D2021%26date%3D2020%26volume%3D26%26issue%3D1%26spage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnankutty Chandrika  Sivakumar</span>, <span class="hlFld-ContribAuthor ">Jin  Haixiao</span>, <span class="hlFld-ContribAuthor ">C. Benjamin  Naman</span>, <span class="hlFld-ContribAuthor ">T. P.  Sajeevan</span>. </span><span class="cited-content_cbyCitation_article-title">Prospects of
              multitarget
              drug designing strategies by linking molecular docking and molecular dynamics to explore the
              protein–ligand
              recognition process. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2020,</strong> <em>81 </em>
                                    (6)
                                     , 685-699. <a href="https://doi.org/10.1002/ddr.21673" title="DOI URL">https://doi.org/10.1002/ddr.21673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21673%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DProspects%252Bof%252Bmultitarget%252Bdrug%252Bdesigning%252Bstrategies%252Bby%252Blinking%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bto%252Bexplore%252Bthe%252Bprotein%2525E2%252580%252593ligand%252Brecognition%252Bprocess%26aulast%3DSivakumar%26aufirst%3DKrishnankutty%2BChandrika%26date%3D2020%26date%3D2020%26volume%3D81%26issue%3D6%26spage%3D685%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Urban  Košak</span>, <span class="hlFld-ContribAuthor ">Nika  Strašek</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Marko  Jukič</span>, <span class="hlFld-ContribAuthor ">Simon  Žakelj</span>, <span class="hlFld-ContribAuthor ">Abida  Zahirović</span>, <span class="hlFld-ContribAuthor ">Anja  Pišlar</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Florian  Nachon</span>, <span class="hlFld-ContribAuthor ">Janko  Kos</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112282. <a href="https://doi.org/10.1016/j.ejmech.2020.112282" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112282%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-alkylpiperidine%252Bcarbamates%252Bas%252Bpotential%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%26aulast%3DKo%25C5%25A1ak%26aufirst%3DUrban%26date%3D2020%26volume%3D197%26spage%3D112282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  do Carmo Carreiras</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Propargylamine-derived multi-target directed ligands for Alzheimer’s disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (3)
                                     , 126880. <a href="https://doi.org/10.1016/j.bmcl.2019.126880" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126880</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126880%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPropargylamine-derived%252Bmulti-target%252Bdirected%252Bligands%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btherapy%26aulast%3Ddo%2BCarmo%2BCarreiras%26aufirst%3DMaria%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D126880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praveen P.N.  Rao</span>, <span class="hlFld-ContribAuthor ">Amy Trinh  Pham</span>, <span class="hlFld-ContribAuthor ">Arash  Shakeri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small molecules for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 289-322. <a href="https://doi.org/10.1016/B978-0-12-818349-6.00011-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-818349-6.00011-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818349-6.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818349-6.00011-X%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252Bsmall%252Bmolecules%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRao%26aufirst%3DPraveen%2BP.N.%26date%3D2020%26spage%3D289%26epage%3D322%26pub%3DElsevier%26atitle%3DSmall%252BMolecule%252BDrug%252BDiscovery%26date%3D2020%26volume%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Indrani  Bera</span>. </span><span class="cited-content_cbyCitation_article-title">Current Therapy and Computational Drug Designing Approaches for Neurodegenerative Diseases -with Focus on Alzheimer’s and Parkinson’s.. </span><span class="cited-content_cbyCitation_journal-name">Current Signal Transduction Therapy</span><span> <strong>2019,</strong> <em>14 </em>
                                    (2)
                                     , 122-128. <a href="https://doi.org/10.2174/1574362413666180312125419" title="DOI URL">https://doi.org/10.2174/1574362413666180312125419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574362413666180312125419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574362413666180312125419%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Signal%2520Transduction%2520Therapy%26atitle%3DCurrent%252BTherapy%252Band%252BComputational%252BDrug%252BDesigning%252BApproaches%252Bfor%252BNeurodegenerative%252BDiseases%252B-with%252BFocus%252Bon%252BAlzheimer%2525E2%252580%252599s%252Band%252BParkinson%2525E2%252580%252599s.%26aulast%3DBera%26aufirst%3DIndrani%26date%3D2019%26volume%3D14%26issue%3D2%26spage%3D122%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Daniela  Secci</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 995-1035. <a href="https://doi.org/10.1080/17460441.2019.1637415" title="DOI URL">https://doi.org/10.1080/17460441.2019.1637415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1637415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1637415%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bapproaches%252Bto%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bhuman%252Bmonoamine%252Boxidase-B%252Binhibitors%25253A%252Bis%252Bthere%252Broom%252Bfor%252Bimprovement%25253F%26aulast%3DGuglielmi%26aufirst%3DPaolo%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D995%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1603-1706. <a href="https://doi.org/10.1002/med.21561" title="DOI URL">https://doi.org/10.1002/med.21561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21561%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMonoamine%252Boxidase-B%252Binhibitors%252Bas%252Bpotential%252Bneurotherapeutic%252Bagents%25253A%252BAn%252Boverview%252Band%252Bupdate%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1603%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhupinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Vijay  Kumar</span>, <span class="hlFld-ContribAuthor ">Vikash  Prashar</span>, <span class="hlFld-ContribAuthor ">Suresh  Saini</span>, <span class="hlFld-ContribAuthor ">Ashish Ranjan  Dwivedi</span>, <span class="hlFld-ContribAuthor ">Beenu  Bajaj</span>, <span class="hlFld-ContribAuthor ">Devashish  Mehta</span>, <span class="hlFld-ContribAuthor ">Jyoti  Parkash</span>, <span class="hlFld-ContribAuthor ">Vinod  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>177 </em>, 221-234. <a href="https://doi.org/10.1016/j.ejmech.2019.05.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDipropargyl%252Bsubstituted%252Bdiphenylpyrimidines%252Bas%252Bdual%252Binhibitors%252Bof%252Bmonoamine%252Boxidase%252Band%252Bacetylcholinesterase%26aulast%3DKumar%26aufirst%3DBhupinder%26date%3D2019%26volume%3D177%26spage%3D221%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 726-739. <a href="https://doi.org/10.1016/j.ejmech.2019.06.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin-silico%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bchalcone-O-carbamate%252Bderivatives%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2019%26volume%3D178%26spage%3D726%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Burak  Kuzu</span>, <span class="hlFld-ContribAuthor ">Meltem  Tan</span>, <span class="hlFld-ContribAuthor ">Parham  Taslimi</span>, <span class="hlFld-ContribAuthor ">İlhami  Gülçin</span>, <span class="hlFld-ContribAuthor ">Mehmet  Taşpınar</span>, <span class="hlFld-ContribAuthor ">Nurettin  Menges</span>. </span><span class="cited-content_cbyCitation_article-title">Mono- or di-substituted imidazole derivatives for inhibition of acetylcholine and butyrylcholine esterases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 187-196. <a href="https://doi.org/10.1016/j.bioorg.2019.01.044" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.01.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.01.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.01.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DMono-%252Bor%252Bdi-substituted%252Bimidazole%252Bderivatives%252Bfor%252Binhibition%252Bof%252Bacetylcholine%252Band%252Bbutyrylcholine%252Besterases%26aulast%3DKuzu%26aufirst%3DBurak%26date%3D2019%26volume%3D86%26spage%3D187%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  He</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Jiaoli  Ding</span>, <span class="hlFld-ContribAuthor ">Yongbing  Sun</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Liyuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 512-528. <a href="https://doi.org/10.1016/j.bioorg.2018.09.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCoumarin-dithiocarbamate%252Bhybrids%252Bas%252Bnovel%252Bmultitarget%252BAChE%252Band%252BMAO-B%252Binhibitors%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DHe%26aufirst%3DQi%26date%3D2018%26volume%3D81%26spage%3D512%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Marija R.  Popovic‐Nikolic</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">A perspective on multi‐target drug discovery and design for complex diseases. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Medicine</span><span> <strong>2018,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40169-017-0181-2" title="DOI URL">https://doi.org/10.1186/s40169-017-0181-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40169-017-0181-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40169-017-0181-2%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Medicine%26atitle%3DA%252Bperspective%252Bon%252Bmulti%2525E2%252580%252590target%252Bdrug%252Bdiscovery%252Band%252Bdesign%252Bfor%252Bcomplex%252Bdiseases%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Alen  Albreht</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetics, mechanism, and inhibition of monoamine oxidase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neural Transmission</span><span> <strong>2018,</strong> <em>125 </em>
                                    (11)
                                     , 1659-1683. <a href="https://doi.org/10.1007/s00702-018-1861-9" title="DOI URL">https://doi.org/10.1007/s00702-018-1861-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00702-018-1861-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00702-018-1861-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neural%2520Transmission%26atitle%3DKinetics%25252C%252Bmechanism%25252C%252Band%252Binhibition%252Bof%252Bmonoamine%252Boxidase%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2018%26date%3D2018%26volume%3D125%26issue%3D11%26spage%3D1659%26epage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Siyu  He</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 463-477. <a href="https://doi.org/10.1016/j.ejmech.2018.09.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-based%252Bmulti-functional%252Bcholinesterase%252Binhibitors%252Bfor%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLi%26aufirst%3DQi%26date%3D2018%26volume%3D158%26spage%3D463%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Si-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 161-176. <a href="https://doi.org/10.1016/j.ejmech.2018.08.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-butylated%252Bhydroxytoluene%252B%252528BHT%252529%252Bhybrids%252Bas%252BAnti-Alzheimer%252527s%252Bdisease%252Bagents%252Bwith%252Bcholinergic%25252C%252Bantioxidant%25252C%252Band%252Bneuroprotective%252Bproperties%26aulast%3DCai%26aufirst%3DPei%26date%3D2018%26volume%3D157%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Talita P.C.  Chierrito</span>, <span class="hlFld-ContribAuthor ">Susimaire  Pedersoli-Mantoani</span>, <span class="hlFld-ContribAuthor ">Carlos  Roca</span>, <span class="hlFld-ContribAuthor ">Victor  Sebastian-Pérez</span>, <span class="hlFld-ContribAuthor ">Loreto  Martínez-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Pérez</span>, <span class="hlFld-ContribAuthor ">Concepción  Perez</span>, <span class="hlFld-ContribAuthor ">Angeles  Canales</span>, <span class="hlFld-ContribAuthor ">F. Javier  Cañada</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Ivone  Carvalho</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>145 </em>, 431-444. <a href="https://doi.org/10.1016/j.ejmech.2018.01.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChameleon-like%252Bbehavior%252Bof%252Bindolylpiperidines%252Bin%252Bcomplex%252Bwith%252Bcholinesterases%252Btargets%25253A%252BPotent%252Bbutyrylcholinesterase%252Binhibitors%26aulast%3DChierrito%26aufirst%3DTalita%2BP.C.%26date%3D2018%26volume%3D145%26spage%3D431%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Korábečný</span>, <span class="hlFld-ContribAuthor ">Eugenie  Nepovimová</span>, <span class="hlFld-ContribAuthor ">Tereza  Cikánková</span>, <span class="hlFld-ContribAuthor ">Katarína  Špilovská</span>, <span class="hlFld-ContribAuthor ">Lucie  Vašková</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiová</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuča</span>, <span class="hlFld-ContribAuthor ">Jana  Hroudová</span>. </span><span class="cited-content_cbyCitation_article-title">Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience</span><span> <strong>2018,</strong> <em>370 </em>, 191-206. <a href="https://doi.org/10.1016/j.neuroscience.2017.06.034" title="DOI URL">https://doi.org/10.1016/j.neuroscience.2017.06.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroscience.2017.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroscience.2017.06.034%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%26atitle%3DNewly%252BDeveloped%252BDrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bin%252BRelation%252Bto%252BEnergy%252BMetabolism%25252C%252BCholinergic%252Band%252BMonoaminergic%252BNeurotransmission%26aulast%3DKor%25C3%25A1be%25C4%258Dn%25C3%25BD%26aufirst%3DJan%26date%3D2018%26volume%3D370%26spage%3D191%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cindy Juliet Cristancho  Ortiz</span>, <span class="hlFld-ContribAuthor ">Matheus  de Freitas Silva</span>, <span class="hlFld-ContribAuthor ">Vanessa Silva  Gontijo</span>, <span class="hlFld-ContribAuthor ">Flávia Pereira Dias  Viegas</span>, <span class="hlFld-ContribAuthor ">Kris Simone Tranches  Dias</span>, <span class="hlFld-ContribAuthor ">Claudio  Viegas</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 255-351. <a href="https://doi.org/10.1007/7653_2018_2" title="DOI URL">https://doi.org/10.1007/7653_2018_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_2%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BMulti-target%252BDirected%252BLigands%252Bas%252Ba%252BModern%252BApproach%252Bfor%252Bthe%252BDevelopment%252Bof%252BInnovative%252BDrug%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DOrtiz%26aufirst%3DCindy%2BJuliet%2BCristancho%26date%3D2018%26date%3D2018%26spage%3D255%26epage%3D351%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Francesco  Ortuso</span>, <span class="hlFld-ContribAuthor ">Anél  Petzer</span>, <span class="hlFld-ContribAuthor ">Donatella  Bagetta</span>, <span class="hlFld-ContribAuthor ">Celeste  De Monte</span>, <span class="hlFld-ContribAuthor ">Daniela  Secci</span>, <span class="hlFld-ContribAuthor ">Daniela  De Vita</span>, <span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Gokhan  Zengin</span>, <span class="hlFld-ContribAuthor ">Abdurrahman  Aktumsek</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Jacobus P.  Petzer</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1543-1552. <a href="https://doi.org/10.1016/j.ejmech.2017.10.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiochemical%252Bevaluation%252Bof%252Bnovel%252Bmulti-target%252Binhibitors%252Bas%252Bpotential%252Banti-Parkinson%252Bagents%26aulast%3DCarradori%26aufirst%3DSimone%26date%3D2018%26volume%3D143%26spage%3D1543%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Mucaji</span>, <span class="hlFld-ContribAuthor ">Atanas G.  Atanasov</span>, <span class="hlFld-ContribAuthor ">Andrzej  Bak</span>, <span class="hlFld-ContribAuthor ">Violetta  Kozik</span>, <span class="hlFld-ContribAuthor ">Karolina  Sieron</span>, <span class="hlFld-ContribAuthor ">Mark  Olsen</span>, <span class="hlFld-ContribAuthor ">Weidong  Pan</span>, <span class="hlFld-ContribAuthor ">Yazhou  Liu</span>, <span class="hlFld-ContribAuthor ">Shengchao  Hu</span>, <span class="hlFld-ContribAuthor ">Junjie  Lan</span>, <span class="hlFld-ContribAuthor ">Norbert  Haider</span>, <span class="hlFld-ContribAuthor ">Robert  Musiol</span>, <span class="hlFld-ContribAuthor ">Jan  Vanco</span>, <span class="hlFld-ContribAuthor ">Marc  Diederich</span>, <span class="hlFld-ContribAuthor ">Seungwon  Ji</span>, <span class="hlFld-ContribAuthor ">Jan  Zitko</span>, <span class="hlFld-ContribAuthor ">Dongdong  Wang</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Slavica  Oljacic</span>, <span class="hlFld-ContribAuthor ">Jelica  Vucicevic</span>, <span class="hlFld-ContribAuthor ">Daniela  Jezova</span>, <span class="hlFld-ContribAuthor ">Anna  Tsantili-Kakoulidou</span>, <span class="hlFld-ContribAuthor ">Fotios  Tsopelas</span>, <span class="hlFld-ContribAuthor ">Constantinos  Giaginis</span>, <span class="hlFld-ContribAuthor ">Teresa  Kowalska</span>, <span class="hlFld-ContribAuthor ">Mieczyslaw  Sajewicz</span>, <span class="hlFld-ContribAuthor ">Jerzy  Silberring</span>, <span class="hlFld-ContribAuthor ">Przemyslaw  Mielczarek</span>, <span class="hlFld-ContribAuthor ">Marek  Smoluch</span>, <span class="hlFld-ContribAuthor ">Izabela  Jendrzejewska</span>, <span class="hlFld-ContribAuthor ">Jaroslaw  Polanski</span>, <span class="hlFld-ContribAuthor ">Josef  Jampilek</span>. </span><span class="cited-content_cbyCitation_article-title">The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1848. <a href="https://doi.org/10.3390/molecules22111848" title="DOI URL">https://doi.org/10.3390/molecules22111848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22111848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22111848%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BForty-Sixth%252BEuro%252BCongress%252Bon%252BDrug%252BSynthesis%252Band%252BAnalysis%25253A%252BSnapshot%252B%2525E2%252580%2525A0%26aulast%3DMucaji%26aufirst%3DPavel%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vaibhav A.  Dixit</span>, <span class="hlFld-ContribAuthor ">L. Arun  Lal</span>, <span class="hlFld-ContribAuthor ">Simran R.  Agrawal</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the prediction of non‐
              CYP450
              ‐mediated drug metabolism. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2017,</strong> <em>7 </em>
                                    (6)
                                     <a href="https://doi.org/10.1002/wcms.1323" title="DOI URL">https://doi.org/10.1002/wcms.1323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1323%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bprediction%252Bof%252Bnon%2525E2%252580%252590%252BCYP450%252B%2525E2%252580%252590mediated%252Bdrug%252Bmetabolism%26aulast%3DDixit%26aufirst%3DVaibhav%2BA.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Óscar M.  Bautista‐Aguilera</span>, <span class="hlFld-ContribAuthor ">Stefanie  Hagenow</span>, <span class="hlFld-ContribAuthor ">Alejandra  Palomino‐Antolin</span>, <span class="hlFld-ContribAuthor ">Víctor  Farré‐Alins</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>, <span class="hlFld-ContribAuthor ">Pierre‐Louis  Joffrin</span>, <span class="hlFld-ContribAuthor ">María L.  Jimeno</span>, <span class="hlFld-ContribAuthor ">Ondřej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jana  Janočková</span>, <span class="hlFld-ContribAuthor ">Lena  Kalinowsky</span>, <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Johannes S.  Schwed</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero Martínez</span>, <span class="hlFld-ContribAuthor ">Francisco  López‐Muñoz</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">José  Marco‐Contelles</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Multipotente Liganden mit kombinierter Cholinesterase‐ und Monoaminooxidase‐Inhibition sowie Histamin‐H
              3
              R‐Antagonismus bei neurodegenerativen Erkrankungen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (41)
                                     , 12939-12943. <a href="https://doi.org/10.1002/ange.201706072" title="DOI URL">https://doi.org/10.1002/ange.201706072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201706072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201706072%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DMultipotente%252BLiganden%252Bmit%252Bkombinierter%252BCholinesterase%2525E2%252580%252590%252Bund%252BMonoaminooxidase%2525E2%252580%252590Inhibition%252Bsowie%252BHistamin%2525E2%252580%252590H%252B3%252BR%2525E2%252580%252590Antagonismus%252Bbei%252Bneurodegenerativen%252BErkrankungen%26aulast%3DBautista%25E2%2580%2590Aguilera%26aufirst%3D%25C3%2593scar%2BM.%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D41%26spage%3D12939%26epage%3D12943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Óscar M.  Bautista‐Aguilera</span>, <span class="hlFld-ContribAuthor ">Stefanie  Hagenow</span>, <span class="hlFld-ContribAuthor ">Alejandra  Palomino‐Antolin</span>, <span class="hlFld-ContribAuthor ">Víctor  Farré‐Alins</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>, <span class="hlFld-ContribAuthor ">Pierre‐Louis  Joffrin</span>, <span class="hlFld-ContribAuthor ">María L.  Jimeno</span>, <span class="hlFld-ContribAuthor ">Ondřej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jana  Janočková</span>, <span class="hlFld-ContribAuthor ">Lena  Kalinowsky</span>, <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Johannes S.  Schwed</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero Martínez</span>, <span class="hlFld-ContribAuthor ">Francisco  López‐Muñoz</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">José  Marco‐Contelles</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H
              3
              R Antagonism for Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (41)
                                     , 12765-12769. <a href="https://doi.org/10.1002/anie.201706072" title="DOI URL">https://doi.org/10.1002/anie.201706072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201706072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201706072%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DMultitarget%2525E2%252580%252590Directed%252BLigands%252BCombining%252BCholinesterase%252Band%252BMonoamine%252BOxidase%252BInhibition%252Bwith%252BHistamine%252BH%252B3%252BR%252BAntagonism%252Bfor%252BNeurodegenerative%252BDiseases%26aulast%3DBautista%25E2%2580%2590Aguilera%26aufirst%3D%25C3%2593scar%2BM.%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D41%26spage%3D12765%26epage%3D12769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>, <span class="hlFld-ContribAuthor ">Urban  Košak</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (8)
                                     , 811-832. <a href="https://doi.org/10.4155/fmc-2017-0036" title="DOI URL">https://doi.org/10.4155/fmc-2017-0036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0036%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDual%252Binhibitors%252Bof%252Bcholinesterases%252Band%252Bmonoamine%252Boxidases%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKnez%26aufirst%3DDamijan%26date%3D2017%26volume%3D9%26issue%3D8%26spage%3D811%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serkan  Levent</span>, <span class="hlFld-ContribAuthor ">Ulviye  Acar Çevik</span>, <span class="hlFld-ContribAuthor ">Begüm Nurpelin  Sağlık</span>, <span class="hlFld-ContribAuthor ">Yusuf  Özkay</span>, <span class="hlFld-ContribAuthor ">Özgür Devrim  Can</span>, <span class="hlFld-ContribAuthor ">Ümide Demir  Özkay</span>, <span class="hlFld-ContribAuthor ">Ümit  Uçucu</span>. </span><span class="cited-content_cbyCitation_article-title">Anticholinesterase activity screening of some novel dithiocarbamate derivatives including piperidine and piperazine moieties. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2017,</strong> <em>192 </em>
                                    (4)
                                     , 469-474. <a href="https://doi.org/10.1080/10426507.2016.1259228" title="DOI URL">https://doi.org/10.1080/10426507.2016.1259228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2016.1259228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2016.1259228%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DAnticholinesterase%252Bactivity%252Bscreening%252Bof%252Bsome%252Bnovel%252Bdithiocarbamate%252Bderivatives%252Bincluding%252Bpiperidine%252Band%252Bpiperazine%252Bmoieties%26aulast%3DLevent%26aufirst%3DSerkan%26date%3D2017%26date%3D2017%26volume%3D192%26issue%3D4%26spage%3D469%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>, <span class="hlFld-ContribAuthor ">Bernard  Refouvelet</span>, <span class="hlFld-ContribAuthor ">Mohamed  Benchekroun</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>, <span class="hlFld-ContribAuthor ">Sandra  Gemma</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>, <span class="hlFld-ContribAuthor ">Slavica  Filipic</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>, <span class="hlFld-ContribAuthor ">Gerard  Esteban</span>, <span class="hlFld-ContribAuthor ">Mercedes  Unzeta</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Stefania  Butini</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2017,</strong> <em>151 </em>, 4-34. <a href="https://doi.org/10.1016/j.pneurobio.2015.12.003" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2015.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2015.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DMultitarget%252Bcompounds%252Bbearing%252Btacrine-%252Band%252Bdonepezil-like%252Bstructural%252Band%252Bfunctional%252Bmotifs%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DIsmaili%26aufirst%3DLhassane%26date%3D2017%26volume%3D151%26spage%3D4%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Urban  Košak</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Nicolas  Coquelle</span>, <span class="hlFld-ContribAuthor ">Boris  Brus</span>, <span class="hlFld-ContribAuthor ">Anja  Pišlar</span>, <span class="hlFld-ContribAuthor ">Florian  Nachon</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Janko  Kos</span>, <span class="hlFld-ContribAuthor ">Jacques-Philippe  Colletier</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer’s agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (2)
                                     , 633-645. <a href="https://doi.org/10.1016/j.bmc.2016.11.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DN-Propargylpiperidines%252Bwith%252Bnaphthalene-2-carboxamide%252Bor%252Bnaphthalene-2-sulfonamide%252Bmoieties%25253A%252BPotential%252Bmultifunctional%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%26aulast%3DKo%25C5%25A1ak%26aufirst%3DUrban%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D633%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacques  Joubert</span>, <span class="hlFld-ContribAuthor ">Germaine B.  Foka</span>, <span class="hlFld-ContribAuthor ">Benjamin P.  Repsold</span>, <span class="hlFld-ContribAuthor ">Douglas W.  Oliver</span>, <span class="hlFld-ContribAuthor ">Erika  Kapp</span>, <span class="hlFld-ContribAuthor ">Sarel F.  Malan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 853-864. <a href="https://doi.org/10.1016/j.ejmech.2016.09.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B7-substituted%252Bcoumarin%252Bderivatives%252Bas%252Bmultimodal%252Bmonoamine%252Boxidase-B%252Band%252Bcholinesterase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DJoubert%26aufirst%3DJacques%26date%3D2017%26volume%3D125%26spage%3D853%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Yu  Wu</span>, <span class="hlFld-ContribAuthor ">Gerard  Esteban</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Masahi  Shionoya</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>, <span class="hlFld-ContribAuthor ">Mercedes  Unzeta</span>, <span class="hlFld-ContribAuthor ">Tsutomu  Inokuchi</span>, <span class="hlFld-ContribAuthor ">Stefania  Butini</span>, <span class="hlFld-ContribAuthor ">Jose  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 864-879. <a href="https://doi.org/10.1016/j.ejmech.2015.10.001" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-like%252Bmultifunctional%252Bagents%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bmolecular%252Bmodeling%252Band%252Bbiological%252Bevaluation%26aulast%3DWu%26aufirst%3DMing-Yu%26date%3D2016%26volume%3D121%26spage%3D864%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Milagros  Medina</span>, <span class="hlFld-ContribAuthor ">Massimo  Valoti</span>. </span><span class="cited-content_cbyCitation_article-title">Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00375" title="DOI URL">https://doi.org/10.3389/fnins.2016.00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00375%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DKey%252BTargets%252Bfor%252BMulti-Target%252BLigands%252BDesigned%252Bto%252BCombat%252BNeurodegeneration%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular aspects of monoamine oxidase B. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neuro-Psychopharmacology and Biological Psychiatry</span><span> <strong>2016,</strong> <em>69 </em>, 81-89. <a href="https://doi.org/10.1016/j.pnpbp.2016.02.005" title="DOI URL">https://doi.org/10.1016/j.pnpbp.2016.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pnpbp.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pnpbp.2016.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neuro-Psychopharmacology%2520and%2520Biological%2520Psychiatry%26atitle%3DMolecular%252Baspects%252Bof%252Bmonoamine%252Boxidase%252BB%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2016%26volume%3D69%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ondrej  Benek</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Marketa  Pasdiorova</span>, <span class="hlFld-ContribAuthor ">Lukas  Hroch</span>, <span class="hlFld-ContribAuthor ">Vendula  Sepsova</span>, <span class="hlFld-ContribAuthor ">Petr  Jost</span>, <span class="hlFld-ContribAuthor ">Martina  Hrabinova</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>, <span class="hlFld-ContribAuthor ">Dominykas  Zala</span>, <span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Kamil  Musilek</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , 1264-1269. <a href="https://doi.org/10.1002/cmdc.201500383" title="DOI URL">https://doi.org/10.1002/cmdc.201500383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500383%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%25252C%252BSynthesis%252Band%252Bin%252Bvitro%252BEvaluation%252Bof%252BIndolotacrine%252BAnalogues%252Bas%252BMultitarget-Directed%252BLigands%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%252527s%252BDisease%26aulast%3DBenek%26aufirst%3DOndrej%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D12%26spage%3D1264%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Lazaros  Mavridis</span>, <span class="hlFld-ContribAuthor ">Teodora  Djikic</span>, <span class="hlFld-ContribAuthor ">Jelica  Vucicevic</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>, <span class="hlFld-ContribAuthor ">Kemal  Yelekci</span>, <span class="hlFld-ContribAuthor ">John B. O.  Mitchell</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00265" title="DOI URL">https://doi.org/10.3389/fnins.2016.00265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00265%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DDrug%252BDesign%252Bfor%252BCNS%252BDiseases%25253A%252BPolypharmacological%252BProfiling%252Bof%252BCompounds%252BUsing%252BCheminformatic%25252C%252B3D-QSAR%252Band%252BVirtual%252BScreening%252BMethodologies%26aulast%3DNikolic%26aufirst%3DKatarina%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>. </span><span class="cited-content_cbyCitation_article-title">One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00177" title="DOI URL">https://doi.org/10.3389/fnins.2016.00177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00177%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DOne%252Bfor%252BAll%25253F%252BHitting%252BMultiple%252BAlzheimer%252527s%252BDisease%252BTargets%252Bwith%252BOne%252BDrug%26aulast%3DHughes%26aufirst%3DRebecca%2BE.%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (7)
                                     , 1528-1539. <a href="https://doi.org/10.1016/j.bmc.2016.02.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bdonepezil%2525E2%252580%252593coumarin%252Bhybrids%252Bas%252Bmulti-target%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DXie%26aufirst%3DSai-Sai%26date%3D2016%26volume%3D24%26issue%3D7%26spage%3D1528%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhupinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Sheetal  Sheetal</span>, <span class="hlFld-ContribAuthor ">Anil K.  Mantha</span>, <span class="hlFld-ContribAuthor ">Vinod  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (48)
                                     , 42660-42683. <a href="https://doi.org/10.1039/C6RA00302H" title="DOI URL">https://doi.org/10.1039/C6RA00302H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA00302H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA00302H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRecent%252Bdevelopments%252Bon%252Bthe%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bof%252BMAO%252Binhibitors%252Band%252Btheir%252Brole%252Bin%252Bdifferent%252Bneurological%252Bdisorders%26aulast%3DKumar%26aufirst%3DBhupinder%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D48%26spage%3D42660%26epage%3D42683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic structural and functional modifications in compounds <b>I</b> and <b>II</b> leading to the new target molecules <b>1</b>–<b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds <b>1</b>–<b>12</b> synthesized and designed from compound <b>II</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesized compounds <b>13</b>–<b>19</b> designed from compound <b>I</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of compound <b>2</b> and its IC<sub>50</sub> values for the inhibition of MAO and ChEs compared with the reference compound <b>II</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Recovery of hMAO-A activity after dilution following incubation (30 min at room temperature) of the 100× enzyme concentration with 10-fold IC<sub>50</sub> concentration of compound <b>2</b> or clorgyline. The control was carried out by preincubating in the absence of inhibitor and diluting in the same way. Results are expressed as percentage of control. Represented data are mean ± SD of five independent assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Recovery of hMAO-B activity after dilution following incubation (30 min at room temperature) of the 100× enzyme concentration with 10-fold IC<sub>50</sub> concentration of compound <b>2</b> or <span class="smallcaps smallerCapital">l</span>-deprenyl. The control was carried out by preincubating in the absence of inhibitor and diluting in the same way. Results are expressed as percentage of control. Represented data are mean ± SD of five independent assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Recovery of hAChE (gray column) and hBuChE (black column) activity after the dilution of the incubation (30 min at room temperature) of the 100× enzyme concentration and 10-fold IC<sub>50</sub> of compound <b>2</b>. The control was carried out by preincubating in the absence of inhibitor and diluting in the same way. Results are expressed as percentage of control. Represented data are mean ± SD of five independent assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/medium/jm-2014-01501a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of ladostigil and M30D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501501a/20141218/images/large/jm-2014-01501a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501501a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolston, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Alzheimer disease</span> <span class="citation_source-journal">Dis. Month</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.disamonth.2010.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=20831921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADC%252BC3cfhslyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=484-546&author=R.+J.+Castellaniauthor=R.+K.+Rolstonauthor=M.+A.+Smith&title=Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease</span></div><div class="casAuthors">Castellani Rudy J; Rolston Raj K; Smith Mark A</div><div class="citationInfo"><span class="NLM_cas:title">Disease-a-month : DM</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">484-546</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmW_WC2z8qAq69lAbTj9rGfW6udTcc2eZ8ygdYTCeikLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfhslyhtw%253D%253D&md5=d754a0efd3421622cd05985364c70c59</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.disamonth.2010.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.disamonth.2010.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DRolston%26aufirst%3DR.%2BK.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DAlzheimer%2520disease%26jtitle%3DDis.%2520Month%26date%3D2010%26volume%3D56%26spage%3D484%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Reitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, R.</span><span> </span><span class="NLM_article-title">Epidemiology of Alzheimer disease</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fnrneurol.2011.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADC%252BC3M3kvF2jtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=137-152&author=C.+Reitzauthor=C.+Brayneauthor=R.+Mayeux&title=Epidemiology+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of Alzheimer disease</span></div><div class="casAuthors">Reitz Christiane; Brayne Carol; Mayeux Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The global prevalence of dementia is estimated to be as high as 24 million, and is predicted to double every 20 years through to 2040, leading to a costly burden of disease.  Alzheimer disease (AD) is the leading cause of dementia and is characterized by a progressive decline in cognitive function, which typically begins with deterioration in memory.  Before death, individuals with this disorder have usually become dependent on caregivers.  The neuropathological hallmarks of the AD brain are diffuse and neuritic extracellular amyloid plaques-which are frequently surrounded by dystrophic neurites-and intracellular neurofibrillary tangles.  These hallmark pathologies are often accompanied by the presence of reactive microgliosis and the loss of neurons, white matter and synapses.  The etiological mechanisms underlying the neuropathological changes in AD remain unclear, but are probably affected by both environmental and genetic factors.  Here, we provide an overview of the criteria used in the diagnosis of AD, highlighting how this disease is related to, but distinct from, normal aging.  We also summarize current information relating to AD prevalence, incidence and risk factors, and review the biomarkers that may be used for risk assessment and in diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDDnLJun7qK8yail4HZd-ifW6udTcc2eZ8ygdYTCeikLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3kvF2jtQ%253D%253D&md5=10ec5b1c3f8cf52b5346896d3402fb37</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2011.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2011.2%26sid%3Dliteratum%253Aachs%26aulast%3DReitz%26aufirst%3DC.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DR.%26atitle%3DEpidemiology%2520of%2520Alzheimer%2520disease%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2011%26volume%3D7%26spage%3D137%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Terry, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonatas, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span> </span><span class="NLM_article-title">Ultrastructural studies in Alzheimer’s presenile dementia</span> <span class="citation_source-journal">Ann. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADyaF2c%252Fns12jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1964&pages=269-297&author=R.+D.+Terryauthor=N.+K.+Gonatasauthor=M.+Weiss&title=Ultrastructural+studies+in+Alzheimer%E2%80%99s+presenile+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S  PRESENILE DEMENTIA</span></div><div class="casAuthors">TERRY R D; GONATAS N K; WEISS M</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">269-97</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSclvTAJVh4qWZyxfu64m4ffW6udTcc2ebA9vdGln_8Wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252Fns12jsQ%253D%253D&md5=cdcaf9fad0ceb4338cad717b01fb79f7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DR.%2BD.%26aulast%3DGonatas%26aufirst%3DN.%2BK.%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DUltrastructural%2520studies%2520in%2520Alzheimer%25E2%2580%2599s%2520presenile%2520dementia%26jtitle%3DAnn.%2520J.%2520Pathol.%26date%3D1964%26volume%3D44%26spage%3D269%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L.I.</span><span> </span><span class="NLM_article-title">Abnormal phosphorylation of the microtubule-associated protein t (tau) in Alzheimer cystoskeletal pathology</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">4913</span><span class="NLM_x">–</span> <span class="NLM_lpage">4917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1986&pages=4913-4917&author=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=Y.+C.+Tungauthor=M.+Quinlanauthor=H.+M.+Wisniewskiauthor=L.I.+Binder&title=Abnormal+phosphorylation+of+the+microtubule-associated+protein+t+%28tau%29+in+Alzheimer+cystoskeletal+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DQuinlan%26aufirst%3DM.%26aulast%3DWisniewski%26aufirst%3DH.%2BM.%26aulast%3DBinder%26aufirst%3DL.I.%26atitle%3DAbnormal%2520phosphorylation%2520of%2520the%2520microtubule-associated%2520protein%2520t%2520%2528tau%2529%2520in%2520Alzheimer%2520cystoskeletal%2520pathology%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D93%26spage%3D4913%26epage%3D4917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Oxidative stress in Alzheimer’s disease: Are we connecting the dots?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2821</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+stress+in+Alzheimer%E2%80%99s+disease%3A+Are+we+connecting+the+dots%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Are%2520we%2520connecting%2520the%2520dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2821%26epage%3D2831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perry, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesseed, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R. H.</span><span> </span><span class="NLM_article-title">Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1457</span><span class="NLM_x">–</span> <span class="NLM_lpage">1459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1136%2Fbmj.2.6150.1457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=719462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A280%3ADyaE1M%252Fmtlarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1978&pages=1457-1459&author=E.+K.+Perryauthor=B.+E.+Tomlinsonauthor=G.+Blesseedauthor=K.+Bergmannauthor=P.+H.+Gibsonauthor=R.+H.+Perry&title=Correlation+of+cholinergic+abnormalities+with+senile+plaques+and+mental+test+scores+in+senile+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia</span></div><div class="casAuthors">Perry E K; Tomlinson B E; Blessed G; Bergmann K; Gibson P H; Perry R H</div><div class="citationInfo"><span class="NLM_cas:title">British medical journal</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6150</span>),
    <span class="NLM_cas:pages">1457-9</span>
        ISSN:<span class="NLM_cas:issn">0007-1447</span>.
    </div><div class="casAbstract">Necropsy brain tissue from normal (control) patients and patients with depression and dementia was examined for activities of various cholinergic components, and these related to the degree of senile plaque formation and extent of intellectual impairment.  Choline acetyltransferase and acetylcholinesterase activities decreased significantly as the mean plaque count rose, and in depressed and demented subjects the reduction in choline acetyltransferase activity correlated with the extent of intellectual impairment as measured by a memory information test; muscarinic cholinergic receptor binding activity remained unchanged with increasing senile plaque formation but butyrylcholinesterase activity increased.  The results suggest a close relation between changes in the cholinergic system and Alzheimer's dementia, but the precise role of the system in this disease remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcQ6QKOYjgVs-crCu0nI_sfW6udTcc2ebA9vdGln_8Wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252Fmtlarsw%253D%253D&md5=800e19ccc531362f8ba149dfd1c8c1ef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fbmj.2.6150.1457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.2.6150.1457%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DE.%2BK.%26aulast%3DTomlinson%26aufirst%3DB.%2BE.%26aulast%3DBlesseed%26aufirst%3DG.%26aulast%3DBergmann%26aufirst%3DK.%26aulast%3DGibson%26aufirst%3DP.%2BH.%26aulast%3DPerry%26aufirst%3DR.%2BH.%26atitle%3DCorrelation%2520of%2520cholinergic%2520abnormalities%2520with%2520senile%2520plaques%2520and%2520mental%2520test%2520scores%2520in%2520senile%2520dementia%26jtitle%3DBr.%2520Med.%2520J.%26date%3D1978%26volume%3D2%26spage%3D1457%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Talesa, V. N.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase in Alzheimer’s disease</span> <span class="citation_source-journal">Mech. Ageing Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2001&pages=1961-1969&author=V.+N.+Talesa&title=Acetylcholinesterase+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalesa%26aufirst%3DV.%2BN.%26atitle%3DAcetylcholinesterase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMech.%2520Ageing%2520Dev.%26date%3D2001%26volume%3D122%26spage%3D1961%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span> </span><span class="NLM_article-title">Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=30-38&author=A.+V.+Terryauthor=J.+J.+Buccafuscoauthor=C.+Wilson&title=Cognitive+dysfunction+in+neuropsychiatric+disorders%3A+selected+serotonin+receptor+subtypes+as+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DWilson%26aufirst%3DC.%26atitle%3DCognitive%2520dysfunction%2520in%2520neuropsychiatric%2520disorders%253A%2520selected%2520serotonin%2520receptor%2520subtypes%2520as%2520therapeutic%2520targets%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D195%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Youdim, M. B. H.; Finberg, J. P. M.; Tipton, K. F.</span><span> </span><span class="NLM_article-title">Monoamine oxidase</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Tredelenburg, U. ; Weiner, N.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">20</span>, pp  <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1007%2F978-3-642-46625-0_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=119-192&author=M.+B.+H.+Youdim&author=J.+P.+M.+Finberg&author=K.+F.+Tiptonauthor=U.+Tredelenburg&author=N.+Weiner&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-46625-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-46625-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMonoamine%2520oxidase%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DTredelenburg%26aufirst%3DU.%26pub%3DSpringer-Verlag%26date%3D1988%26volume%3D20%26spage%3D119%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Johnston, J. P.</span><span> </span><span class="NLM_article-title">Some observations upon a new inhibitor of monoamine oxidasein brain tissue</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1968&pages=1285-1297&author=J.+P.+Johnston&title=Some+observations+upon+a+new+inhibitor+of+monoamine+oxidasein+brain+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BP.%26atitle%3DSome%2520observations%2520upon%2520a%2520new%2520inhibitor%2520of%2520monoamine%2520oxidasein%2520brain%2520tissue%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1968%26volume%3D17%26spage%3D1285%26epage%3D1297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Tissue distribution of human monoamine oxidase A and B mRNA</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1111%2Fj.1471-4159.1990.tb03121.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=2398352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=1166-1169&author=J.+Grimsbyauthor=N.+C.+Lanauthor=R.+Neveauthor=K.+Chenauthor=J.+C.+Shih&title=Tissue+distribution+of+human+monoamine+oxidase+A+and+B+mRNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of human monoamine oxidase A and B mRNA</span></div><div class="casAuthors">Grimsby, Joseph; Lan, Nancy C.; Neve, Rachael; Chen, Kevin; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1166-9</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Northern anal. using 32P-labeled subfragments of human liver MAO A and B cDNA clone detected a 5- and 3-kb transcript, resp., in most human tissues examd.  However, fetal heart and thymus express minute amts. of MAO A transcript, whereas fetal brain, muscle, thymus, spleen, meninges, and placenta express minute amts. of MAO B transcript.  Small intestine and placenta express, in addn. to the MAO A 5-kb transcript, a 2-kb transcript, which may arise from an alternative polyadenylation site.  MAO A and B transcripts are expressed in similar regions of adult human being.  The highest concns. of these transcripts were located in frontal cortex and locus ceruleus.  This study demonstrates the tissue-specific distribution of the MAO genes and will provide insight into the physiol. functions of MAO A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNhXyOI-PQ87Vg90H21EOLACvtfcHk0lhHxgik2ps85w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D&md5=e3f1af76b4168d94b13811471cf46fc5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1990.tb03121.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1990.tb03121.x%26sid%3Dliteratum%253Aachs%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DN.%2BC.%26aulast%3DNeve%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DTissue%2520distribution%2520of%2520human%2520monoamine%2520oxidase%2520A%2520and%2520B%2520mRNA%26jtitle%3DJ.%2520Neurochem.%26date%3D1990%26volume%3D55%26spage%3D1166%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Harfenist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuseur, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyner, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, H. L.</span><span> </span><span class="NLM_article-title">Selective inhibitors of monoamine oxidase. 3. Structure–activity relationship of tricyclics bearing imidazoline, oxadiazole, or tetrazole groups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1857</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950595m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1857-1863&author=H.+Harfenistauthor=D.+J.+Heuseurauthor=C.+T.+Joynerauthor=J.+F.+Batchelorauthor=H.+L.+White&title=Selective+inhibitors+of+monoamine+oxidase.+3.+Structure%E2%80%93activity+relationship+of+tricyclics+bearing+imidazoline%2C+oxadiazole%2C+or+tetrazole+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm950595m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950595m%26sid%3Dliteratum%253Aachs%26aulast%3DHarfenist%26aufirst%3DH.%26aulast%3DHeuseur%26aufirst%3DD.%2BJ.%26aulast%3DJoyner%26aufirst%3DC.%2BT.%26aulast%3DBatchelor%26aufirst%3DJ.%2BF.%26aulast%3DWhite%26aufirst%3DH.%2BL.%26atitle%3DSelective%2520inhibitors%2520of%2520monoamine%2520oxidase.%25203.%2520Structure%25E2%2580%2593activity%2520relationship%2520of%2520tricyclics%2520bearing%2520imidazoline%252C%2520oxadiazole%252C%2520or%2520tetrazole%2520groups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1857%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielczyk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünblatt, E.</span><span> </span><span class="NLM_article-title">Monoamine oxidase-B inhibition in Alzheimer’s disease</span> <span class="citation_source-journal">Neurotoxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=271-277&author=P.+Riedererauthor=W.+Danielczykauthor=E.+Gr%C3%BCnblatt&title=Monoamine+oxidase-B+inhibition+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DDanielczyk%26aufirst%3DW.%26aulast%3DGr%25C3%25BCnblatt%26aufirst%3DE.%26atitle%3DMonoamine%2520oxidase-B%2520inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotoxicology%26date%3D2004%26volume%3D25%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS neurotransmitters</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.pharmthera.2014.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=24607445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=133-152&author=J.+P.+M.+Finberg&title=Update+on+the+pharmacology+of+selective+inhibitors+of+MAO-A+and+MAO-B%3A+focus+on+modulation+of+CNS+neurotransmitters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span></div><div class="casAuthors">Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhibitors of monoamine oxidase (MAO) were initially used in medicine following the discovery of their antidepressant action.  Subsequently their ability to potentiate the effects of an indirectly-acting sympathomimetic amine such as tyramine was discovered, leading to their limitation in clin. use, except for cases of treatment-resistant depression.  More recently, the understanding that: a) potentiation of indirectly-acting sympathomimetic amines is caused by inhibitors of MAO-A but not by inhibitors of MAO-B, and b) that reversible inhibitors of MAO-A cause minimal tyramine potentiation, has led to their re-introduction to clin. use for treatment of depression (reversible MAO-A inhibitors and new dose form MAO-B inhibitor) and treatment of Parkinson's disease (MAO-B inhibitors).  The profound neuroprotective properties of propargyl-based inhibitors of MAO-B in preclin. expts. have drawn attention to the possibility of employing these drugs for their neuroprotective effect in neurodegenerative diseases, and have raised the question of the involvement of the MAO-mediated reaction as a source of reactive free radicals.  Despite the long-standing history of MAO inhibitors in medicine, the way in which they affect neuronal release of monoamine neurotransmitters is still poorly understood.  In recent years, the detailed chem. structure of MAO-B and MAO-A has become available, providing new possibilities for synthesis of mechanism-based inhibitors.  This review describes the latest advances in understanding the way in which MAO inhibitors affect the release of the monoamine neurotransmitters dopamine, noradrenaline and serotonin (5-HT) in the CNS, with an accent on the importance of these effects for the clin. actions of the drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSGMvtQ1Ca5bVg90H21EOLACvtfcHk0lhHxgik2ps85w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D&md5=0f31959bad34842d4aaaba7b8162e5b8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DUpdate%2520on%2520the%2520pharmacology%2520of%2520selective%2520inhibitors%2520of%2520MAO-A%2520and%2520MAO-B%253A%2520focus%2520on%2520modulation%2520of%2520CNS%2520neurotransmitters%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D133%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gura, T.</span><span> </span><span class="NLM_article-title">Hope in Alzheimer’s fight emerges from unexpected places</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=894&author=T.+Gura&title=Hope+in+Alzheimer%E2%80%99s+fight+emerges+from+unexpected+places"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGura%26aufirst%3DT.%26atitle%3DHope%2520in%2520Alzheimer%25E2%2580%2599s%2520fight%2520emerges%2520from%2520unexpected%2520places%26jtitle%3DNature%2520Med.%26date%3D2008%26volume%3D14%26spage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzucchelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porrello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, S.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors: novel activities of old molecules</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.phrs.2003.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=15304241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=441-451&author=M.+Racchiauthor=M.+Mazzucchelliauthor=E.+Porrelloauthor=C.+Lanniauthor=S.+Govoni&title=Acetylcholinesterase+inhibitors%3A+novel+activities+of+old+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors: novel activities of old molecules</span></div><div class="casAuthors">Racchi, Marco; Mazzucchelli, Michela; Porrello, Emanuela; Lanni, Cristina; Govoni, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The therapeutic approach for improving the cognitive function in patients with Alzheimer's disease (AD) is mainly based on the potentiation of central cholinergic activity and is achieved clin. by the use of acetylcholinesterase (AChE) inhibitors such as tacrine, donepezil, rivastigmine, galantamine and other drugs currently in clin. trials.  These are, by their pharmacol., only symptomatic drugs yet recently these mols. have shown some potential also in the modulation of amyloid precursor protein (APP) processing.  We explore in this review the exptl. evidence that suggests a role for AChEIs in APP processing and point to multiple complex mechanisms involving either a cholinergic agonist effect, coupled to multiple signal transduction pathways, or post-transcriptional effects that modulate the expression of cellular APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpOo04QwYy7Vg90H21EOLACvtfcHk0liBonI22eOOww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCqsr8%253D&md5=7f81d066fa285380f75c36d18ec46313</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2003.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2003.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DMazzucchelli%26aufirst%3DM.%26aulast%3DPorrello%26aufirst%3DE.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DGovoni%26aufirst%3DS.%26atitle%3DAcetylcholinesterase%2520inhibitors%253A%2520novel%2520activities%2520of%2520old%2520molecules%26jtitle%3DPharmacol.%2520Res.%26date%3D2004%26volume%3D50%26spage%3D441%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F092986708785909067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=18855672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2433-2455&author=D.+Mu%C3%B1oz-Torrero&title=Acetylcholinesterase+inhibitors+as+disease-modifying+therapies+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease</span></div><div class="casAuthors">Munoz-Torrero, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2433-2455</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic arsenal for the treatment of Alzheimer's disease (AD) remains confined to a group of four inhibitors of AChE and one NMDA receptor antagonist, which are used to provide a relief of the very late symptoms of the dementia, i.e. the cognitive and functional decline.  In line with the growing body of evidence of the pivotal role of the β-amyloid peptide (Aβ) in the pathogenesis of AD, alternative classes of drugs targeting mainly the formation or the aggregation of Aβ are actively pursued by the pharmaceutical industry, as they could pos. modify the course of AD, stopping or slowing down disease progression.  While the first amyloid-directed disease-modifying drugs go ahead with their clin. development and could reach the market as soon as 2009, mounting preclin. and clin. evidences is pointing towards a disease-modifying role also for currently marketed anti-Alzheimer AChE inhibitors (AChEIs), particularly for donepezil.  In this review, the neuroprotective effects exhibited by currently commercialized AChEIs will be briefly discussed, together with the secondary mechanisms through which they could exert such effects.  This review will focus also on particular classes of AChEIs, namely dual binding site AChEIs, which are being purposely designed to target Aβ aggregation and / or other biol. targets that contribute to AD pathogenesis, thus constituting very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqII-Yg4R84wrVg90H21EOLACvtfcHk0liBonI22eOOww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI&md5=a27eaf0ba08a4d9e5c8363f6b5621e5d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F092986708785909067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785909067%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520as%2520disease-modifying%2520therapies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2433%26epage%3D2455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span> </span><span class="NLM_article-title">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F138161206778792985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=17105433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4377-4387&author=A.+Castroauthor=A.+Mart%C3%ADnez&title=Targeting+beta-amyloid+pathogenesis+through+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4377-4387</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of the current difficulties is related to the lack of solid evidence about the ultimate factors that give rise to the pathogenesis of this disease, creating a great challenge for the definition of efficient treatments for Alzheimer's disease (AD).  Current therapeutic option for AD patients is the use of acetylcholinesterase (AChE) inhibitors, which gives only a symptomatic relief.  However, recent studies show a long-lasting effect in a certain percentage of patients.  In fact, there is accumulating evidence that an AChE has secondary non-cholinergic functions including the processing and deposition of β-amyloid (Aβ).  AChE could play a role in the Aβ metab. and during an early step in the development of the senile plaque, as revealed by the finding that AChE accelerates Aβ deposition.  Considering the non-classical AChE functions, their relationships with AD hallmarks, and the putative role of peripheral anionic site in all these functions, the dual binding site AChE inhibitors may acquire importance for AD treatment.  On the other hand, the interference of AChE inhibitors with Aβ processing is not a general rule for this class of compds. with the involvement of other features such as chem. structure and/or genetic regulation.  This review highlights the collection of several compds. with an outstanding profile against AChE-induced amyloid aggregation and potent AChE inhibitory activity, indicating the possibility of targeting Aβ through the inhibition of AChE and reveals the emergence of a new generation of AChE inhibitors aiming to be excellent candidate drugs for the future cure of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrisn7G_dIHxrVg90H21EOLACvtfcHk0liBonI22eOOww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI&md5=fd41eca56c6433d9ee6a3989908ff2c5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F138161206778792985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792985%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DTargeting%2520beta-amyloid%2520pathogenesis%2520through%2520acetylcholinesterase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4377%26epage%3D4387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0liBonI22eOOww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lhgn8oCZaQQnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Anighoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7874</span><span class="NLM_x">–</span> <span class="NLM_lpage">7887</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0lhgn8oCZaQQnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for α<sub>1</sub>-adrenoreceptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4895</span><span class="NLM_x">–</span> <span class="NLM_lpage">4903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030952q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4895-4903&author=M.+Rosiniauthor=A.+Antonelloauthor=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=G.+Marucciauthor=E.+Poggesiauthor=A.+Leonardiauthor=C.+Melchiorre&title=Prazosin-related+compounds.+Effect+of+transforming+the+piperazinylquinazoline+moiety+into+an+aminomethyltetrahydroacridine+system+on+the+affinity+for+%CE%B11-adrenoreceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm030952q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030952q%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAntonello%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DPrazosin-related%2520compounds.%2520Effect%2520of%2520transforming%2520the%2520piperazinylquinazoline%2520moiety%2520into%2520an%2520aminomethyltetrahydroacridine%2520system%2520on%2520the%2520affinity%2520for%2520%25CE%25B11-adrenoreceptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4895%26epage%3D4903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appenroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiehntopf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roegler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deufel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of NO-donor–tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701491k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=713-716&author=L.+Fangauthor=D.+Appenrothauthor=M.+Deckerauthor=M.+Kiehntopfauthor=C.+Roeglerauthor=T.+Deufelauthor=C.+Fleckauthor=S.+Pengauthor=Y.+Zhangauthor=J.+Lehmann&title=Synthesis+and+biological+evaluation+of+NO-donor%E2%80%93tacrine+hybrids+as+hepatoprotective+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm701491k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701491k%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DKiehntopf%26aufirst%3DM.%26aulast%3DRoegler%26aufirst%3DC.%26aulast%3DDeufel%26aufirst%3DT.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520NO-donor%25E2%2580%2593tacrine%2520hybrids%2520as%2520hepatoprotective%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D713%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Stosel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuppers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span> </span><span class="NLM_article-title">Dual targeting of adenosine A2A receptors and monoamine oxidase B by 4<i>H</i>-3,1-benzothiazin-4-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4580-4596&author=A.+Stoselauthor=M.+Schlenkauthor=S.+Hinzauthor=P.+Kuppersauthor=J.+Heerauthor=M.+Gutschowauthor=C.+E.+Muller&title=Dual+targeting+of+adenosine+A2A+receptors+and+monoamine+oxidase+B+by+4H-3%2C1-benzothiazin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStosel%26aufirst%3DA.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DKuppers%26aufirst%3DP.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DGutschow%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26atitle%3DDual%2520targeting%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520monoamine%2520oxidase%2520B%2520by%25204H-3%252C1-benzothiazin-4-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4580%26epage%3D4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of tacrine–ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates</span> <span class="citation_source-journal">Bioorg. Med. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2905</span><span class="NLM_x">–</span> <span class="NLM_lpage">2909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.bmcl.2008.03.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=18406135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVWjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2905-2909&author=L.+Fangauthor=B.+Krausauthor=J.+Lehmannauthor=J.+Heilmannauthor=Y.+Zhangauthor=M.+Decker&title=Design+and+synthesis+of+tacrine%E2%80%93ferulic+acid+hybrids+as+multi-potent+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates</span></div><div class="casAuthors">Fang, Lei; Kraus, Birgit; Lehmann, Jochen; Heilmann, Joerg; Zhang, Yihua; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2905-2909</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Five tacrine-ferulic acid hybrids were designed and synthesized as multi-potent anti-Alzheimer drug candidates.  All target compds. have better acetylcholinesterase inhibitory activity and comparable butyrylcholinesterase inhibitory activity in relation to tacrine.  Interestingly, I showed a reversible and non-competitive inhibitory action for acetylcholinesterase indicating interaction with the peripheral anionic site, whereas a reversible but competitive inhibitory action for butyrylcholinesterase.  The antioxidant study revealed that four target compds. have, compared to Trolox, high ability to absorb reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQXuASkdXTpbVg90H21EOLACvtfcHk0lg8d_No1lD5ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVWjsLs%253D&md5=897c1f2da05a30e87e5042ce59cb125f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.03.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.03.073%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DKraus%26aufirst%3DB.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tacrine%25E2%2580%2593ferulic%2520acid%2520hybrids%2520as%2520multi-potent%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DBioorg.%2520Med.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2905%26epage%3D2909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">V. Pérez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Álvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fsj.bjp.0702600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=10433493" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1999&pages=869-876&author=V.+V.+P%C3%A9rezauthor=J.+L.+Marcoauthor=E.+Fern%C3%A1ndez-%C3%81lvarezauthor=M.+Unzeta&title=Relevance+of+benzyloxy+group+in+2-indolyl+methylamines+in+the+selective+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702600%26sid%3Dliteratum%253Aachs%26aulast%3DV.%2BP%25C3%25A9rez%26aufirst%3DV.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DFern%25C3%25A1ndez-%25C3%2581lvarez%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DRelevance%2520of%2520benzyloxy%2520group%2520in%25202-indolyl%2520methylamines%2520in%2520the%2520selective%2520MAO-B%2520inhibition%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D127%26spage%3D869%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2013&pages=893-902&author=I.+Boleaauthor=A.+Gellaauthor=M.+Unzeta&title=Propargylamine-derived+multitarget-directed+ligands%3A+fighting+Alzheimer%E2%80%99s+disease+with+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DPropargylamine-derived%2520multitarget-directed%2520ligands%253A%2520fighting%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2013%26volume%3D120%26spage%3D893%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Ríos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouplana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling of donepezil and <i>N</i>-[(5-(benzyloxy)-1-methyl-1<i>H</i>-indol-2-yl)methyl]-<i>N</i>-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8251</span><span class="NLM_x">–</span> <span class="NLM_lpage">8270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200853t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8251-8270&author=I.+Boleaauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=C.+de+los+R%C3%ADosauthor=M.+Chiouaauthor=R.+Pouplanaauthor=F.+J.+Luqueauthor=M.+Unzetaauthor=J.+Marco-Contellesauthor=A.+Samadi&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+of+donepezil+and+N-%5B%285-%28benzyloxy%29-1-methyl-1H-indol-2-yl%29methyl%5D-N-methylprop-2-yn-1-amine+hybrids+as+new+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200853t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200853t%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DPouplana%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520of%2520donepezil%2520and%2520N-%255B%25285-%2528benzyloxy%2529-1-methyl-1H-indol-2-yl%2529methyl%255D-N-methylprop-2-yn-1-amine%2520hybrids%2520as%2520new%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8251%26epage%3D8270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span> </span><span class="NLM_article-title">Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234 a multi-target compound for designed for use in Alzheimer’s disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1844</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.bbapap.2014.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVeqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1844&publication_year=2014&pages=1104-1110&author=G.+Estebanauthor=J.+Allanauthor=A.+Samadiauthor=A.+Matteviauthor=M.+Unzetaauthor=J.+Marco-Contellesauthor=C.+Bindaauthor=R.+R.+Ramsay&title=Kinetic+and+structural+analysis+of+the+irreversible+inhibition+of+human+monoamine+oxidases+by+ASS234+a+multi-target+compound+for+designed+for+use+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease</span></div><div class="casAuthors">Esteban, Gerard; Allan, Jennifer; Samadi, Abdelouahid; Mattevi, Andrea; Unzeta, Mercedes; Marco-Contelles, Jose; Binda, Claudia; Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1844</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1104-1110</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Monoamine oxidases (MAO) and cholinesterases are validated targets in the design of drugs for the treatment of Alzheimer's disease.  The multi-target compd. N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (ASS234), bearing the MAO-inhibiting propargyl group attached to a donepezil moiety that inhibits cholinesterases, retained activity against human acetyl- and butyryl-cholinesterases.  The inhibition of MAO A and MAO B by ASS234 was characterized and compared to other known MAO inhibitors.  ASS234 was almost as effective as clorgyline (kinact/KI = 3 × 106 min- 1 M- 1) and was shown by structural studies to form the same N5 covalent adduct with the FAD cofactor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqdbntEH0c5rVg90H21EOLACvtfcHk0lg8d_No1lD5ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVeqtLg%253D&md5=6bb57337217cbf2813593c9cb36eea0f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DAllan%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DKinetic%2520and%2520structural%2520analysis%2520of%2520the%2520irreversible%2520inhibition%2520of%2520human%2520monoamine%2520oxidases%2520by%2520ASS234%2520a%2520multi-target%2520compound%2520for%2520designed%2520for%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2014%26volume%3D1844%26spage%3D1104%26epage%3D1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">The multipotent, permeable drug ASS234 inhibits Aβ aggregation, possesses antioxidant properties and protects from Aβ-induced apoptosis</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F15672050113109990151" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=797-808&author=I.+Boleaauthor=A.+Gellaauthor=L.+Monjasauthor=C.+P%C3%A9rezauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=J.+L.+Marco-Contellesauthor=A.+Samadiauthor=M.+Unzeta&title=The+multipotent%2C+permeable+drug+ASS234+inhibits+A%CE%B2+aggregation%2C+possesses+antioxidant+properties+and+protects+from+A%CE%B2-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F15672050113109990151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15672050113109990151%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%2BL.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DThe%2520multipotent%252C%2520permeable%2520drug%2520ASS234%2520inhibits%2520A%25CE%25B2%2520aggregation%252C%2520possesses%2520antioxidant%2520properties%2520and%2520protects%2520from%2520A%25CE%25B2-induced%2520apoptosis%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2013%26volume%3D9%26spage%3D797%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">del Pino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span> </span><span class="NLM_article-title">Wnt signaling pathway, a potential target for Alzheimer’s disease treatment, is activated by a novel multitarget compound ASS234</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1111%2Fcns.12269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=24712554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ygsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=568-570&author=J.+del+Pinoauthor=E.+Ramosauthor=O.+M.+Bautista+Aguileraauthor=J.+Marco-Contellesauthor=A.+Romero&title=Wnt+signaling+pathway%2C+a+potential+target+for+Alzheimer%E2%80%99s+disease+treatment%2C+is+activated+by+a+novel+multitarget+compound+ASS234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt Signaling Pathway, a Potential Target for Alzheimer's Disease Treatment, is Activated by a Novel Multitarget Compound ASS234</span></div><div class="casAuthors">del Pino, Javier; Ramos, Eva; Aguilera, Oscar M. Bautista; Marco-Contelles, Jose; Romero, Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">568-570</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This article discusses the Wnt signaling pathway, potential target for Alzheimer's disease treatment, as activated by novel multitarget compd. ASS234.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLOsI2pG90nbVg90H21EOLACvtfcHk0lgKWxFR0ANhhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ygsbw%253D&md5=9820f13ea52a716359b2ae215bd90e7f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fcns.12269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12269%26sid%3Dliteratum%253Aachs%26aulast%3Ddel%2BPino%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DE.%26aulast%3DBautista%2BAguilera%26aufirst%3DO.%2BM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DA.%26atitle%3DWnt%2520signaling%2520pathway%252C%2520a%2520potential%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%252C%2520is%2520activated%2520by%2520a%2520novel%2520multitarget%2520compound%2520ASS234%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2014%26volume%3D20%26spage%3D568%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Stasiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, W. A.</span><span> </span><span class="NLM_article-title">Effects of novel monoamine oxidases and cholinesterases targeting compounds on brain neurotransmitters and behavior in rat model of vascular dementia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F13816128113199990026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=23701539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=161-171&author=A.+Stasiakauthor=M.+Mussurauthor=M.+Unzetaauthor=A.+Samadiauthor=J.+L.+Marco-Contellesauthor=W.+A.+Fogel&title=Effects+of+novel+monoamine+oxidases+and+cholinesterases+targeting+compounds+on+brain+neurotransmitters+and+behavior+in+rat+model+of+vascular+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia</span></div><div class="casAuthors">Stasiak, Anna; Mussur, Miroslaw; Unzeta, Mercedes; Samadi, Abdelouahid; Marco-Contelles, Jose L.; Fogel, W. Agnieszka</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Neurodegenerative disorders are assocd. with different neurochem. and morphol. alterations in the brain leading to cognitive and behavioral impairments.  New therapeutic strategies comprise multifunctional drugs.  The aim of the presented studies is to evaluate in vivo the novel compds. - ASS188 and ASS234 - which combine the benzylpiperidine moiety of the acetylcholinesteras (AChE) inhibitor donepezil and the indolyl propargylamino moiety of the monoaminooxidase (MAO) inhibitor, N-[(5-benzyloxy-1- methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine, with respect to their influence on cerebral amine neurotransmitters systems and neuroprotective activity.  The presumed therapeutic potential of these compds. has been evaluated following their administration to rats with exptl. vascular dementia.  A rat model of the permanent bilateral occlusion of the common carotid arteries (BCCAO) and the holeboard memory test were employed for this purpose.  Wistar rats were used, either intact or 1 day after BCCAO.  ASS188 (1 mg/kg) and ASS234 (5 mg/kg) were given s.c. for 5 consecutive days.  Working and ref. memory in rats was evaluated by holeboard tests before- and 7 and 12 days after BCCAO.  The activities of MAOs, AChE and histamine N-methyltransferase (HMT), as well as cerebral amines concns. were assayed.  A significant inhibition of brain MAO A (>95%) and weaker MAO B (ca 60%) and HMT (<30%) and reduced AChE activities were recorded with a pronounced (2 - 10 fold) increase in the cerebral concns. of serotonin, dopamine, and noradrenaline and smaller rises (up to 30%) of histamine.  The BCCAO rats treated with ASS188 or ASS234 tended to perform holeboard tests better than the BCCAO untreated group, indicating a beneficial effect of the administered therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod78mIR4gCubVg90H21EOLACvtfcHk0lgKWxFR0ANhhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOhtr4%253D&md5=45a25792f918f9f1b481cedf84f75e50</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F13816128113199990026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128113199990026%26sid%3Dliteratum%253Aachs%26aulast%3DStasiak%26aufirst%3DA.%26aulast%3DMussur%26aufirst%3DM.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%2BL.%26aulast%3DFogel%26aufirst%3DW.%2BA.%26atitle%3DEffects%2520of%2520novel%2520monoamine%2520oxidases%2520and%2520cholinesterases%2520targeting%2520compounds%2520on%2520brain%2520neurotransmitters%2520and%2520behavior%2520in%2520rat%2520model%2520of%2520vascular%2520dementia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D161%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zhu, Z. J.</span><span> </span><span class="NLM_article-title">‘Clik’ assemby of selective inhibitors of MAO-A</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6222</span><span class="NLM_x">–</span> <span class="NLM_lpage">6225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6222-6225&author=Z.+J.+Zhu&title=%E2%80%98Clik%E2%80%99+assemby+of+selective+inhibitors+of+MAO-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%2BJ.%26atitle%3D%25E2%2580%2598Clik%25E2%2580%2599%2520assemby%2520of%2520selective%2520inhibitors%2520of%2520MAO-A%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6222%26epage%3D6225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbaba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil–indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=82-95&author=O.+M.+Bautista-Aguileraauthor=G.+Estebanauthor=I.+Boleaauthor=K.+Nikolicauthor=D.+Agbabaauthor=I.+Moraledaauthor=I.+Iriepaauthor=A.+Samadiauthor=E.+Sorianoauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Design%2C+synthesis%2C+pharmacological+evaluation%2C+QSAR+analysis%2C+molecular+modeling+and+ADMET+of+novel+donepezil%E2%80%93indolyl+hybrids+as+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+potential+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DAgbaba%26aufirst%3DD.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520pharmacological%2520evaluation%252C%2520QSAR%2520analysis%252C%2520molecular%2520modeling%2520and%2520ADMET%2520of%2520novel%2520donepezil%25E2%2580%2593indolyl%2520hybrids%2520as%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D75%26spage%3D82%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikcolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxyl aminoindan and phenethylamine as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Mikcolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=J.+Finbergauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxyl+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMikcolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxyl%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D54%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span> </span><span class="NLM_article-title">Site-activated multifunctional chelator with acetycholinesterase and neuroprotective-neurorestorative moieties for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4098</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900504c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4095-4098&author=H.+Zhengauthor=M.+B.+H.+Youdimauthor=M.+Fridkin&title=Site-activated+multifunctional+chelator+with+acetycholinesterase+and+neuroprotective-neurorestorative+moieties+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm900504c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900504c%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DFridkin%26aufirst%3DM.%26atitle%3DSite-activated%2520multifunctional%2520chelator%2520with%2520acetycholinesterase%2520and%2520neuroprotective-neurorestorative%2520moieties%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4095%26epage%3D4098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1096%2Ffj.05-4910fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=16935943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2177-2179&author=M.+Yogev-Falachauthor=O.+Bar-Amauthor=T.+Amitauthor=O.+Weinrebauthor=M.+B.+Youdim&title=A+multifunctional%2C+neuroprotective+drug%2C+ladostigil+%28TV3326%29%2C+regulates+holo-APP+translation+and+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span></div><div class="casAuthors">Yogev-Falach, Merav; Bar-Am, Orit; Amit, Tamar; Weinreb, Orly; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2177-2179</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of the bifunctional drug ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5-yl)-Et Me carbamate].  Ladostigil combines the neuroprotective effects of the antiparkinson drug rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine in a single mol., as a potential treatment for Alzheimer's disease (AD) and Lewy Body disease.  Here, we assessed the dual effects of lodostigil in terms of the mol. mechanism of neuroprotection and amyloid precursor protein (APP) regulation/processing by using an apoptotic model of neuroblastoma SK-N-SH cells.  Ladostigil dose-dependently decreased cell death via inhibition of the cleavage and prevention of caspase-3 activation (IC50=1.05 μM) through a mechanism related to regulation of the Bcl-2 family proteins, which resulted in reduced levels of Bad and Bax and induced levels of Bcl-2 gene and protein expression.  We have also followed APP regulation/processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP protein without altering APP mRNA levels, suggesting a posttranscriptional mechanism.  In addn., the drug-elevated phosphorylated protein kinase C (pPKC) levels and stimulated the release of the nonamyloidogenic ot-secretase proteolytic pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor but lacks MAO inhibitory activity, exerted neuroprotective properties and regulated APP processing, indicating that these effects are independent of MAO inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEeVwmkmV5FrVg90H21EOLACvtfcHk0lhUJFjFZ2X-WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ&md5=98af5388c49c4d1a4cf7b56752367fc6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1096%2Ffj.05-4910fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.05-4910fje%26sid%3Dliteratum%253Aachs%26aulast%3DYogev-Falach%26aufirst%3DM.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DA%2520multifunctional%252C%2520neuroprotective%2520drug%252C%2520ladostigil%2520%2528TV3326%2529%252C%2520regulates%2520holo-APP%2520translation%2520and%2520processing%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D2177%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1023%2FA%3A1015131516649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=555-573&author=M.+B.+Youdimauthor=M.+Weinstock&title=Molecular+basis+of+neuroprotective+activities+of+rasagiline+and+the+anti-Alzheimer+drug+TV3326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]</span></div><div class="casAuthors">Youdim, Moussa B. H.; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-573</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review.  Rasagiline (N-propargyl-1-(R)-aminoindan) is a selective, irreversible monoamine oxidase B (MAO B) inhibitor which has been developed as an anti-Parkinson drug.  In controlled monotherapy and as adjunct to L-dopa it has shown anti-Parkinson activity.  In cell culture (PC-12 and neuroblastoma SH-SY5Y cells) it exhibits neuroprotective and antiapoptotic activity against several neurotoxins (SIN-1, MPTP, 6-hydroxydopamine and N-methyl-(R)-salsolinol) and ischemia.  In vivo, it reduces the sequelae of traumatic brain injury in mice and speeds their recovery.  The neuroprotective activity of rasagaline does not result from MAO B inhibition, since its S-enantiomer, TVP1022, which has 1000-fold weaker MAO inhibitory activity, exhibits similar neuroprotective properties.  Introduction of a carbamate moiety into the rasagiline mol. to confer cholinesterase inhibitory activity for the treatment of Alzheimer's disease, resulted in compds. TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Et Me Carbamate] and its S-enantiomer TV3279 [(N-Propargyl-(3S)Aminoindan-5-YL)-Et Me Carbamate], which retain the neuroprotective activities of rasagiline and TVP1.022.  They also antagonize scopolamine-induced impairments in spatial memory.  In addn., TV3326 exhibits brain-selective MAO A and B inhibitory activity after chronic administration and has antidepressant-like activity in the forced swim test.  This is assocd. with an increase in brain levels of serotonin.  The antiapoptotic activity of these propargylamine-contg. derivs. may be related to their ability to delay the opening of voltage-dependent anion channels (VDAC), which are part of the mitochondrial permeability transition pore.  The propargylarnine moiety is responsible for the increase in the mitochondrial family of Bcl-2 proteins, prevention in the fall in mitochondrial membrane potential, prevention of the activation of caspase 3, and of translocation of glycerlatdehyde-3-phosphate dehydrogenase from the cytoplasm to the nucleus.  The latter processes are closely assocd. with neurotoxin-induced apoptosis.  Rasagiline interacts with and prevents the binding of PK11195 to the pro-apoptotic peripheral benzodiazepine receptor, which together with Bcl-2, hexokinase, porin, and adenine nucleotide translocator constitutes part of the VDAC.  Furthermore, rasagiline, TV3326 and TV3279 are able to influence the processing of amyloid precursor protein by activation of alpha-secretase and increasing the release of sol. alpha APP in rat PC-12 and human neuroblastoma SH-SY5Y cells and in rat and mice cortex and hippocampus.  This process has been shown to involve the upregulation of PKC and MAP kinase.  It is quite likely that the induction of Bcl-2 and activation of PKC by rasagiline and TV3326 is closely linked to the anti-apoptotic action of these drugs and their ability to process APP by activation of alpha-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLWVipqroE7Vg90H21EOLACvtfcHk0lhUJFjFZ2X-WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D&md5=6069320591cce7df19a0f29f91cf6911</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015131516649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015131516649%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DMolecular%2520basis%2520of%2520neuroprotective%2520activities%2520of%2520rasagiline%2520and%2520the%2520anti-Alzheimer%2520drug%2520TV3326%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2002%26volume%3D21%26spage%3D555%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=B.+J.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lj13AGGogN93Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DB.%2BJ.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraiz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span> </span><span class="NLM_article-title">Inhibitory effects of <i>cis</i>- and <i>trans</i>-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2006&pages=688-695&author=M.+Y%C3%A1%C3%B1ezauthor=N.+Fraizauthor=E.+Canoauthor=F.+Orallo&title=Inhibitory+effects+of+cis-+and+trans-resveratrol+on+noradrenaline+and+5-hydroxytryptamine+uptake+and+on+monoamine+oxidase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DFraiz%26aufirst%3DN.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DInhibitory%2520effects%2520of%2520cis-%2520and%2520trans-resveratrol%2520on%2520noradrenaline%2520and%25205-hydroxytryptamine%2520uptake%2520and%2520on%2520monoamine%2520oxidase%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D344%26spage%3D688%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">Reevaluation of reference inhibitors has been carried out under different conditions (enzymatic source and concentrations, measurement method) than our previous study (refs <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">29</a> and <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>, cited herein) but finding similar qualitative inhibition and selectivity for all compounds tested. Because IC<sub>50</sub> values depends directly on enzyme and substrate concentrations, normal quantitative discrepancies were achieved.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26pub%3DWiley-Interscience%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Youdim, B. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The therapeutic potential of monoamine oxidase inhibitors</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fnrn1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=16552415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=295-309&author=B.+H.+M.+Youdimauthor=D.+Edmondsonauthor=K.+F.+Tipton&title=The+therapeutic+potential+of+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of monoamine oxidase inhibitors</span></div><div class="casAuthors">Youdim, Moussa B. H.; Edmondson, Dale; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such.  It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity.  However, many claims and some counter-claims have been made about the physiol. importance of these enzymes and the potential of their inhibitors.  We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3A0wRL6nnL7Vg90H21EOLACvtfcHk0lj13AGGogN93Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D&md5=b35546920d95fa031ff2f884949372a7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrn1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1883%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DB.%2BH.%2BM.%26aulast%3DEdmondson%26aufirst%3DD.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Palhagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinonen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagglund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaugesaar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki-Ikola, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palm, R.</span><span> </span><span class="NLM_article-title">Selegiline slows the progression of the symptoms of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1200-1206&author=S.+Palhagenauthor=E.+Heinonenauthor=J.+Hagglundauthor=T.+Kaugesaarauthor=O.+Maki-Ikolaauthor=R.+Palm&title=Selegiline+slows+the+progression+of+the+symptoms+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalhagen%26aufirst%3DS.%26aulast%3DHeinonen%26aufirst%3DE.%26aulast%3DHagglund%26aufirst%3DJ.%26aulast%3DKaugesaar%26aufirst%3DT.%26aulast%3DMaki-Ikola%26aufirst%3DO.%26aulast%3DPalm%26aufirst%3DR.%26atitle%3DSelegiline%2520slows%2520the%2520progression%2520of%2520the%2520symptoms%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D1200%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lairez, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calise, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordener, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreux-Varoquaux, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbeau-Frugier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escourrou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seif, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncalli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzinat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mialet-Pérez, J.</span><span> </span><span class="NLM_article-title">Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload</span> <span class="citation_source-journal">J. Mol. Cell Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2Fj.yjmcc.2008.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=19162038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVenu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2009&pages=587-95&author=O.+Lairezauthor=D.+Caliseauthor=P.+Bianchiauthor=C.+Ordenerauthor=O.+Spreux-Varoquauxauthor=C.+Guilbeau-Frugierauthor=G.+Escourrouauthor=I.+Seifauthor=J.+Roncalliauthor=N.+Pizzinatauthor=M.+Galinierauthor=A.+Pariniauthor=J.+Mialet-P%C3%A9rez&title=Genetic+deletion+of+MAO-A+promotes+serotonin-dependent+ventricular+hypertrophy+by+pressure+overload"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload</span></div><div class="casAuthors">Lairez, Olivier; Calise, Denis; Bianchi, Pascale; Ordener, Catherine; Spreux-Varoquaux, Odile; Guilbeau-Frugier, Celine; Escourrou, Ghislaine; Seif, Isabelle; Roncalli, Jerome; Pizzinat, Nathalie; Galinier, Michel; Parini, Angelo; Mialet-Perez, Jeanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">587-595</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The potential role of serotonin (5-HT) in cardiac function has generated much interest in recent years.  In particular, the need for a tight regulation of 5-HT to maintain normal cardiovascular activity has been demonstrated in different exptl. models.  However, it remains unclear how increased levels of 5-HT could contribute to the development of cardiac hypertrophy.  Availability of 5-HT depends on the mitochondrial enzyme monoamine oxidase A (MAO-A).  Therefore, we investigated the consequences of MAO-A deletion on ventricular remodeling in the model of aortic banding in mice.  At baseline, MAO-A deletion was assocd. with an increase in whole blood 5-HT (39.4 ± 1.9 μM vs. 24.0 ± 0.9 μM in KO and WT mice, resp.).  Cardiac 5-HT2A, but not 5-HT2B receptors were overexpressed in MAO-A KO mice, as demonstrated by real-time PCR and Western-blot expts.  After aortic banding, MAO-A KO mice demonstrated greater increase in heart wall thickness, heart to body wt. ratios, cardiomyocyte cross-section areas, and myocardial fibrosis compared to WT.  Exacerbation of hypertrophy in KO mice was assocd. with increased amts. of 5-HT in the heart.  In order to det. the role of 5-HT and 5-HT2A receptors in ventricular remodeling in MAO-A KO mice, we administered the 5-HT2A receptor antagonists ketanserin (1 mg/kg/day) or M100907 (0.1 mg/kg/day) during 4 wk of aortic banding.  Chronic administration of these antagonists strongly prevented exacerbation of ventricular hypertrophy in MAO-A KO mice.  These results show for the first time that regulation of peripheral 5-HT by MAO-A plays a role in ventricular remodeling via activation of 5-HT2A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ7tr-XWyH5bVg90H21EOLACvtfcHk0lj13AGGogN93Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVenu70%253D&md5=73094fae33c2a704eb17c522d27d09e0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2008.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2008.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DLairez%26aufirst%3DO.%26aulast%3DCalise%26aufirst%3DD.%26aulast%3DBianchi%26aufirst%3DP.%26aulast%3DOrdener%26aufirst%3DC.%26aulast%3DSpreux-Varoquaux%26aufirst%3DO.%26aulast%3DGuilbeau-Frugier%26aufirst%3DC.%26aulast%3DEscourrou%26aufirst%3DG.%26aulast%3DSeif%26aufirst%3DI.%26aulast%3DRoncalli%26aufirst%3DJ.%26aulast%3DPizzinat%26aufirst%3DN.%26aulast%3DGalinier%26aufirst%3DM.%26aulast%3DParini%26aufirst%3DA.%26aulast%3DMialet-P%25C3%25A9rez%26aufirst%3DJ.%26atitle%3DGenetic%2520deletion%2520of%2520MAO-A%2520promotes%2520serotonin-dependent%2520ventricular%2520hypertrophy%2520by%2520pressure%2520overload%26jtitle%3DJ.%2520Mol.%2520Cell%2520Cardiol.%26date%3D2009%26volume%3D46%26spage%3D587%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Di Lisa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaludercic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menabo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giogio, M.</span><span> </span><span class="NLM_article-title">Mitochondrial pathways for ROS formation and myocardial injury: The relevance of p66She and monoamine oxidase</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1007%2Fs00395-009-0008-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=19242637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVSis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=131-139&author=F.+Di+Lisaauthor=N.+Kaludercicauthor=A.+Carpiauthor=R.+Menaboauthor=M.+Giogio&title=Mitochondrial+pathways+for+ROS+formation+and+myocardial+injury%3A+The+relevance+of+p66She+and+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66Shc and monoamine oxidase</span></div><div class="casAuthors">Di Lisa, Fabio; Kaludercic, Nina; Carpi, Andrea; Menabo, Roberta; Giorgio, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">A review.  Although mitochondria are considered the most relevant site for the formation of reactive oxygen species (ROS) in cardiac myocytes, a major and unsolved issue is where ROS are generated in mitochondria.  Respiratory chain is generally indicated as a main site for ROS formation.  However, other mitochondrial components are likely to contribute to ROS generation.  Recent reports highlight the relevance of monoamine oxidases (MAO) and p66Shc.  The importance of these systems in the irreversibility of ischemic heart injury will be discussed along with the cardioprotective effects elicited by both MAO inhibition and p66Shc knockout.  Finally, recent evidence will be reviewed that highlight the relevance of mitochondrial ROS formation also in myocardial failure and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNAiKfgbSe9LVg90H21EOLACvtfcHk0lj2u_CtS_xWWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVSis7k%253D&md5=4003f9329d680b8787fb383c3ed9ea0b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00395-009-0008-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-009-0008-4%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DCarpi%26aufirst%3DA.%26aulast%3DMenabo%26aufirst%3DR.%26aulast%3DGiogio%26aufirst%3DM.%26atitle%3DMitochondrial%2520pathways%2520for%2520ROS%2520formation%2520and%2520myocardial%2520injury%253A%2520The%2520relevance%2520of%2520p66She%2520and%2520monoamine%2520oxidase%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2009%26volume%3D104%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.2174%2F13816128113190990406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=23701542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=155-160&author=D.+E.+Edmondson&title=Hydrogen+peroxide+produced+by+mitochondrial+monoamine+oxidase+catalysis%3A+biological+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications</span></div><div class="casAuthors">Edmondson, Dale E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The biol. roles of mitochondrial-produced reactive oxygen species continue to receive intensive investigation since one of the products (H2O2) has important cellular signaling roles as well as contributing to apoptotic responses.  In general, the source of mitochondrial reactive oxygen species is thought to be the superoxide anion produced from Complex I and Complex III components of the electron transport chain.  Superoxide anion readily dismutates to H2O2 with subsequent transformation to the hydroxyl radical by Fenton chem.  An overlooked source of H2O2 in the mitochondrion is its prodn. as a catalytic reaction product from the outer membrane enzymes: monoamine oxidases A and B.  The literature is reviewed to document identified degenerative reactions attributed to H2O2 produced by MAO A and by MAO B catalysis.  Available information on the topologies of these enzymes in the mitochondrial outer membrane is also discussed with relevance to H2O2 prodn. and involvement in cell signaling functions as well as degenerative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHat4RJctm7Vg90H21EOLACvtfcHk0lj2u_CtS_xWWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D&md5=75d670b395b063ff5c876121a7d6dd0b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F13816128113190990406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128113190990406%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DHydrogen%2520peroxide%2520produced%2520by%2520mitochondrial%2520monoamine%2520oxidase%2520catalysis%253A%2520biological%2520implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D155%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Finberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loboda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1038%2Fsj.bjp.0706908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=17016505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=647-656&author=J.+P.+Finbergauthor=A.+Grossauthor=O.+Bar-Amauthor=R.+Friedmanauthor=Y.+Lobodaauthor=M.+B.+Youdim&title=Cardiovascular+responses+to+combined+treatment+with+selective+monoamine+oxidase+type+B+inhibitors+and+L-DOPA+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat</span></div><div class="casAuthors">Finberg, J. P. M.; Gross, A.; Bar-Am, O.; Friedman, R.; Loboda, Y.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Postural hypotension is a common side-effect of L-DOPA treatment of Parkinson's disease, and may be potentiated when L-DOPA is combined with selegiline, a selective inhibitor of monoamine oxidase B (MAO-B).  Rasagiline is a new, potent and selective MAO-B inhibitor, which does not possess the sympathomimetic effects of selegiline.  The authors have studied the effects of these selective MAO inhibitors, L-DOPA and dopamine on the cardiovascular system of the rat.  Blood pressure and heart rate was measured in conscious rats following acute or chronic administration of rasagiline, selegiline and L-DOPA, by comparison with the selective MAO-A inhibitor clorgyline, or the MAO-A/B inhibitor tranylcypromine.  Cardiovascular responses, catecholamine release, and modification of pressor response to dopamine were studied in pithed rats.  In conscious rats neither rasagiline nor selegiline caused significant potentiation of the effects of L-DOPA (50, 100, 150 mg/kg) on blood pressure or heart rate at doses which selectively inhibited MAO-B, but L-DOPA responses were potentiated by clorgyline and tranylcypromine.  In rats treated twice daily for 8 days with L-DOPA and carbidopa, selegiline (5 mg/kg) but not rasagiline (0.2 mg/kg) caused a significant hypotensive response to L-DOPA and carbidopa, although both drugs caused similar inhibition of MAO-A and MAO-B.  In pithed rats, selegiline but not rasagiline increased catecholamine release and heart rate, and potentiated dopamine pressor response at MAO-B selective dose.  The different responses to the two MAO-B inhibitors may be explained by the amine releasing effect of amphetamine metabolites formed from selegiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltdSrkYUF2LVg90H21EOLACvtfcHk0lj2u_CtS_xWWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbrM&md5=cb6df4252517715f16e86a6efb46ebba</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706908%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DLoboda%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DCardiovascular%2520responses%2520to%2520combined%2520treatment%2520with%2520selective%2520monoamine%2520oxidase%2520type%2520B%2520inhibitors%2520and%2520L-DOPA%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D647%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Finberg, J. P.; Gillman, P. K.</span><span> </span><span class="NLM_article-title">Selective inhibitors of monoamine oxidase Type B and the “cheese effect”</span>. In  <span class="citation_source-book">International Review of Neurobiology</span>; <span class="NLM_contrib-group">Youdim, M. B.; Riederer, P.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Burlington</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">100</span>, pp  <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1016%2FB978-0-12-386467-3.00009-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=169-190&author=J.+P.+Finberg&author=P.+K.+Gillmanauthor=M.+B.+Youdim&author=P.+Riederer&title=International+Review+of+Neurobiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-386467-3.00009-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-386467-3.00009-1%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26atitle%3DSelective%2520inhibitors%2520of%2520monoamine%2520oxidase%2520Type%2520B%2520and%2520the%2520%25E2%2580%259Ccheese%2520effect%25E2%2580%259D%26btitle%3DInternational%2520Review%2520of%2520Neurobiology%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26pub%3DAcademic%2520Press%26date%3D2011%26volume%3D100%26spage%3D169%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorodetsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=999-1005&author=M.+Weinstockauthor=E.+Gorodetskyauthor=R.+H.+Wangauthor=A.+Grossauthor=O.+Weinrebauthor=M.+B.+Youdim&title=Limited+potentiation+of+blood+pressure+response+to+oral+tyramine+by+brain-selective+monoamine+oxidase+A-B+inhibitor%2C+TV-3326+in+conscious+rabbits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DGorodetsky%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DR.%2BH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DLimited%2520potentiation%2520of%2520blood%2520pressure%2520response%2520to%2520oral%2520tyramine%2520by%2520brain-selective%2520monoamine%2520oxidase%2520A-B%2520inhibitor%252C%2520TV-3326%2520in%2520conscious%2520rabbits%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D999%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1096%2Ffj.05-4910fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=16935943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2177-2179&author=M.+Yogev-Falachauthor=O.+Bar-Amauthor=T.+Amitauthor=O.+Weinrebauthor=M.+B.+H.+Youdim&title=A+multifunctional%2C+neuroprotective+drug%2C+ladostigil+%28TV3326%29%2C+regulates+holo-APP+translation+and+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing</span></div><div class="casAuthors">Yogev-Falach, Merav; Bar-Am, Orit; Amit, Tamar; Weinreb, Orly; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2177-2179</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of the bifunctional drug ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5-yl)-Et Me carbamate].  Ladostigil combines the neuroprotective effects of the antiparkinson drug rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine in a single mol., as a potential treatment for Alzheimer's disease (AD) and Lewy Body disease.  Here, we assessed the dual effects of lodostigil in terms of the mol. mechanism of neuroprotection and amyloid precursor protein (APP) regulation/processing by using an apoptotic model of neuroblastoma SK-N-SH cells.  Ladostigil dose-dependently decreased cell death via inhibition of the cleavage and prevention of caspase-3 activation (IC50=1.05 μM) through a mechanism related to regulation of the Bcl-2 family proteins, which resulted in reduced levels of Bad and Bax and induced levels of Bcl-2 gene and protein expression.  We have also followed APP regulation/processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP protein without altering APP mRNA levels, suggesting a posttranscriptional mechanism.  In addn., the drug-elevated phosphorylated protein kinase C (pPKC) levels and stimulated the release of the nonamyloidogenic ot-secretase proteolytic pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor but lacks MAO inhibitory activity, exerted neuroprotective properties and regulated APP processing, indicating that these effects are independent of MAO inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEeVwmkmV5FrVg90H21EOLACvtfcHk0liVLuWQGf-KAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyrurvJ&md5=98af5388c49c4d1a4cf7b56752367fc6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1096%2Ffj.05-4910fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.05-4910fje%26sid%3Dliteratum%253Aachs%26aulast%3DYogev-Falach%26aufirst%3DM.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DA%2520multifunctional%252C%2520neuroprotective%2520drug%252C%2520ladostigil%2520%2528TV3326%2529%252C%2520regulates%2520holo-APP%2520translation%2520and%2520processing%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D2177%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2117</span><span class="NLM_x">–</span> <span class="NLM_lpage">2123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1007%2Fs11064-010-0293-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm501501a&amp;key=20981484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm501501a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2117-2123&author=H.+Zhengauthor=M.+Fridkinauthor=M.+B.+H.+Youdim&title=Site-activated+chelators+derived+from+anti-Parkinson+drug+rasagiline+as+a+potential+safer+and+more+effective+approach+to+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Activated Chelators Derived from Anti-Parkinson Drug Rasagiline as a Potential Safer and More Effective Approach to the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Zheng, Hailin; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2117-2123</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Chelators can modulate β-amyloid accumulation, protect against tau hyperphosphorylation, and block metal-related oxidative stress, and thereby hold considerable promise as effective anti-AD drugs.  At present, a growing interest is focusing on increasing the efficacy and targeting of chelators through drug design.  To this end, we have developed a new class of multifunctional prochelators from three FDA- approved drugs rasagiline, rivastigmine, and donepezil or tacrine.  HLA20 A was designed by merging the important pharmacophores of rasagiline, rivastigmine, and donepezil into our newly developed multifunctional chelator HLA20.  M30D was constructed using the key pharmacophoric moieties from rasagiline, rivastigmine, and tacrine.  Expts. showed that both compds. possess potent anti-acetylcholinesterase (AChE) activity in vitro with weak inhibition of butyrylcholinesterase (BuChE), and without significant metal-binding activity.  M30D was found also to be a highly potent MAO A inhibitor with moderate inhibition of MAO B in vitro.  Both HLA20 and M30D can be activated by inhibition of AChE to release active chelators HLA20 and M30, resp.  HLA20 and M30 have been shown to be able to modulate amyloid precursor protein regulation and beta-amyloid redn., suppress oxidative stress, and passivate excess metal ions (Fe, Cu, and Zn).  Compared with the activated chelator HLA20 or M30, both HLA20A and M30D exhibited lower cytotoxicity in SH-SY5Y neuroblastoma cells, substantiating the prochelator strategy for minimizing toxicity assocd. with poor targeted chelators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRLPYQHRVwWrVg90H21EOLACvtfcHk0liVLuWQGf-KAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtrbP&md5=2198fbf602fc18106e8216e4b46c1387</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs11064-010-0293-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-010-0293-1%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DSite-activated%2520chelators%2520derived%2520from%2520anti-Parkinson%2520drug%2520rasagiline%2520as%2520a%2520potential%2520safer%2520and%2520more%2520effective%2520approach%2520to%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26spage%3D2117%26epage%3D2123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández-Ledesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, B.</span><span> </span><span class="NLM_article-title">Novel tacrine–melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=B.+Hern%C3%A1ndez-Ledesmaauthor=B.+Bartolom%C3%A9&title=Novel+tacrine%E2%80%93melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DHern%25C3%25A1ndez-Ledesma%26aufirst%3DB.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DNovel%2520tacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New tacrine-4-oxo-4<i>H</i>-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine-4-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+beta-amyloid-reducing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine-4-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520beta-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">López-Iglesias, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso-Gil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New melatonin-<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3773</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5000613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3773-3785&author=B.+L%C3%B3pez-Iglesiasauthor=C.+P%C3%A9rezauthor=J.+A.+Morales-Garc%C3%ADaauthor=S.+Alonso-Gilauthor=A.+P%C3%A9rez-Castilloauthor=A.+Romeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=S.+Condeauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+melatonin-N%2CN-dibenzyl%28N-methyl%29amine+hybrids%3A+potent+neurogenic+agents+with+antioxidant%2C+cholinergic%2C+and+neuroprotective+properties+as+innovative+drugs+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm5000613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000613%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Iglesias%26aufirst%3DB.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520melatonin-N%252CN-dibenzyl%2528N-methyl%2529amine%2520hybrids%253A%2520potent%2520neurogenic%2520agents%2520with%2520antioxidant%252C%2520cholinergic%252C%2520and%2520neuroprotective%2520properties%2520as%2520innovative%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3773%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassib, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Two diseases, one approach: multitarget drug discovery in Alzheimer’s and neglected tropical diseases</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm501501a&amp;key=10.1039%2Fc4md00069b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=853-861&author=F.+Pratiauthor=E.+Uliassibauthor=M.+L.+Bolognesi&title=Two+diseases%2C+one+approach%3A+multitarget+drug+discovery+in+Alzheimer%E2%80%99s+and+neglected+tropical+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2Fc4md00069b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4md00069b%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DUliassib%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTwo%2520diseases%252C%2520one%2520approach%253A%2520multitarget%2520drug%2520discovery%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520neglected%2520tropical%2520diseases%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D853%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="note"><p class="first last">ADMET and molecular modeling details and results have been reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i11"><a href="/doi/suppl/10.1021/jm501501a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_73804"></div></div></div></div></div><hr /></hr><p class="last">QSAR methods, ADMET analysis and descriptors, the synthesis of the target compounds, the <sup>1</sup>H and <sup>13</sup>C spectra, biological evaluation, molecular modeling, and in vitro blood–brain barrier permeation assay of compound <b>2</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501501a/suppl_file/jm501501a_si_001.pdf">jm501501a_si_001.pdf (11.37 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501501a&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501501a%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501501a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                707KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799323d9a2c3d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
